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Summary
Strict coupling of  energy metabolism and neurotransmission with cellular function and 
cerebral regionalization is mandatory for an adequate operation of  the Central Nervous System. 
Despite decades of  work, the classical neurochemical approaches proved limited in unravelling the 
coupling mechanisms involved in these complex interactions. The combination of  several frontier 
methodologies, including imaging and spectroscopy by Magnetic Resonance methods, is currently 
contemplated as a more powerful alternative.
Intra- and intercellular pyruvate and lactate metabolisms play an important role in the 
metabolic coupling of  neurons and glial cells. However, the directionality of  intra- and intercellular 
monocarboxylate exchange, the role of  neuronal and glial redox states and monocarboxylate 
compartmentation and the relationship of  these variables with neurotransmission, remain crucial 
and insuffi ciently understood aspects. In this thesis, I address the cerebral metabolism of  pyruvate 
and lactate, its intra- and extracellular compartmentation, its relationship to the neuronal and glial 
tricarboxylic acid cycles of  neurons and glial cells, and how all these processes are integrated in 
vivo and in vitro into a functionally operating unit during glutamatergic neurotransmission. To this 
end I combined the classical neurochemical approach, including conventional biochemical assays, 
with more recent developments such as 13C and (13C,2H) Nuclear Magnetic Resonance (NMR) 
techniques. I emphasize how these novel approaches have modifi ed the earlier interpretations of  
neuroglial coupling during glutamatergic neurotransmission.
In chapter 1, I begin with a general description of  brain energy metabolism, including the 
main pathways of  cerebral energetics and the experimental approaches used for these studies. I 
review the vital roles of  pyruvate and lactate in the neuronal and glial cells, providing an updated 
revision of  the cerebral energetics, integrating previous proposals. I address in more detail NMR 
Spectroscopy methods, in order to allow later a better understanding and discussion of  the results 
presented. On these grounds, I show that modern NMR methods acquire vital importance for the 
understanding of  the neuroglial coupling during glutamatergic, GABAergic or even serotoninergic 
neurotransmissions. 
Chapters 2 and 3 present new methodologies to investigate lactate recycling between 
extracellular space and the cytosolic pool of  pyruvate through the monocarboxylate transporters 
of  the plasma membrane and the lactate dehydrogenase isozymes of  C6 glioma cells. In chapter 2, 
two novel 1H NMR approaches are presented to characterize the recycling process, one of  them 
based in a specifi c lactate editing sequence. In chapter 3, a novel (13C,2H) NMR approach was also 
formulated to address alternatively this question. In these experiments, C6 glioma cells were 
incubated in Krebs-Henseleit buffer containing 50% 2H2O and (3-
13C) lactate. Samples of  
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incubation medium were collected at different time points and analyzed by 13C NMR to 
determine the kinetics of  deuteration of  (3-13C) lactate. The use of  13C NMR spectroscopy 
to detect deuteration in the 13C labeled precursor proved to be a powerful technique 
to study hydrogen turnover, providing complementary information to the traditional 
13C NMR methods routinely used to investigate carbon turnover. Additionally, several 
experiments were done with different mixtures of  labeled substrates, demonstrating that 
the deuteration process that allows the study of  this lactate recycling is redox sensitive and that 
glycolysis is a redox controlled process.
Chapter 4 presents our novel hypothesis describing the metabolic coupling between neuronal 
and glial cells in the brain during neurotransmission. The results obtained in the previous chapters 
provide the basis to this new theory, including the presence of  subcellular compartmentation of  
pyruvate and monocarboxylate recycling through the plasma membrane of  both neurons and glial 
cells. We describe the mechanisms underlying this Redox Switch/Redox Coupling hypothesis, 
as well as its kinetic properties, in primary cultures of  cortical neurons and astrocytes from rat 
brain. With these results we delineated a revised interpretation of  the mechanisms underlying 
metabolic coupling, compatible also with the subcellular compartmentation of  monocarboxylates 
and glutamate, as well as with the redox switch and monocarboxylate recycling through the plasma 
membrane. The proposed redox shuttles may couple the activity of  glycolytic and oxidative 
environments, providing a general mechanism of  intra- and intercellular coupling supporting 
universally metabolic heterogeneity in cells.
Gene targeting technology has become recently a valuable tool for the understanding of  
some specifi c neurodegenerative diseases and Magnetic Resonance Spectroscopy is a very 
appropriate technique to characterize these transgenic mice models. Chapter 5 combines 13C NMR 
spectroscopy and gene targeting techniques to investigate glutamatergic neurotransmission and 
glutamate-glutamine cycle in brain extracts of  D1 or D2 dopamine receptors defi cient mice. We 
complemented our experimental design using a pharmacological approach based on reserpine, 
a dopamine depleting drug, and also on L-DOPA, the basis of  the clinical antiparkinsonian 
treatment. Additional behavioural and c-Fos expression tests were used to investigate in more detail 
the dopamine receptor subtype that mediates the communication between both neurotransmission 
systems. Together, our results indicate that the lack of  dopamine or D1 dopamine receptors, but 
not D2 receptors, results in increased glutamatergic activity. Our data reveal that the D1 dopamine 
receptor subtype is the main mediator of  the metabolic interactions between glutamatergic and 
dopaminergic neurotransmissions. 
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Resumo
O adequado funcionamento do Sistema Nervoso Central requer uma integração precisa do 
metabolismo energético e da neurotransmissão entre os diversos tipos celulares involvidos, assim 
como a sua distribuição precisa entre as diferentes regiões cerebrais. Apesar de décadas de trabalho, 
os métodos da neuroquímica clássica provaram ser muito limitadas na clarifi cação dos mecanismos 
de acoplamento envolvidos nestas complexas interacções. A combinação de várias metodologias, 
incluindo métodos de imagem e de espectroscopia por Ressonância Magnética, contempla-se mais 
recentemente como uma alternativa mais robusta.
O metabolismo do piruvato e do lactato intra- e extracelular tem um papel importante no 
acoplamento metabólico de neurónios e células gliais. No entanto, a direccionalidade dos 
intercâmbios intra- e intercelular de monocarboxilatos, o papel dos estados redox neuronais e gliais 
e a compartimentação intracelular dos monocarboxilatos, assim como a relação destas variáveis 
com a neurotransmissão continuam ainda a ser aspectos insufi cientemente compreendidos. Nesta 
tese, pretende-se avaliar o metabolismo do piruvato e do lactato, a sua compartimentação intra- 
e extracelular, a sua relação aos ciclos dos ácidos tricarboxílicos neuronais e gliais, bem como 
a interligação desta rede de processos numa unidade funcional durante a neurotransmissão 
glutamatérgica, tanto in vivo como in vivo. Com vista a alcançar este objectivo, combinam-se 
abordagens da neuroquímica clássica, como os ensaios enzimáticos convencionais, com os 
mais recentes avanços tecnológicos, como sejam as técnicas de Ressonância Magnética Nuclear 
(RMN) de 13C e de (13C,2H). Neste trabalho destaca-se como estas novas abordagens modifi cam as 
interpretações tradicionais do acoplamento neuroglial durante a neurotransmissão glutamatérgica.
No capítulo 1, inicia-se com uma descrição geral do metabolismo energético cerebral, 
descrevendo as principais vias metabólicas da energética cerebral e as abordagens experimentais 
utilizadas nestes estudos. Em concreto, resumem-se os papéis fundamentais do piruvato e do 
lactato nas células neuronais e gliais, apresentando-se uma actualizada revisão do funcionamento da 
energética cerebral, integrando as propostas apresentadas anteriormente. Foi dado especial ênfase 
na explicação da Espectroscopia por RMN, com o objectivo de possibilitar ao leitor uma adequada 
compreensão e discussão dos resultados apresentados. Neste contexto, os métodos modernos de 
RMN adquirem uma importância fulcral para a compreensão do acoplamento neuroglial durante 
as neurotransmissões glutamatérgica,  GABAérgica, e mesmo serotoninérgica. 
Os capítulos 2 e 3 apresentam novas metodologias para estudar a reciclagem de monocarboxilatos 
entre o espaço extracelular e o citosólico, através dos transportadores de monocarboxilatos da 
membrana plasmática e da lactato desidrogenase de células de glioma C6. O capítulo 2 descreve 
duas novas abordagens de RMN de 1H para caracterizar este processo de reciclagem, sendo uma 
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delas baseada numa sequência específi ca de edição de RMN de 1H para lactato. Por outro lado, 
no capítulo 3 desenvolveu-se também uma nova técnica de RMN de (13C,2H), com o intuito de 
resolver, de forma alternativa, esta questão. Para este fi m, incubaram-se células de glioma C6 em 
tampão Krebs-Henseleit, contendo 50% 2H2O e (3-
13C) lactato. Recolheram-se, a diferentes 
tempos de incubação, amostras do meio, analisando-se por RMN de 13C, com o objectivo 
de determinar a cinética de deuteração de (3-13C) lactato. A utilização da Espectroscopia 
de RMN de 13C para detectar deuteração nos precursores marcados com 13C demonstrou 
ser uma técnica muito robusta para o estudo dos intercâmbios de hidrogénio, fornecendo 
informação complementar à RMN de 13C tradicional, utilizada de forma rotineira para 
elucidar os intercâmbios de carbono. Adicionalmente, várias experiências foram realizadas 
com diferentes combinações de compostos marcados, demonstrando-se que o processo 
de deuteração que permite o estudo da reciclagem de lactato é sensível às condições 
redox, e que a glicólise é também um processo modulado pelo estado redox.
O capítulo 4 inclui a nossa nova hipótese de acoplamento metabólico entre as células 
neuronais e gliais no cérebro. Os resultados obtidos nos capítulos prévios proporcionam a 
base para esta nova interpretação, que inclui a presença da compartimentação  sub-celular 
do piruvato e da reciclagem de monocarboxilatos através da membrana plasmática, tanto 
de neurónios como de células gliais. Descrevem-se também os mecanismos que estão na 
base da hipótese Interruptor Redox/Acoplamento Redox, assim como as suas propriedades 
cinéticas, em culturas primárias de neurónios corticais e de astrócitos de cérebro de 
rato. Com estes resultados, pudemos construir uma interpretação revista do acoplamento 
metabólico, sendo compatível com a compartimentação sub-celular de piruvato, lactato e 
glutamato, com o interruptor redox e com a reciclagem de monocarboxilatos através da 
membrana plasmática. Por fim, os shuttles redox propostos podem acoplar a actividade dos 
ambientes oxidativos e glicolíticos, fornecendo um mecanismo geral para o acoplamento 
intra- e intercelular que sustentam a heterogeneidade metabólica nas células.
A tecnologia associada à manipulação de genes tem-se tornado recentemente uma valiosa 
ferramenta para a compreensão de algumas doenças neurodegenerativas específi cas, sendo a 
Espectroscopia por RMN uma das técnicas mais apropriadas para a caracterização fenotípica destes 
modelos de ratos transgénicos. O capítulo 5 combina a Espectroscopia por RMN de 13C e as 
técnicas associadas à manipulação de genes para investigar a neurotransmissão glutamatérgica e o 
ciclo glutamina-glutamato, em extractos cerebrais de ratos defi cientes nos receptores dopamina D1 
ou D2. Complementamos o nosso protocolo experimental usando uma abordagem farmacológica 
baseada na administração de reserpina, um fármaco que reduz a quantidade disponível de dopamina, 
e de L-DOPA, que constitui a base de tratamentos clínicos anti-parkinsonianos. Ampliamos a nossa 
abordagem com testes de comportamento e de expressão de c-Fos adicionais para caracterizar com 
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maior profundidade o sub-tipo de receptores de dopamina que medeia a comunicação entre ambos 
sistemas de neurotransmissão. Os nossos resultados indicam que a falta de dopamina ou a ausência 
de receptores D1 (mas não de receptores D2) produz um aumento na actividade glutamatérgica. 
Estes resultados associam claramente o receptor D1 da dopamina na regulação das interacções 
metabólicas entre as neurotrasmissões glutamatérgica e dopaminérgica.
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Sumario
El funcionamiento adecuado del Sistema Nervioso Central requiere una integración precisa del 
metabolismo energético y de la neurotransmisión entre los diversos tipos celulares involucrados, así 
como su distribución precisa entre las diferentes regiones cerebrales. A pesar del trabajo realizado 
durante décadas, los métodos de neuroquímica clásica resultan muy limitados en la clarifi cación de 
los mecanismos de acoplamiento involucrados en estas complejas interacciones. La combinación 
de varias metodologías, incluyendo métodos de imagen y de espectroscopia por Resonancia 
Magnética, se contempla más recientemente como una alternativa más robusta.
El metabolismo del piruvato y del lactato intra- y extracelular adquiere un papel importante en 
el acoplamiento metabólico de neuronas y de células gliales. Sin embrago, la direccionalidad de los 
intercambios intra- e intercelular de monocarboxilatos, el papel de los estados redox neuronales 
y gliales y la compartimentación de los monocarboxilatos, así como la relación de estas variables 
con la neurotransmisión permanecen aún como aspectos insufi cientemente comprendidos. En 
esta tesis proponemos evaluar el funcionamiento del metabolismo de piruvato y de lactato, su 
compartimentación intra- y extracelular, su relación con los ciclos de los ácidos tricarboxílicos 
neuronales y gliales, y entender como se integran todos estos procesos en una unidad funcional 
durante la neurotransmisión glutamatérgica in vivo e in vitro. Para alcanzar este objetivo, hemos 
combinado abordajes de la neuroquímica clásica, como los ensayos enzimáticos convencionales, 
con los más recientes avances, como son las técnicas de Resonancia Magnética Nuclear (RMN) 
de 13C y de (13C,2H). En este trabajo, destacamos como estos nuevos abordajes han modifi cado 
las interpretaciones tradicionales del acoplamiento neuroglial durante la neurotransmisión 
glutamatérgica.
En el capítulo 1, se presenta una descripción general del metabolismo energético cerebral, 
describiendo las principales rutas metabólicas de la energética cerebral y las técnicas experimentales 
utilizadas en estos estudios. En particular, se resúmen las funciones fundamentales del piruvato y del 
lactato en las células neuronales y gliales, presentándose una revisión actualizada del funcionamiento 
de la energética cerebral, integrando las propuestas presentadas con anterioridad. Se ha concedido 
un énfasis especial a la explicación de la Espectroscopia por RMN, con el objetivo de hacer posible 
al lector una adecuada comprensión y discusión de los resultados presentados. En este contexto, 
los modernos métodos de RMN adquieren una importancia central para la comprensión del 
acoplamiento neuroglial durante las neurotransmisiones glutamatérgica, GABAérgica, e incluso 
serotoninérgica.
Los capítulos 2 y 3 presentan nuevas metodologías para estudiar el reciclaje de 
monocarboxilatos entre el espacio extracelular y el citosólico, a través de los transportadores de 
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monocarboxilatos de la membrana plasmática y de lactato deshidrogenasa en células de glioma 
C6. El capitulo 2 describe dos nuevos abordajes de RMN de 1H para caracterizar este proceso de 
reciclaje, uno de ellos basado en una secuencia específi ca de edición de RMN de 1H para lactato. 
Por otro lado, en el capítulo 3, desarrolla una nueva técnica de RMN de (13C,2H) con el objetivo 
de resolver, de forma alternativa, esta cuestión. Con este fi n, se incubaron células de glioma C6 en 
tampón Krebs-Henseleit, conteniendo 50% 2H2O y (3-
13C) lactato. A diferentes tiempos 
de incubación, se recogieron muestras del medio, y se analizaron por RMN de 13C, con 
objetivo de determinar la cinética de deuteración de (3-13C) lactato. La utilización de la 
Espectroscopia de RMN de 13C para detectar deuteración en los precursores marcados 
con 13C ha demostrado ser una técnica muy robusta para el estudio de los intercambios de 
hidrogeno, proporcionando información complementaria a la RMN de 13C tradicional, que 
se utiliza de forma rutinaria para dilucidar los intercambios de carbono. Adicionalmente, 
se realizaron varios experimentos con diferentes combinaciones de compuestos marcados, 
demostrando que el proceso de deuteración que permite el estudio del reciclaje de lactato 
es sensible al estado redox, y que la glucólisis es también un proceso modulado por el 
estado redox.
El capítulo 4 incluye nuestra nueva hipótesis de acoplamiento metabólico entre 
las células neuronales y gliales en el cerebro. Los resultados obtenidos en los capítulos 
previos proporcionan la base para esta nueva interpretación, que incluye la presencia de la 
compartimentación subcelular de piruvato y del reciclaje de monocarboxilatos a través de 
la membrana plasmática, tanto de neuronas como de células gliales. Se describen también 
los mecanismos que constituyen la base de la hipótesis Interruptor Redox/Acoplamiento 
Redox, así como sus propiedades cinéticas en cultivos primarios de neuronas corticales y de 
astrocitos de cerebro de rata. Con estos resultados, pudimos construir una interpretación 
revisada del acoplamiento metabólico neuroglial, compatible con la compartimentación 
subcelular de piruvato, lactato y glutamato, con el interruptor redox y con el reciclaje 
de monocarboxilatos a través de la membrana plasmática. Finalmente, las lanzaderas 
redox propuestas pueden acoplar la actividad de los ambientes oxidativos y glucolíticos, 
ofreciendo un mecanismo general para el acoplamiento intra- e intercelular que sustenta 
la heterogeneidad metabólica en las células.
La tecnología asociada a la manipulación de genes se ha convertido recientemente en una 
valiosa herramienta para la comprensión de algunas enfermedades neurodegenerativas específi cas, 
siendo la Espectroscopia por RMN una de las técnicas más apropiadas para la caracterización 
fenotípica de estos modelos de ratones transgénicos. El capítulo 5 combina la Espectroscopia por 
RMN de 13C y las técnicas asociadas a la manipulación de genes para investigar la neurotransmisión 
glutamatérgica y el ciclo glutamina-glutamato en extractos cerebrales de ratones con defi ciencias en 
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los receptores dopamina D1 o D2. Complementamos nuestro protocolo experimental utilizando un 
abordaje farmacológico basado en la administración de reserpina, un fármaco que reduce la cantidad 
disponible de dopamina, y de L-DOPA, que proporciona la base de tratamientos clínicos anti-
parkinsonianos. Hemos ampliado este abordaje con estudios de comportamiento y de expresión de 
c-Fos adicionales para caracterizar con mayor profundidad el subtipo de receptores de dopamina 
que median la comunicación entre ambos sistemas de neurotransmisión. Nuestros resultados 
indican que la falta de dopamina o la ausencia de receptores D1 (pero no de receptores D2) produce 
un aumento en la actividad glutamatérgica. Estos resultados asocian claramente el receptor D1 
de la dopamina con la regulación de las interacciones metabólicas entre las neurotransmisiones 
glutamatérgica e dopaminérgica.
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1.  General Introduction
The brain is metabolically the most active organ of  the economy. Adequate cerebral physiology 
depends on the continuous supply of  suffi cient amounts of  glucose and oxygen from the blood. 
Consequently, limitations in the delivery of  these two vital substrates cause most physiopathological 
responses. Briefl y, an adult human brain of  1400 g consumes approximately 55 mg of  glucose.min-
1 and produces 110 mg of  pyruvate.min-1 approximately. Oxidation of  these pyruvate molecules 
requires ca. 49 mL of  O2.min
-1. This indicates that approximately 20% of  the total oxygen used by 
the adult body is consumed by the brain, an organ accounting for only 2% of  the total body weight 
(Nicholls 2007; Okada and Lipton 2007).
Pyruvate plays a pivotal role in the metabolism of  Central Nervous System (CNS), linking 
the anaerobic and aerobic portions of  glucose catabolism and providing the carbon skeletons that 
couple the vital energy exchange between neurons and astrocytes (Denton and Halestrap 1979; 
Sokoloff  1989; Sokoloff  1992). Pyruvate is known to be an essential nutrient for neural cells in 
culture and has important neuroprotective actions, contributing also the building blocks for many 
anabolic activities in the brain (Desagher et al. 1997; Izumi et al. 1997; Matsumoto et al. 1994). 
Among these functions, pyruvate oxidation entails vital bioenergetic importance for appropriate 
cerebral performance, having a pronounced infl uence on the general physiology of  the individual 
(Dienel 2002). 
The cerebral metabolism of  pyruvate, and that of  its precursor glucose, has been reviewed 
several times. Classical approaches involved the use of  radioactive isotopes or optical methods 
which required the isolation and purifi cation of  the enzymes or transport systems involved to 
investigate their in vitro kinetics (Bachelard 1989; Clark and Lai 1989; Siesjo 1982; Sokoloff  1989). 
This reductionist approach provided fundamental information on the operation of  the CNS, 
despite the limitations brought by the minute amounts of  proteins present in neural tissues and by 
the fact that its use is restricted to cerebral extracts or post mortem biopsies.
The impressive development during the past three decades of  powerful non-invasive tools for 
studying the human brain has had a tremendous impact on our ability to investigate and understand 
brain function. Positron Emission Tomography (PET) with (18F)-2-deoxyglucose (FDG) was the 
fi rst technique used to investigate non invasively cerebral glucose uptake in animals and man with 
moderate resolution (Wienhard 2002). Similarly, functional Magnetic Resonance Imaging (fMRI) 
allowed indirectly the investigation of  the hemodynamic and blood oxygenation changes associated 
with sensory or motor stimulation (Heeger and Ress 2002). Despite their importance, FDG uptake 
or fMRI provide no information on the pathways and metabolic interactions underlying the 
cerebral activation process, implying that further advances in this fi eld would necessarily rely on 
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the implementation of  additional methods. 
From this perspective, genome cloning and sequencing techniques, as well as the development 
of  novel 13C Nuclear Magnetic Resonance (NMR) strategies have overcome many of  the limitations 
of  the traditional approaches. In particular, sequencing of  the human and mouse genomes has 
provided a comprehensive view of  the different isoforms of  enzymes and transporters present 
in the brain, without the need to isolate and purify the corresponding proteins (Consortium 
2001; Consortium 2002). However, the genomic methods do not allow the investigation of  the 
function and in vivo performance of  the genes sequenced or cloned. In this respect 13C NMR, and 
more recently (13C,2H) NMR, technologies have become more helpful, providing the quantitative 
assessment of  transport steps, metabolic fl uxes and subcellular compartmentation of  glycolysis, 
pyruvate oxidation and tricarboxylic acid (TCA) cycle in a plethora of  neural systems ranging from 
primary cell cultures to the intact rodent or human brain (Cerdán 2003; Gruetter et al. 2003; Morris 
and Bachelard 2003; Shulman et al. 2004).
Several recent reviews complement and extend the information presented here (De Meirleir 
2002; García-Espinosa et al. 2004; Gruetter 2002; Magistretti and Pellerin 1999; Rodrigues and 
Cerdán 2007; Rothman et al. 2003; Schurr 2002). 
2. Overview of  Pyruvate Metabolism
Figure 1.1 provides a general overview of  pyruvate oxidation in the brain and its interactions 
with other cerebral metabolic pathways. Pyruvate oxidation involves: (i) the transport of  glucose or 
monocarboxylate precursors through the blood brain barrier (BBB) and the plasma membrane of  
neural cells, (ii) the production of  cytosolic pyruvate and reducing equivalents through the glycolytic 
pathway, (iii) the transport of  cytosolic pyruvate and reducing equivalents to the mitochondrial 
matrix by the carriers of  the inner mitochondrial membrane and fi nally, (iv) the terminal oxidation 
of  pyruvate in the mitochondrial TCA cycle. 
Glucose and monocarboxylates are transported through the plasma membrane through the 
family of  glucose and monocarboxylate transporters (Figure 1.1, processes 1 and 2) (Dwyer et al. 
2002; Halestrap and Meredith 2004; Palmieri 2004). Glycolytic pyruvate production from glucose 
in the cytosol generates two molecules of  NADH and ATP (Dienel 2002) (process 3). Cytosolic 
pyruvate may then be transaminated to alanine by alanine aminotransferase (ATT, process 4), 
reduced to lactate by lactate dehydrogenase (LDH, process 5), or transported to the mitochondrial 
matrix (process 6) and oxidized (processes 7-16) (Denton and Halestrap 1979). Under normoxic 
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conditions, the mitochondrial respiratory chain is able to reoxidize completely the reducing 
equivalents (NADH and FADH2) generated in aerobic glycolysis and TCA cycle (process 18). 
Since the mitochondrial membrane is impermeable to NADH, the transfer of  cytosolic reducing 
equivalents through the inner mitochondrial membrane requires the operation of  specifi c shuttle 
mechanisms (processes 20-22) (Palmieri 1994; Palmieri et al. 1996). Oxygen limitations in hypoxic 
Figure 1.1. Overview of  pyruvate oxidation. Intercellular compartmentation is not considered for simplicity. 
1: GLUT transporters of  the plasma membrane, 2: MCT transporters of  the plasma membrane, 3: glycolysis, 
4: alanine aminotransferase, 5: lactate dehydrogenase, 6: pyruvate carrier (PyC) of  the inner mitochondrial 
membrane, 7: pyruvate dehydrogenase complex, 8: pyruvate carboxylase, 9: malic enzyme, 10: citrate synthase, 
11: aconitase, 12: isocitrate dehydrogenase, 13: α-ketoglutarate dehydrogenase, 14: succinate dehydrogenase, 
15: fumarase, 16: malate dehydrogenase, 17: aspartate aminotransferase (mitochondrial), 18: respiratory chain, 
19: aspartate aminotransferase + glutamate decarboxylate (mitochondrial), 20: aspartate/glutamate exchanger, 
21: α-ketoglutarate/malate exchanger (OGC), 22: tricarboxylate carrier (CIC), 23: aspartate aminotransferase 
(cytosolic), 24: citrate lyase, 25: malate dehydrogenase (cytosolic), 26: glutamate decarboxylase (vesicular), 27: 
glutamate decarboxylase (cytosolic), 28: glutamine syntethase, 29: GABA transporters, 30: glutamate transporters, 
31: glutamine transporters. Subscripts c, m and v refer to cytosolic, mitochondrial or vesicular (synaptosomal) 
compartments. FFA: Free Fatty Acids.
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or ischemic conditions may preclude the respiratory chain to reoxidize completely the reducing 
equivalents generated by glycolysis or during TCA cycle activity. This decreases the mitochondrial 
and cytosolic NAD(P)/NAD(P)H ratio and causes cytosolic pyruvate to be reduced to lactate 
and extruded (processes 5 and 2) (Bachelard et al. 1974). Under these conditions, the oxidative 
production of  ATP is reduced and fl ux through the glycolytic pathway upregulated, resulting in 
increased glucose consumption, increased glycerol-3-P levels and increased lactate and alanine 
productions (Ben-Yoseph et al. 1993; Siesjo 1982). 
Cerebral pyruvate plays, additionally, other vital roles. Pyruvate is the main precursor for fatty 
acid synthesis in the CNS (Moore 2001). In this process, intramitochondrial citrate is transported 
to the cytosol, in exchange for malate (process 22), to produce cytosolic oxalacetate and acetyl-CoA 
by citrate lyase (process 24) to support fatty acid synthesis (Palmieri 1994; Palmieri 2004). Cytosolic 
pyruvate can also be produced from mitochondrial TCA cycle intermediates, as malate, through 
the malic enzyme reaction in the process known as pyruvate recycling (ME, process 9), a NADPH 
producing pathway thought to support fatty acid synthesis and free-radical scavenging activities of  
neural cells (Cerdán et al. 1990; Cruz et al. 1998; Pascual et al. 1998). Finally, mitochondrial pyruvate 
is a crucial precursor for cerebral anaplerosis, helping to replace amino acids and TCA cycle 
intermediates liberated to the extracellular space during neurotransmission. Anaplerosis involves 
a net increase in oxalacetate molecules produced through pyruvate carboxylase in astrocytes and, 
possibly, through the reversal of  malic enzyme activity in neurons (process 8 or 9) (Gamberino et 
al. 1997; Hassel 2000). Closely associated to this anaplerotic role, pyruvate (lactate or alanine) may 
produce glucose and glycogen in astroglial cells, in a similar way to that observed in liver (Dringen 
et al. 1993; Schmoll et al. 1995). The following sections address in more detail all these aspects.
3. Transport of  Pyruvate and Monocarboxylates Through the Blood Brain Barrier and 
the Plasma Membrane of  Neural Cells
Pyruvate and other monocarboxylates are classically known to pass the BBB through facilitated 
diffusion (Cremer et al. 1979; Crone and Sorensen 1970). Transport of  monocarboxylates through 
the plasma membrane was attributed initially to non ionic diffusion, until it was demonstrated that 
it could be inhibited by α-cyano-4-hydroxycinamate and organomercurials (Halestrap and Price 
1999). This led to the identifi cation of  the fi rst member of  the family of  monocarboxylate-proton 
cotransporter proteins, MCT1 (Enerson and Drewes 2003). MCTs were shown to operate under 
near equilibrium conditions, catalyzing the reversible cotransport of  the monocarboxylate and one 
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proton. In the case of  pyruvate the following reaction applies,
Pyruvateout + H
+
out   ↔    Pyruvatein + H
+
in                       [1.1]
where the subscripts -in or -out refer to intra- or extracellular concentrations, respectively. A similar 
reaction can be written for other monocarboxylates including lactate, acetate, acetoacetate, among 
others. Under near equilibrium conditions the relative concentration of  pyruvate molecules in the 
intra- and extracellular spaces is believed to be dictated by the transmembrane pH gradient,
   Pyruvatein/ Pyruvateout = H
+
out / H
+
in          [1.2]
For a physiological pH gradient of  0.1 pH units (acidic inside), the concentration of  
intracellular monocarboxylates is predicted to be approximately 1.25 times lower than that 
found in the extracellular space. However, under severe hypoxic or ischemic conditions, when 
the transmembrane pH gradient may reach one pH unit (alkaline inside), the concentration of  
intracellular pyruvate or lactate may become one order of  magnitude higher than that of  the 
extracellular space. These important changes in monocarboxylate distribution through the plasma 
membrane refl ect the reversibility of  MCT transport. Its kinetic parameters are known to be 
constrained by the Haldane relationship
      (Vmax/Km)infl ux = (Vmax/Km)effl ux                        [1.3]
where Vmax of  infl ux or effl ux can be stimulated by either decreasing the pH in the same side of  the 
monocarboxylate or by increasing it in the opposite, respectively (Halestrap and Price 1999).
The MCT proteins are coded by the SCL16 gene family (Halestrap and Meredith 2004). Up 
to fourteen, relatively homologous, monocarboxylate transporters are coded by this gene family 
of  which only four have been isolated, purifi ed and overexpressed in Xenopus oocytes. Although 
the three dimensional structure of  these transmembrane proteins has not been determined, it is 
possible to infer some of  their structural properties, from their resemblance with other receptors. 
The common topology involves up to twelve transmembrane domains, with both C and N terminus 
facing the intracellular side. In addition, at least MCT1 and MCT4 (and probably MCT3) require 
the ancillary protein CD147 for their correct expression in the plasma membrane (Kirk et al. 2000). 
MCT1, MCT2 and MCT4 are heterogeneously expressed in brain (Fayol et al. 2004; Rafi ki et al. 
2003). MCT1 is almost ubiquitously expressed, being found in endothelial cells, neurons, astrocytes 
as well as in glioma cells. Conversely, MCT2 is expressed only in neurons and MCT4 is expressed 
in the endothelial or glial cells (Mac and Nalecz 2003).
The pattern of  expression and the kinetic properties of  these transporters support the classical 
model of  vectorial traffi cking of  monocarboxylates between neurons and astrocytes (Pellerin et al. 
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1998b). The low affi nity of  astrocytic MCT4 favours lactate extrusion from astrocytes, a situation 
similar to that found in highly glycolytic tissues such as the white muscle fi bers. In contrast, the 
lower affi nity of  neuronal MCT2 favours lactate uptake, as found primarily in oxidative tissues as 
heart and the red muscle fi bers (Brooks 2002). Thus, heterogeneous distribution of  MCT with 
different kinetic properties supports astrocytic lactate production and neuronal lactate consumption 
(Pellerin et al. 1998a) (explained with more detail later).
MCT experience important changes in the expression of  the different isoforms during 
ontogenic development (Leino et al. 1999; Vannucci and Simpson 2003). Neuronal MCT2 is 
expressed in most brain areas including hippocampus and cerebellum, being most abundant during 
the fi rst three weeks after birth and decreasing progressively later. This pattern appears to be 
complementary to that of  the glucose transporters GLUT1, endothelial, and GLUT3, neuronal 
(Vannucci et al. 1997). Both GLUT1 and GLUT3 increase progressively after birth, while MCT2 
decreases. In contrast, MCT4 expression is low at birth and increases progressively through 
development. The temporal pattern of  expression of  MCTs and GLUT transporters parallel the 
decrease in lactate utilization and the increase in glucose metabolism observed during cerebral 
maturation (Clark et al. 1994; Clark et al. 1993; Dwyer et al. 2002; Medina et al. 1996; Vannucci et al. 
1997; Vannucci and Simpson 2003). 
4. Cytosolic Metabolism of  Pyruvate
Pyruvate is produced in the cytosol of  neural cells either from glucose, through the glycolytic 
pathway, or from extracellular lactate, alanine or pyruvate, after transport and equilibration 
in the LDH or ATT reactions (cf. Figure 1.1). Cytosolic pyruvate may then be removed to the 
mitochondrial matrix through the monocarboxylate carriers of  the inner mitochondrial membrane, 
or extruded to the extracellular space as lactate or alanine. Cytosolic pyruvate may also be produced 
from malate in the malic enzyme reaction. The following paragraphs analyze these aspects.
The glycolytic pathway (Figure 1.2) is the sequence of  ten enzyme catalyzed reactions 
degrading glucose to two molecules of  pyruvate
Glucose + 2NAD+ + 2ADP + 2Pi → 2 Pyruvate + 2NADH + 2H
+ + 2ATP + 2H2O   [1.4]
Hexokinase, phosphofructokinase and pyruvate kinase are able to modulate glycolytic fl ow 
in most tissues. However, the classical work of  Lowry and Saktor showed that in brain, aerobic 
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glycolysis is regulated primarily at the phosphofructokinase and hexokinase steps (Passonneau and 
Lowry 1964; Sacktor et al. 1966). A schematic description of  this pathway is given in Figure 1.2, 
with maximal activities of  the enzymes involved and concentrations of  metabolites (Clarke et al. 
1989). Glycolytic fl ux in vivo represents approximately 5% of  the maximal possible fl ux through 
the pathway, revealing the important metabolic capacity of  this pathway and the need for a strict 
regulation. The literature on the kinetic properties and structure of  the main glycolytic enzymes is 
large. I will herein focus exclusively in LDH, because of  its crucial role for the understanding of  
some of  the developed methodologies. 
LDH represents the end point of  anaerobic glycolysis, catalyzing the NADH dependent 
reduction of  pyruvate to lactate and NAD+, in a reversible manner (Everse and Kaplan 1973). 
Pyruvate + NADH  + H+ ↔ Lactate + NAD+                        [1.5]
Cerebral LDH appears in fi ve different isoforms, derived from two parental homotetramers 
and three hybrids. These are: LDH1 (also known as LDH-H or LDH-A, isolated from heart) 
or LDH5 (also known as LDH-M or LDH-B, isolated from muscle) (Bonavita et al. 1964). The 
remaining isoforms arise from different combinations of  H and M subunits (approximately 36 
kDa), H4 (LDH1), H3M (LDH2), H2M2 (LDH3), HM3 (LDH4), M4 (LDH5). LDH1 is only 
Figure 1.2. The cerebral glycolytic pathway. Numbers below the enzymes and metabolites refer to the maximal 
velocity (µmol.g-1 wet weight. min-1) and concentration (nmol. g-1 wet weight) as measured in brain homogenates 
and acid extracts, respectively. Taken from (Clarke et al. 1989). Reproduced with permission of  the publisher.
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detected in neurons and its kinetic properties favour mainly pyruvate formation (Bittar et al. 1996; 
Laughton et al. 2000) while LDH5 is present mainly in astrocytes and its kinetic properties favour 
lactate formation (Dawson et al. 1964; Richard 1963). Thus, the distribution of  LDH isoenzymes 
is also adequate to support the astrocyte to neuron lactate shuttle (Pellerin et al. 1998a). Cerebral 
LDH is believed to be cytosolic in most tissues, with the exception of  the testis, where it has a 
mitochondrial distribution. Nonetheless, recent evidence indicates that at least part of  hepatic and 
cardiac LDH may be mitochondrial (Brooks et al. 1999). LDH1 and LDH5 isoenzymes are also 
heterogeneously distributed within the different cerebral structures, as revealed by in situ mRNA 
hybridization (Laughton et al. 2000). LDH also experiences important changes during ontogeny, 
increasing progressively after birth, in parallel with other glycolytic enzymes and transporters 
(Medina et al. 1996).
5. Mitochondrial Transport - General Characteristics of  Mitochondrial Carrier Proteins
Pyruvate and other cytosolic metabolites are transported through the inner mitochondrial 
membrane by the mitochondrial carrier family of  proteins MCF (LaNoue and Schoolwerth 1979; 
Palmieri 1994; Palmieri 2004; Palmieri et al. 1996; Satrustegui et al. 2007).
MCF carriers are integral proteins of  the inner mitochondrial membrane coded in man by 
SLC25 genes family (Palmieri 2004). Approximately 35 mRNA transcripts of  this family have been 
observed, although only ten MCFs have been purifi ed, sequenced and reconstituted. The main 
members of  the MCF family include: the ATP translocators (AAC), the phosphate exchanger 
(PiC), the α-ketoglutarate-malate exchanger (OGC), the dicarboxylate carrier (DIC), the citrate-
malate exchanger (CIC), the aspartate-glutamate exchanger (AGC), the carnitine and ornithine 
carriers (CAC and ORC), the uncoupling proteins (UCP) and the pyruvate carrier (PyC). The 
primary structure of  transmembrane MCF proteins is relatively constant. It depicts a tripartite 
sequence with three tandemly repeated domains of  approximately 100 amino acids in length. 
Each domain contains two hydrophobic portions, believed to span the membrane as α-helices, 
separated by hydrophilic regions with the N and C terminals facing the intracellular side. Most 
isolated MCF proteins have been shown to be homodimer, probably consisting of  a total of  
twelve transmembrane segments, as in the majority of  carrier proteins. Figure 1.3 summarizes 
the operation of  different shuttle systems that exchange cytosolic and mitochondrial metabolites 
related to pyruvate metabolism and the transfer of  reducing equivalents. 
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6. Intramitochondrial Pyruvate Oxidation and the Tricarboxylic Acid Cycle
Once transported to the mitochondrial matrix, pyruvate may enter the TCA cycle through the 
pyruvate dehydrogenase complex (PDHC) or through pyruvate carboxylase (PC).
The TCA cycle plays a central role in cerebral metabolism, providing the main pathway where 
carbohydrates, fats and amino acids are oxidized to obtain the energy needed to maintain cerebral 
functions (Dienel 2002; Hertz and Dienel 2002). It fulfi ls also a fundamental role, providing 
intermediates for many cerebral biosynthetic processes and neurotransmitters such as glutamate 
and γ-aminobutyric acid (GABA) (Gruetter 2002; Owen et al. 2002). Pioneering work, performed 
shortly after its discovery in 1937, allowed the understanding of  the basic enzymology of  the cycle 
and the principles of  its metabolic regulation (Krebs 1964; Krebs 1970; Krebs and Johnson 1937). 
Later progress has lead to the purifi cation of  all the enzymes involved and the elucidation of  
their primary amino acid sequence and 3D structure. Recently, the sequencing of  the mouse and 
human genomes has allowed the localization of  the corresponding genes in specifi c chromosomes 
(Consortium 2001; Consortium 2002). Despite these impressive progresses, many aspects of  the 
integrated operation of  the TCA cycles in different cellular environments of  the in vivo brain 
and their coordinated response to fundamental physiological processes such as cerebral activation, 
remain today incompletely understood.
A brief  historical background will help to gain a more defi ned perspective over the 
plurality of  TCA cycles in brain and evolution of  the classical concepts towards our more recent 
interpretations. Initial evidences supporting the existence of  two kinetically different TCA cycles 
in brain were obtained in the sixties (Figure 1.4). Soon after the intracerebral administration of  14C 
acetate, authors measured higher specifi c radioactivity in glutamine than in its precursor glutamate 
(Berl 1965; Berl et al. 1968; Berl et al. 1970). A similar situation was found with 14CO3H
- and 
butyrate, but not with glucose or glycerol. These fi ndings could only be explained through the 
◄ Figure 1.3. The mitochondrial transporters present in neural cells and their roles. The schemes do not 
show all the mitochondrial transporters nor all the metabolic pathways in which individual carriers are involved. 
A: The malate-aspartate shuttle for the transfer of  cytosolic NADH to the mitochondrial matrix. B: Extrusion of  
NADH to the cytosol for gluconeogenesis from pyruvate in astrocytes. C: The pyruvate-malate shuttle; extrusion of  
reducing equivalents (NADPH) to the cytosol. D: The citrate-malate shuttle; extrusion of  citrate to the cytosol for 
acetyl-CoA generation and sterols and fatty acid synthesis. E: The citrate-pyruvate shuttle; simultaneous extrusion 
of  mitochondrial citrate, NAD+ and NADPH for cytosolic sterol and fatty acid synthesis. F: The α-ketoglutarate-
isocitrate shuttle. Extrusion of  mitochondrial isocitrate for cytosolic NADPH synthesis. Adapted from (Palmieri 
2004). Reproduced with permission of  the publisher.
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existence of  two slowly exchanging pools of  glutamate, denoted then as “large” and “small”, which 
exchanged radioactivity with “small” and “large” glutamine pools, respectively. Soon, the “large” 
and “small” glutamate and glutamine pools were associated to the operation of  the “energy” and 
“synthetic” TCA cycles, proposed to represent the neuronal and glial compartments, respectively 
(Van den Berg et al. 1969; Van den Berg et al. 1966). Subsequently, both cycles were connected by 
Figure 1.4. The two kinetically different tricarboxylic acid cycles of  adult mammalian brain as originally 
proposed by Berl and Clarke. The metabolic compartmentation concept was proposed to explain the unexpected 
relationships found between the radioactive specifi c activities (RSA) of  cerebral glutamine to glutamate. The 
“synthetic cycle”, associated to the “large” glutamine pool was assigned to the astrocytes while the “energy cycle”, 
in contact with the “large” glutamate pool was assigned to the neurons. The size of  the circles and the thickness of  
the arrows refer approximately to the pool sizes and preferred compartment for metabolism, respectively. Note the 
incomplete glutamine cycle with no transfer of  glutamine to the neurons and arrow suggesting neuronal pyruvate 
carboxylation. Adapted from (Berl and Clarke 1969). Reproduced with permission of  the publisher.
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vectorial transfers of  glutamate from the neuronal to the glial cycle, and glutamine in the opposite 
direction. The “glutamate-glutamine cycle” was conceived then only as a mechanism to replenish 
small glutamate looses in the neurons during neurotransmission (Garfi nkel 1966; Van den Berg 
and Garfi nkel 1971).
Figure 1.5 illustrates the current status of  these concepts, emphasizing the aspects that remain 
incompletely understood. Plasma glucose is taken up by neural cells from the capillaries, mainly 
by the astrocytic end feet (process 1) and possibly also to some extent by the neurons (process 
2). Both neurons and astrocytes contain mitochondria equipped with the enzymatic machinery 
required for glycolytic (processes 3 and 4) and oxidative glucose metabolism (processes 6 and 
7). However, the quantitative contribution of  neuronal and glial metabolisms to overall cerebral 
Figure 1.5. Metabolic interactions between oxidative and non oxidative metabolisms in neurons and 
glia. 1: Glucose uptake by the astrocyte, 2: Glucose uptake by the neuron, 3: Astroglial glycolysis, 4: Neuronal 
glycolysis, 5: Exchange of  lactate between the neurons and glia, 6: Astroglial TCA cycle, 7: Neuronal TCA cycle, 
8 and 9: Astrocytic and neuronal mitochondrial transporters allowing exchange of  reducing equivalents between 
mitochondria and cytosol, 10: Intercellular exchange of  glutamate, glutamine and GABA, 11: Astrocytic and 
neuronal respiratory chain. 
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glycolysis or oxidation in vivo remains imprecise. Similarly, it has not been possible to quantify 
unambiguously the relative proportions of  glucose or lactate used to support neuronal oxidative 
metabolism in vivo (process 5). Finally, the operation of  the TCA cycle in neural cells, demands the 
transfer of  reducing equivalents from cytosol to mitochondria as well as the exchange of  TCA 
cycle intermediates between these subcellular compartments (processes 8 and 9). The rate at which 
these processes occur in vivo and how subcellular transport may modulate TCA cycle activity in 
neurons and astrocytes constitute important challenges of  modern neurochemistry.
In the following paragraph, I will focus on the operation of  the neuronal and glial TCA 
cycles and their interactions. I begin with an update on the mechanism, regulation and regional 
distribution of  the cerebral TCA cycle, describing later the main methodologies used to investigate 
the cycle fl ux. Other recent reviews on the cerebral TCA cycles and neuroenergetics complement 
appropriately the information presented here (Cruz and Cerdán 1999; García-Espinosa et al. 2004; 
Gruetter 2002; Hertz 2004; Hertz and Dienel 2002; Rothman et al. 2003; Shulman et al. 2004).
Figure 1.6 and Table 1.1 summarize the individual reactions of  the TCA cycle and the main 
properties of  the enzymes involved, respectively. As mentioned above, mitochondrial pyruvate 
oxidation begins with its decarboxylation to acetyl-CoA by pyruvate dehydrogenase. The pyruvate 
dehydrogenase complex (PDHC, EC 1.2.4.1) plays a key role in the oxidative metabolism of  
pyruvate and its regulation, catalyzing the irreversible decarboxylation of  pyruvate to CO2, acetyl-
CoA and NADH (Patel and Korotchkina 2001).
The TCA cycle starts by the irreversible condensation of  oxaloacetate and acetyl-CoA to 
produce cytril-CoA, then hydrolyzed to citrate and CoA. This reaction is catalyzed by citrate 
synthase (EC 2.3.3.1), a homodimer of  52-kDa subunits coded in man by the CS gene, the enzyme 
being found in the mitochondrial matrix of  all cells capable of  oxidative metabolism (Goldenthal 
et al. 1998). The synthesis of  citrate is a crucial control point of  the TCA cycle. Citrate synthase 
is allosterically inhibited by ATP, through an increase in the Km for acetyl-CoA. This inhibition is 
easily reversed by an increase in the ADP concentration, which induces an allosteric stimulation. 
Concomitantly, high concentrations of  NADH and succinyl-CoA also retroinhibit this enzyme 
(Matsuoka and Srere 1973).
The next step is catalyzed by the 85-kDa monomeric mitochondrial aconitase (EC 4.2.1.3). 
It is a sequential reaction comprising dehydration and hydration processes. Citrate is isomerized 
to isocitrate via cis-aconitate. Aconitase is an iron-sulfur protein encoded by the ACO2 gene 
containing a [4Fe-4S] cluster to which the substrate binds (Mirel et al. 1998). 
The mitochondrial NAD+-dependent isocitrate dehydrogenase (EC 1.1.1.41) catalyzes 
an ordered reaction consisting of  the initial oxidation of  isocitrate to the unstable β-keto acid 
oxalosuccinate, followed by decarboxylation to α-ketoglutarate. This constitutes the second rate-
limiting step of  the TCA cycle, being allosterically activated by increasing intramitochondrial 
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ADP/ATP ratios and Ca2+. There are additional cytosolic and mitochondrial NADP+ dependent 
isoenzymes which contribute actively to the NADP+/NADPH dependent detoxifi cation reactions 
and fatty acid synthesis (Sazanov and Jackson 1994). Both isoenzymes are heterotetramers of  two 
40-kDa alpha subunits (coded by the IDH3A gene), one 42-kDa beta subunit (IDH3B), and one 
43-kDa gamma subunit (IDH3G) (Brenner et al. 1997; Kim et al. 1995; Kim et al. 1999). It is possible 
that the fate of  cytosolic or mitochondrial isocitrate trough the NAD+ or NADP+ isoenzymes is 
determined by the availability for corresponding reducing equivalents.
The reaction mechanism of  the mitochondrial α-ketoglutarate dehydrogenase complex is 
analogous to the conversion of  pyruvate to acetyl-CoA by PDHC, due to the structural similarity of  
both complexes (Sheu and Blass 1999). The assembly contains multiple copies of  three enzymatic 
components: α-ketoglutarate dehydrogenase (E1, EC 1.2.4.2, encoded by the OGDH gene, 113 
kDa), transsuccinylase (E2, EC 2.3.1.61, encoded by the DLST gene, 49 kDa) and dihydrolipoyl 
dehydrogenase (E3, EC 1.8.1.4, encoded by the DLD gene, 54 kDa) (Ali et al. 1994; Feigenbaum 
and Robinson 1993; Szabo et al. 1994). The α-ketoglutarate dehydrogenase complex requires several 
cofactors including: lipoamide, thiamine pyrophosphate, CoA, FAD and NAD+. Succinyl-CoA and 
NADH inhibit the reaction, providing the third control point of  the TCA cycle fl ux, after citrate 
synthase and isocitrate dehydrogenase (NAD+).
Succinyl-CoA synthetase (EC 6.2.1.4) is a mitochondrial enzyme that performs the only 
substrate-level phosphorylation of  the TCA cycle, converting succinyl-CoA into succinate. GDP 
is phosphorylated to GTP, which then goes on to phosphorylate ADP, resulting in the only ATP 
molecule directly produced by the TCA cycle. It is a heterodimer of  an alpha (35 kDa) and a beta 
chain (41 kDa), encoded by SUCLG1 and SUCLG2 genes, respectively (James et al. 1997; Johnson 
et al. 1998).
The succinate dehydrogenase complex (EC 1.3.5.1) oxidizes succinate to fumarate. It is 
composed of  a 70-kDa fl avoprotein (fp), a 27-kDa iron-sulfur protein (ip), and a cytochrome b 
►Figure 1.6. The turnover of  carbon and hydrogen in the tricarboxylic acid cycle. Using (1,2-13C2) acetyl-
CoA as substrate, the 13C is incorporated successively in (4,5-13C2) citrate (citrate synthase), (4,5-
13C2) cis-aconitate 
(aconitase), (4,5-13C2) isocitrate (aconitase) and (4,5-
13C2) α-ketoglutarate (NAD-isocitrate dehydrogenase). α-
ketoglutarate dehydrogenase produces (3,4-13C2) succinyl-CoA and an equimolar mixture of  (1,2-
13C2) and (3,4-
13C2) succinate (succinyl CoA synthetase), followed by the production of  (1,2-
13C2) or (3,4-
13C2) fumarate (succinate 
dehydrogenase) and (1,2-13C2) or (3,4-
13C2) malate or oxaloacetate. Hydrogens from water incorporate in the 
H3proR and H3proS of  isocitrate, α-ketoglutarate and glutamate, the H2 (or H3) of  succinate and fumarate and 
the H3 of  oxalacetate and malate. 13C atoms are indicated in red or green (lost by decarboxylation). Hydrogen 
exchange is considered to start from fumarate on, being indicated in cyan and light blue (H3 and H3’ hydrogens 
of  α-ketoglutarate) or white contour (H3 malate or oxalacetate). The same color is maintained in the different 
intermediates to follow the metabolic history of  every carbon or hydrogen.
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composed of  two integral membrane proteins, encoded by SDHA, SDHB, SDHC and SDHD 
genes, respectively (Au et al. 1995; Elbehti-Green et al. 1998; Hirawake et al. 1999; Morris et al. 1994). 
The succinate dehydrogenase complex is the only one among the enzymes of  the TCA cycle to 
be imbedded in the inner mitochondrial membrane. Due to the fact that the free-energy change 
for this oxidation is not suffi cient to reduce NAD+, FAD is used as the hydrogen acceptor for this 
reaction (de Gomez-Puyou et al. 1972).
The next step is the hydration of  fumarate to form L-malate. This stereospecifi c trans addition 
of  H and OH is catalyzed by 55-kDa fumarase (EC 4.2.1.2), a homotetramer that exists both in 
the mitochondrial and cytosolic compartments of  the intact brain and is encoded by the FH gene 
(Akiba et al. 1984; Kinsella and Doonan 1986).
Finally, malate dehydrogenase (EC 1.1.1.37) catalyzes the reversible oxidation of  L-malate to 
Enzyme
(EC number) Substrates Products
Prosthetic
group MW/structure 
Genetic sequence
/cloned
TABLE 1.1. Structural and genomic properties of the tricarboxylic acid cycle enzymes
Citrate synthase
(EC: 2.3.3.1)
Aconitase
(EC: 4.2.1.3)
NAD+-dependent
isocitrate
dehydrogenase
(EC: 1.1.1.41)
α-Ketoglutarate
dehydrogenase
complex
Succinyl-CoA 
synthetase
(EC: 6.2.1.4)
Succinate
dehydrogenase
(EC: 1.3.5.1)
Fumarase
(EC: 4.2.1.2)
Malate
dehydrogenase
(EC: 1.1.1.37)
Oxaloacetate
acetyl-CoA
Citrate
Isocitrate
α-Ketoglutarate
Succinyl-CoA
Succinate
Fumarate
Malate
Citrate
Isocitrate
α-Ketoglutarate
Succinyl-CoA
Succinate
  
Fumarate
Malate
Oxaloacetate
 
Fe–S
 
Lipoic acid,
FAD, TPP
  
FAD, Fe–S
52 kDa, homodimer (by 
similarity)
85 kDa, monomer (by 
similarity)
Heterooligomer of subunits 
α (40 kDa), β (42 kDa), and 
γ (43 kDa) in the apparent 
ratio of 2:1:1 (by similarity)
Three enzymatic
components: α−
ketoglutarate
dehydrogenase (E1, EC: 
1.2.4.2, 113 kDa), trans-
succiylase (E2, EC:2.3.1.61, 
49 kDa), and dihydrolipoyl 
dehydrogenase
(E3, EC: 1.8.1.4, 54 kDa)
Heterodimer of an α
(35 kDa) and a β chain
(41 kDa) (by similarity)
Three enzymatic
components: a flavoprotein 
(fp, 70 kDa), an iron protein 
(ip, 27 kDa), and a 
cytochrome b composed of 
two integral membrane 
proteins
55 kDa, homotetramer
36 kDa, homodimer
CS
ACO2
IDH3A (α), 
IDH3B (β), 
IDH3G(γ)
OGDH (E1), 
DLST (E2),
DLD (E3)
SUCLG1(α) 
SUCLG2 (β)
SDHA (fp), 
SDHB (ip), 
and SDHC
and SDHB
(integral 
membrane
proteins)
FH
MDH2
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oxaloacetate. This 36-kDa homodimer is located in the mitochondrial matrix, using the NAD+/
NADH cofactor system. The enzyme is encoded by the MDH2 gene (Benn et al. 1977). Moreover, 
malate dehydrogenase plays a crucial role in the redox coupling between the mitochondrial and the 
cytosolic compartments, through the malate-aspartate shuttle (Malik et al. 1993).
6.1. Regionalization and Subcellular Distribution
Classical studies determined the maximal activities of  TCA cycle enzymes both in whole 
brain and different cerebral regions. Maximal activities of  TCA cycle enzymes were, in most cases, 
higher in rodent than in human brain and higher in the cerebral cortex than in the mid brain, basal 
ganglia and cerebellum, a fi nding consistent with the higher oxidative capacity of  the cortex.
Concerning the cellular distribution, both neurons and astrocytes in primary culture show 
TCA cycle activity and therefore contain its complete enzymatic machinery. However, the specifi c 
activity of  TCA cycle enzymes is much higher in cultures of  neurons than in cultures of  astrocytes, 
in agreement with the higher oxidative capacity of  the former (Hertz 2004; Hertz and Hertz 2003; 
Stewart et al. 1998). At the subcellular level, the TCA cycle occurs exclusively in the mitochondria. 
Consistent with this localization, pyruvate dehydrogenase, citrate synthase, succinyl-CoA synthetase 
activities are found only in this fraction (Almeida and Medina 1997; Almeida and Medina 1998; 
Lai and Clark 1989). However, many of  the remaining enzymes are found also in the cytosol of  
both neurons and astrocytes. These are the cases of  aconitase, isocitrate dehydrogenase and malate 
dehydrogenase. Interestingly enough, cytosolic fumarase has been reported to be lacking in the 
brain (Akiba et al. 1984). Various reports have proposed the functional organization of  TCA cycle 
enzymes in mitochondrial supramolecular complexes (Robinson and Srere 1985).
6.2. Regulation
The regulation of  the TCA cycle demands a close integration with the activities of  the 
upstream glycolytic pathway and the downstream mitochondrial respiratory chain. To this end, the 
TCA cycle fl ux is inhibited by NADH and ATP as its products, or activated by NAD+ and ADP 
as its substrates (Bachelard et al. 1974; Clarke et al. 1989; Krebs 1970; McIlwain and Bachelard 
1985; Sokoloff  1989). Control by these allosteric effectors occurs mainly at the fi rst irreversible 
step of  pyruvate dehydrogenase, with additional modulations at the citrate synthase, isocitrate 
dehydrogenase (NAD+) and α-ketoglutarate dehydrogenase steps (Gibson et al. 2000; Patel and 
Korotchkina 2001). These relatively simple substrate activation or product inhibition mechanisms 
allow for an effective increase in TCA cycle activity under circumstances of  augmented energy 
demand, or for a decrease in TCA cycle fl ux when overproduction of  NADH or ATP occurs. 
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The integrated regulation of  glycolysis and the TCA cycle activity has a profound impact in 
cerebral energetics (Bachelard et al. 1974; Clarke et al. 1989; McIlwain and Bachelard 1985; Siesjo 
1982). This process involves a series of  highly sophisticated redox and energetic signalling processes 
that communicate between mitochondrial and cytosolic environments. Under physiological 
circumstances, tight coupling between TCA cycle and glycolysis relies on the fast exchange between 
mitochondrial and cytosolic ATP/ADP and NAD+/NADH ratios, respectively. This occurs 
through the ATP/ADP exchanger and the various transporters involved in the transfer of  reducing 
equivalents in the inner mitochondrial membrane (Palmieri 2004; Palmieri et al. 1996; Palmieri et 
al. 2001). In this way, mitochondrial perturbations in ATP/ADP or NAD/NADH ratios should 
appear refl ected in the corresponding cytosolic ratios and vice versa. 
The glycolytic pathway is classically known to be modulated in brain, mainly at the 
phosphofructokinase step, through the balance of  positive and negative effectors (Passonneau and 
Lowry 1964; Sacktor et al. 1966). ATP and NADH inhibit phosphofructokinase activity, while citrate, 
ADP, NAD+ and NH4
+ increase it. Under hypoxic conditions, oxygen limitations make diffi cult the 
reoxidation of  mitochondrial NADH, resulting in a more reduced intramitochondrial NAD+/
NADH ratio which inhibits TCA cycle fl ux. As a consequence, the mitochondrial and cytosolic 
ATP/ADP ratios decrease, activating glycolytic fl ux and net lactate production because cytosolic 
NADH cannot be completely reoxidized by the respiratory chain. This situation is reversible upon 
return to physiological oxygen tensions, which normalize intracellular ATP/ADP and NAD+/
NADH ratios, restoring the coupling between glycolysis and the TCA cycle fl ux (Almeida et al. 
2004). Finally, it should be mentioned here that even though general properties of  the integration 
between glycolysis and the TCA cycle are suffi ciently understood, many aspects concerning the 
subcellular redox and energetic coupling mechanisms as well as the mitochondrial transporters and 
shuttles involved in neurons and glia, remain to be quantitatively and kinetically characterized. 
7. Methodologies to Investigate Tricarboxylic Acid Cycle Activity
Experimental procedures to investigate the activity of  the TCA cycle in vitro involved 
traditionally polarographic measurements of  oxygen consumption in suspensions of  isolated 
synaptic or non-synaptic mitochondria from brain. The approach required the preparation of  
mitochondrial suspensions and the determination of  oxygen consumption and ATP/ADP cycling, 
under different substrate conditions (Barrientos 2002; Rossignol et al. 2000). Despite the important 
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information obtained on the mechanisms of  oxidative phosphorylation using these methods, this in 
vitro approach did not allow the investigation of  the more complex aspects of  TCA cycle  regulation 
and intercellular coupling between astrocytic and neuronal environments, as they occur in the 
in vivo brain. Basically, four different methods have been implemented to address these aspects: 
Autoradiography, PET, NMR and Dual Photon Fluorescence Confocal Microscopy (Figure 1.7). 
The following sections describe these in more detail.
7.1. Radioactive Procedures
Autoradiography and PET methods are normally based on the measurement of  regional 
cerebral glucose consumption, after the administration of  2-deoxyglucose, either labeled with 14C 
or with 18F, respectively (Herholz and Heiss 2004; Sokoloff  1981a; Sokoloff  1981b; Sokoloff  1983a; 
Sokoloff  1983b; Wienhard 2002). These methodologies determine the regional accumulation of  2- 
(14C or 18F)-deoxyglucose-6-phosphate, a virtually unmetabolizable analog of  glucose 6-phosphate, 
using autoradiography or PET. Autoradiography was one of  the fi rst methods to be proposed. 
It provided ex vivo images of  the regional accumulation of  radioactive 2-deoxyglucose (or other 
radioactive substrates as acetate, butyrate, among others), as refl ected in photographic plates 
obtained from sections of  fi xed brain tissue. PET yielded in vivo images of  the regional uptake 
of  FDG (or other positron emitters) in different brain sections, as resolved tomographycally by a 
coronal arrangement of  positron selective gamma cameras. Both methods allow the determination 
of  cerebral metabolic rates for glucose (CMRglc) in different brain regions after appropriate modeling 
of  the underlying tracer kinetics (Price 2003). In addition, the use of  15O2 as inspired gas or 
15OH2 
as a freely diffusible tracer allow measuring by PET, regional oxygen consumption, cerebral blood 
volume and blood fl ow (Hatazawa et al. 1995). Both radioactive approaches are limited in resolution 
and chemical specifi city, making it not possible to image single neural cells in the examined area, or 
to investigate the downstream metabolism of  glucose below the phosphofructokinase step.
7.2. Nuclear Magnetic Resonance Methods
Pioneering nuclear Magnetic Resonance approaches to cerebral energetics begun most 
probably with the application of  31P NMR (Moore et al. 1999; Ross and Sachdev 2004). 31P NMR 
spectra from rodent, cat, dog or human brain, depicted resonances from ATP, phosphocreatine 
(PCr), inorganic phosphate (Pi), phosphomonoesters (PME, mainly phosphorylethanolamine) 
and phosphodiesters (PDE, glycerophosphorylcholine) (Gyulai et al. 1987; Hilberman et al. 1984; 
Komatsumoto et al. 1987; Nioka et al. 1991). It was possible to follow non invasively the rates of  
PCr breakdown and recovery after hypoxic and ischemic episodes. In general, PCr decrease was 
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Figure 1.7. Different approaches to measure oxidative capacity in the brain. A: Autoradiography after (1-
14C) acetate refl ects glial TCA cycle activity during spreading cortical depression (Dienel et al. 2001), B: A PET 
scan during the paradigm of  “reading words” detects increased 18FDG accumulation in the visual cortex (Mintun 
et al. 2004), C: Localized 31P NMR spectra in vivo depict resonances from α, β and γ phosphates of  nucleotide 
triphosphates NTP (mainly MgATP), phosphocreatine (PCr), phosphodiesters (PDE), inorganic phosphate (Pi) and 
phosphomonoesters (PME) (Ross and Sachdev 2004), D: Localized 1H NMR spectrum in vivo showing resonances 
from N-acetyl-aspartic acid (NAA), glutamate and glutamine (Glx), creatine and phosphocreatine (Cr), choline 
derivatives (Cho) and myo-inositol (mI) (Ross and Sachdev 2004), E: Localized 13C NMR spectroscopy during (1-
13C) glucose infusion shows resonances from the C3, C4 and C2 carbons of  glutamate (GLU) and glutamine (GLN) 
and the C3 and C2 carbons of  aspartate (Asp) and N-acetyl-aspartate (NAA) (Gruetter et al. 2003). Reproduced 
with permission of  the publisher.
10 5 0 -5
ppm
PCr
C
E
D
NTP
[1-14C] Acetate
γ α β
PDE
Pi
PME
-10 -15 -20
ppm
4 3 2 1
ppm
55 50 45 40 35 30 25
lactate
NAA
GLX
Cr
Cho
ml 
A B
Glu C2
Gln C2
NAA C2
Asp C2
NAA C3
Asp C3
Glu C4
Glu C3
Gln C4 Gln C3
GABA C4
23
Brain Energy Metabolism
the fi rst phenomenon observed, with ATP concentrations remaining initially relatively constant 
and decreasing eventually after PCr stores had been depleted. The recovery rates of  PCr after 
restoring normal oxygen delivery conditions, refl ected directly oxidative phosphorylation and TCA 
cycle activity in vivo. Under these circumstances, the Pi resonance increased and shifted to a more 
acidic pH. PME increased in the late phases of  hypoxia/ischemia, in agreement with increased 
phospholipase activation and intracellular Ca2+ rises due to membrane depolarization.
1H NMR approaches to cerebral competence are probably the most extended today in the 
clinic (Burtscher and Holtas 2001). 1H NMR spectra from human or rodent brain show resonances 
from the methyl group of  N-acetyl-aspartic acid (NAA), the methyl groups of  creatine (Cr) and 
PCr, the trimethylammonium groups of  choline (Cho) containing compounds and the myo-inositol 
(Ino) resonances. NAA and Ino are thought to represent the neuronal or glial contributions to 
the observed voxel, respectively. Notably, the methyl group of  lactate becomes readily observable 
under hypoxic or ischemic conditions, providing an unambiguous proof  of  increased net glycolytic 
fl ux under these circumstances.
13C NMR approaches constitute probably the most elaborated, chemically specifi c, tool to 
trace the metabolic fate of  13C labeled glucose or acetate in the brain, both in vivo and in vitro (Cerdán 
2003; Cruz and Cerdán 1999; de Graaf  et al. 2003; García-Espinosa et al. 2004; Gruetter et al. 2003; 
Rodrigues and Cerdán 2005). The 13C NMR approach is so useful because it makes possible to 
investigate the activities of  the neuronal and glial TCA cycles in vivo and in vitro, providing direct 
insight into cerebral metabolic compartmentation. Traditionally, either (13C) glucose, a universal 
substrate for neurons or glial cells or (13C) acetate, an exclusive substrate for the glia, have been 
used (Badar-Goffer et al. 1990; Cerdán et al. 1990; Fitzpatrick et al. 1990; Mason et al. 1992b). (1-
13C) glucose is metabolized to (3-13C) pyruvate which eventually labels (4-13C) glutamate and (4-
13C) glutamine. Similarly, (2-13C) or (1,2-13C2) acetate produce (4-
13C) or (4,5-13C2) glutamate and 
glutamine, respectively (see Figure 1.6). Consequently, dynamic or steady state measurements of  the 
turnover and fractional 13C enrichments of  glutamate C4 and glutamine C4, as labeled from (13C) 
glucose or (13C) acetate precursors, have been often interpreted to refl ect the neuronal (VTCAn) and 
glial (VTCAg) TCA cycle fl uxes, respectively. These interpretations rely, however, on the assumption 
that exchange of  α-ketoglutarate and glutamate through the cytosolic and mitochondrial aspartate 
aminotransferases and through the inner mitochondrial membrane (Vx) of  both neurons and 
astrocytes is faster than the TCA cycle rate. This assumption allows considering a single cerebral 
glutamate pool in both neural cell types and approximating the neuronal and glial TCA cycles by the 
kinetics (or steady state values) of  13C enrichment in glutamate C4 and glutamine C4, respectively. 
Table 1.2 summarizes the values for the TCA cycle fl ux obtained using different in vivo and 
in vitro 13C NMR approaches, as compared to earlier radioactive isotope methods and more recent 
13C isotopomer approaches. In general, TCA cycle fl uxes calculated for the normoxic adult rat 
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Process/model Garfinkela
Van den Berg
and Garfinkelb
Kunnecke et al.,c
Preece and Cerdand
Mason et al.,e
  Sibson et al.,f,g
   Shen et al.,h
Lebon et al.i
TABLE 1.2. Tricarboxylic acid cycle and glutamate/glutamine exchange between the neuronal and glial
 compartments of the adult mammalian brain as calculated with different models and methodologies
Total cerebral TCA
cycle flux
(µmol/min/g)
Neuronal TCA
cycle flux
(µmol/min/g)
Glial TCA cycle flux
(µmol/min/g)
Size (µmol/g)/turnover
(per min) of large
glutamate pool
Size (µmol/g)/turnover
(per min) of small
glutamate pool
Net transfer of neuronal
glutamate to glial
compartment
(µmol/min/g)
Net transfer of glial
glutamine to neuronal
compartment
(µmol/min/g)
1.05
0.40
0.65
8.8/21.7
1.7/2.6
0.08m
0.45
1.5
1.2
0.3
7.0/5.7
1.25/4.16
0.14
n.a.
1.4
1.0
0.4
5.8/5.8
0.5/1.25
0.1
0.1
1.6 or 0.7,e 
0.6,f 1.0- 
0.2,g 0.8h
1.6,e 0.6,f 
1.0-0.2,g 
0.8h
0.14i
n.a.
n.d./7.7l
0.21,f 0.40-
0.0,g 0.32,h 
0.3i
0.21,f 0.40-
0.0,g 0.32,h 
0.3i
Gruetter
et al.j
0.6
0.6
  
  
  
0.3 (0.2)n
0.3 (0.2)k,n
Bluml
et al.k
0.84
0.70
0.14
n.a.
n.a.
n.a.
n.a.
aCalculated from specific radioactivity measurements in brain extracts obtained after intracranial injections of  various radioactive 
precursors including (U-14C)glutamate, (U-14C) aspartate, 14CO3H-, and 15NH4 acetate (Garfinkel, 1966)
bCalculated from specific radioactivity measurements in glutamate, glutamine, and aspartate from mouse brain extracts prepared after 
intraperitoneal injections of  14C-labeled glucose and acetate (van den Berg and Garfinkel, 1971)
cRelative flux values were calculated as described in (Kunnecke et al., 1993) and from the relative 13C isotopomer populations in 
glutamate, glutamine, and GABA measured by highresolution 13C NMR in rat brain extracts after infusion of  (1,2-13C2) acetate (Chapa 
et al., 1995)
dAbsolute flux values were determined from the relative values described in note c by measuring the absolute rate of  GABA accumulation 
induced by vigabatrin, a selective inhibitor of  GABA transaminase (Preece and Cerdan, 1996)
eDetermined in vivo from the kinetics of  13C enrichment in glutamate and glutamine C4 carbons from rat or human brain during infusion 
of  (1-13C) glucose, respectively (Mason et al., 1992a; Mason et al., 1995)
fDetermined in vivo from the kinetics of  13C labeling in glutamate and glutamine C4 (Sibson et al., 1997)
gDetermined in vivo from the kinetics of  13C enrichment in glutamate and glutamine C4, under different conditions of  morphine, 
α-chloralose, and pentobarbital anesthesia (Sibson et al., 1998a)
hDetermined in the human brain in vivo during (1-13C) glucose infusion. Glutamate/glutamine exchange concluded to be stoichiometric 
1:1 with CMRglc (Shen et al., 1999)
iDetermined in the human brain during metabolism of  (2-13C) acetate (Lebon et al., 2002)
jDetermined in the human brain during (1-13C) glucose infusion with a different model than that used in f-i (Gruetter et al., 2001)
kDetermined in the human brain during (1-13C) acetate metabolism (Bluml et al., 2002)
lDetermined in vivo as the inverse of  the rate constant of  13C labeling in cerebral glutamate C4 during (1-13C) glucose infusions (Mason 
et al., 1992b)
mOriginally proposed as an α-ketoglutarate exchange between the large and small compartments (Garfinkel, 1966)
nOnly a fraction of  glutamine synthesis considered to be derived from neurotransmitter glutamate. Glutamate/glutamine exchange 
concluded nonstoichiometric with CMRglc, approaching 0.4 rather than the value of  1 concluded in f-i (Gruetter et al., 2001)
n.a.; not applicable, n.d.; not detectable, Adapted from Cruz and Cerdan (1999). Reproduced with permission of  the publisher
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or human brain were in the range 0.5 - 1.4 µmol.min-1.g-1. More accurate measurements provide 
recently values for the neuronal TCA cycle fl ux in the vicinity of  0.5 µmol. min-1.g-1. This value may 
decrease to virtually undetectable levels with increasing states of  anesthesia (Sibson et al. 1998b) 
or increase by 25-50% with different cerebral activation protocols (Chhina et al. 2001; Hyder et al. 
1996; Hyder et al. 1997). TCA cycle fl uxes in the glial compartment of  rodent or human brain are in 
the range 0.4-0.14 µmol.min-1.g-1, representing approximately 20% of  the total cerebral TCA cycle 
activity. Table 1.2 also shows sizes and turnover rates of  the glutamate compartments associated to 
the “large” and “small” glutamate pools. No direct measurements exist to our knowledge of  these 
pool sizes. The values shown are based on the assumption that the small glutamate pool accounts 
for approximately 10% of  total cerebral glutamate during (1-13C) glucose metabolism. Recently it 
has been possible to determine simultaneously the relative labeling of  the large and small glutamate 
pools ex vivo using (1-13C) glucose and (2-13C, 2-2H3) acetate as substrates (Chapa et al. 2000).
Although there is strong evidence supporting fast α-ketoglutarate/glutamate exchange 
in the cytosolic and mitochondrial aminotransferases (Erecinska and Silver 1990), there is less 
information concerning the in situ activity of  the neuronal or glial dicarboxylate carrier and the 
glutamate-aspartate exchanger, which are responsible for α-ketoglutarate-glutamate exchange 
between mitochondria and cytosol in these cells. However, experiments with purifi ed mitochondrial 
preparations from brain incubated with (U-14C) glutamate, have revealed that the exchange of  α-
ketoglutarate-glutamate is slower than the TCA cycle fl ux in vitro (Berkich et al. 2005). Moreover, 
hydrogen turnover experiments, as monitored by (13C,2H) NMR, have recently revealed the 
existence of  more than one glutamate pool in the neuronal and glial compartments of  the adult rat 
brain ex vivo (Sierra et al. 2004). Taken together, these results suggest that α-ketoglutarate-glutamate 
exchange through the mitochondrial membrane of  neural cells is of  the same order of  magnitude 
or slightly slower than the TCA cycle fl ux. The infl uence of  these fi ndings on previous 13C NMR 
modeling results, which assumed fast α-ketoglutarate-glutamate exchange, remains to be analyzed.
The main advantage of  hydrogen turnover experiments over the classical 13C turnover 
approach is that hydrogen exchange occurs in a much faster time scale than 13C exchange (García-
Martín et al. 2002). Using (13C,2H) NMR it is possible to monitor faster processes, which could 
not be monitored with 13C NMR (García-Martín et al. 2001). Because most metabolite carbons are 
attached to one or more hydrogen atoms, 13C NMR additionally could serve as a valuable tool to 
analyze hydrogen turnover. This is a much faster process than 13C turnover and therefore allows 
studying faster reactions. Our laboratory has proposed a double labeling strategy to investigate 
hydrogen turnover. Our approach follows by 13C NMR spectroscopy the exchange of  pre-existing 
1H by 2H at the steady state, when metabolism occurs in media containing a 13C labeled substrate 
and 2H2O (Chapa et al. 2000; García-Martín et al. 2001; García-Martín et al. 2002; Hansen 1983; 
Moldes et al. 1994; Rodrigues and Cerdán 2007; Rodrigues et al. 2005). This is possible because 
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high-resolution 13C NMR spectroscopy is well suited to detect complex deuteration patterns in 13C 
labeled metabolites (Figure 1.8).
The presence of  one or more deuterons geminally or vicinally bound to the observed 13C 
implies the appearance of  characteristic 2H isotopic shifts and 2H-13C couplings (Dziembowska et 
al. 2004; García-Martín et al. 2001; García-Martín et al. 2002; Hansen 1983). Therefore, coupling 
patterns to 2H may appear as split and/or shifted resonances in relation to the perprotonated 
13C resonance. Figure 1.8 depicts this behavior. If  one of  the protons directly bonded to 13C 
is substituted by 2H, the original resonance is split into a 1:1:1 triplet (19.21 < 1JC-H < 22 Hz), 
inducing a geminal upfield isotopic shift (-0.25 < ∆1 < -0.33 ppm). Two or three deuterons bound 
to the same 13C atom would result in additive isotopic shifts and 2H-13C couplings patterns of  
Figure 1.8. 2H-13C multiplets and deuterium induced isotopic shifts in proton decoupled 13C MRS spectra. A: 
preprotonated carbon, B: vicinal deuteration, C-E: geminal deuteration by one, two or three deuterons. Simulations 
were performed with the program WINDAISY using the following parameters: 1JC-H = 20.06 Hz; geminal isotopic 
shift, ∆1 = -22.89 Hz/deuteron; vicinal isotopic shift, ∆2 = -9.89 Hz/deuteron. Reproduced from (Garcia-Martin et 
al. 2001) with permission of  the publisher.
27
Brain Energy Metabolism
fi ve or seven line multiplets, shifted by –0.5 or –0.75 ppm respectively. Even a vicinal deuterium 
substitution induces smaller and additive upfi eld isotopic shifts (-0.03 < ∆2 < -0.11 ppm). Vicinal 
couplings to deuterium are too small to be resolved and resonances shifted vicinally maintain the 
multiplet structure of  their geminal couplings. Thus high-resolution 13C NMR allows determining 
the number of  deuterium replacements, their relative contributions and their geminal or vicinal 
location with respect to the observed 13C carbon of  a specifi c 13C isotopomers through the analysis 
of  shifted and unshifted (1H,2H)13C multiplets. 
This kind of  approach makes it possible to develop novel procedures to investigate and resolve 
in time fast metabolic processes, as long as they involve exchange of  hydrogens by deuterons.  The 
exchange of  the different hydrogens of  glutamate and glutamine molecules by deuterons from 
heavy water is stereospecifi c (Cerdán et al. 2003). The H2 hydrogen of  glutamate is exchanged 
mainly by aspartate aminotransferase, while the H3proR and H3proS hydrogens are exchanged by 
aconitase and isocitrate dehydrogenase, respectively. The H4 hydrogens of  glutamate are derived 
from the methyl group of  acetyl-CoA and one of  them is exchanged during the citrate synthase 
reaction. This stereospecifi c exchange is conveniently illustrated by the sequence of  exchange of  
the H3proR and H3proS hydrogens of  (2-
13C) glutamate by deuterons from the solvent (Figure 1.9).
 High-resolution 13C NMR allows distinguishing between perprotonated, monodeuterated 
and doubly deuterated 13C labeled glutamate and glutamine isotopomers. This is possible because, 
deuterium substitutions induce readily observable, additive, isotopic shifts in 13C NMR resonances. 
It has been possible to show, in the perfused liver, that exchange of  the H3 hydrogens can be 
resolved in two different kinetic components (García-Martín et al. 2002). A fast exchange of  
either the H3proR or H3proS hydrogens occurs fi rst on pre-existing (2-
13C) glutamate or glutamine 
molecules. This fast process, substitutes only one of  the H3 hydrogens, in a way that substitution 
of  H3proR precludes substitution of  the H3proS and vice versa. The fast process may be catalyzed by 
either cytosolic aconitase or isocitrate dehydrogenases (NADP+). A slower double deuteration of  
the H3proR and H3proS occurs later, but is only possible on the (2-
13C) glutamate molecules newly 
synthesized during TCA cycle activity. Thus, the (13C,2H) NMR approach allows resolving the fast 
turnover of  cytosolic (2-13C, 3-2H) glutamate and the slower turnover of  (2-13C, 3,3’-2H2) glutamate 
produced in the TCA cycle. The fact that the fast and slow components of  H3 exchange can be 
resolved by (13C,2H) NMR indicates that the exchange of  glutamate across the inner mitochondrial 
membrane is slow in the H3 hydrogen exchange timescale.
Finally, despite their enormous potential in the evaluation of  metabolic pathways in vivo 
and in vitro, 13C NMR procedures (and to a smaller extent 31P NMR or 1H NMR) are limited by 
their low sensitivity and spatial resolution. Unfortunately, in vivo and in vitro 13C NMR spectra are 
often obtained from relatively large voxels (up to ca. 50 mL in humans) or extracts prepared from 
suffi ciently large tissue biopsies, respectively. These often include, the weighted contributions from 
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Figure 1.9. The turnover of  the H3 hydrogens of  cerebral glutamate and glutamine reveals subcellular 
compartmentation. A fast deuterium exchange occurs in the H3proS or H3proR hydrogens of  pre-existing molecules 
of  (2-13C) glutamate during the metabolism of  (1-13C) glucose, catalyzed by cytosolic isocitrate dehydrogenase 
(NADP+) or aconitase, respectively. A slower double exchange of  the H3proR and H3proS  occurs only in newly formed 
(2-13C) glutamate molecules in the TCA cycle (upper panel). Additive isotopic shifts make it possible to distinguish 
between perprotonated (2-13C) glutamate (GLU C2) or glutamine (GLN C2) (singlets, s), (2-13C, 2H) glutamate or 
glutamine (shifted singlets, ss) and (2-13C, 3,3’-2H2) glutamate or glutamine (doubly shifted singlet, dss) by high 
resolution (13C, 2H) NMR (lower panel). Deuterons are indicated by black triangles. 13C atoms are shown as grey 
circles.
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grey and white matters, as well as from smaller cerebral structures, making it not possible to resolve 
the metabolism of  individual neurons or astrocytes.
7.3. Dual Photon NADH Fluorescence Microscopy
Dual photon fl uorescence microscopy is able to provide cellular resolution of  fl uorescent 
indicators at moderate tissue depths smaller than 0.5 mm (Gratton et al. 2001; Kim and Schwille 
2003). The technique is based on classical approaches used previously to measure surface 
fl uorescence (single photon) of  NADH (Chance 2004). Dual photon fl uorescence microscopy 
uses pulsed laser excitation with two photons, the emission being detected with confocal optics. 
Advantages of  the technique over classical single photon fl uorescence involve deeper penetration 
(because of  the lower wavelength of  the excitation pulses), lower “bleaching” and the possibility 
to use longer examination times because of  the lower energy involved. NADH fl uorescence is 
particularly attractive from the point of  view of  TCA cycle activity measurements. A net increase 
in glycolytic activity is revealed by increased NADH fl uorescence and a net increase in TCA cycle 
activity is associated to a decrease in NADH fl uorescence. Notably, the important limitation of  
dual photon NADH fl uorescence stems from the fact that only net increases or decreases in 
NADH can be measured. This reveals the net metabolic balance between NADH producing and 
consuming pathways only, but not the individual activities of  glycolysis or the TCA cycle. Thus, it 
is not appropriate to interpret net NADH changes as revealing exclusively glycolytic or TCA cycle 
activity, since they could contain opposite contributions from either or both processes.
8. The Cerebral Tricarboxylic Acid Cycles During Cerebral Activation
8.1. The Metabolic Coupling Hypothesis
Figure 1.10 summarizes the main aspects of  the Astrocyte to Neuron Lactate Shuttle (ANLS) 
metabolic coupling hypothesis between neurons and glia during glutamatergic neurotransmission, 
according the early formulations of  Pellerin, Tsacopoulos and Magistretti (Pellerin and Magistretti 
1994; Tsacopoulos and Magistretti 1996). Their interpretation was based on pioneering experiments 
on the honey bee drone retina, demonstrating that these Muller cells released alanine to the 
medium during photostimulation (Tsacopoulos et al. 1994). These results were soon confi rmed 
with preparations of  brain astrocytes, showing that these cells liberated lactate (instead of  alanine) 
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to the incubation medium after a glutamate challenge (Pellerin and Magistretti 1994). Together, 
these fi ndings matched well with earlier evidences on cerebral activation in vivo as derived from 
autoradiography, PET, fMRI and NMR Spectroscopy (Magistretti and Pellerin 1999; Magistretti 
and Pellerin 2000).
After presynaptic action potential on glutamatergic neurons, glutamate is released to the 
synaptic cleft and then recaptured by the surrounding astrocytes. Presynaptic glutamate release 
largely exceeds the amount needed for neurotransmission, making extracellular glutamate levels 
to increase transiently from approximately 4-5 µM in the resting state, to well over 100 µM just 
after its release from presynaptic vesicles. These high glutamate concentrations could preclude 
further neurotransmission events or even become neurotoxic, unless rapidly cleared from the 
Figure 1.10. The traditional metabolic coupling hypothesis between neurons and glial cells during 
glutamatergic neurotransmission. Glutamate released to the synaptic cleft during glutamatergic neurotransmission 
is co-transported with Na+ to the astrocytes. Astroglial Na+ is exchanged by extracellular K+ through the Na+/K+ 
ATPase, consuming one ATP molecule. Astrocytic glutamate produces glutamine through glutamine syntethase, 
consuming one additional ATP molecule. Lactate produced exclusively in astroglial glycolysis to support these 
energy demands, is extruded to the extracellular medium, taken up by the surrounding neurons and oxidized as their 
main metabolic fuel. Note the apparent stoichiometric coupling between glutamate-glutamine cycling and glucose 
uptake as well as the exclusive glycolytic or oxidative metabolisms in astrocytes and neurons, respectively. MCT1 
and MCT2: monocarboxylate transporters 1 and 2. GLUT 1 and GLUT 3: glucose transporters 1 and 3. PGK: 
Phosphoglycerate kinase. Adapted with permission from (Tsacopoulos and Magistretti 1996).
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synapses. This vital task is performed by the astrocytes surrounding the synapses, which are 
able to remove the large excess of  synaptic glutamate through their highly effi cient glutamate 
transporters. Glutamate is co-transported to the astrocyte together with three Na+, which need 
to be returned into the extracellular medium in order to restore the membrane potential. This 
is thought to involve the activity of  the Na+/K+ ATPase, at the expense of  one ATP molecule. 
Once in the astrocyte, glutamate is amidated to glutamine by glutamine synthetase, an exclusively 
astrocytic enzyme consuming one additional ATP molecule. Thus, complete transformation of  
astrocytic glutamate into glutamine demands two ATP molecules, which were originally proposed 
to be derived exclusively from the anaerobic metabolism of  glucose. According to this proposal, 
astrocytes would only need the anaerobic degradation of  one glucose molecule taken from nearby 
capillaries to transform one glutamate molecule into glutamine, in a process producing two lactate 
molecules. Glutamine or lactate released from astrocytes would be taken up by the neurons, to 
regenerate neurotransmitter glutamate or become oxidized in the neuronal TCA cycle to maintain 
neuronal energetics, respectively. On these grounds, glutamatergic neurotransmission was proposed to 
be stoichiometrically coupled to astrocytic glucose uptake and lactate production, the latter becoming 
the main oxidative fuel for neurons (Magistretti et al. 1999; Rothman et al. 1999; Shulman et al. 2004).
8.2. 13C NMR Evidences and the Neuronal Tricarboxylic Acid Cycle
Early in vivo 13C NMR experiments provided support to this hypothesis (Sibson et al. 1997; 
Sibson et al. 1998a). Authors infused (1-13C) glucose and followed its brain metabolism using 13C 
NMR. It was possible to observe the accumulation of  13C label in the C4 carbons of  glutamate 
and glutamine (Figures 1.11-A and 1.11-B). The turnover of  the C4 carbon of  glutamate was 
considered to refl ect the activity of  the neuronal TCA cycle (VTCAn) while the turnover of  the 
glutamine C4 carbon was thought to indicate the turnover of  the glutamate-glutamine cycle (Vcycle). 
The results obtained confi rmed earlier measurements of  the cerebral TCA cycle fl ux in vivo (VTCAn 
= 0.5-0.6 µmol.min-1.g-1), assuming its predominant neuronal location under these conditions. It 
was also possible to calculate the fl ux through glutamine synthetase (0.2 µmol. min-1.g-1), describing 
that it accounted for a major part of  glutamate turnover in the brain. These in vivo results were 
consistent with the stoichiometric coupling of  glucose metabolism and glutamate-glutamine 
cycle. Further experiments monitored dynamically the cerebral metabolism of  (1-13C) glucose in 
rats subjected to increasing degrees of  anesthesia obtained with α-chloralose, morphine or 
pentobarbital (Figure 1.11-C). Quantitative analysis of  the time courses of  13C enrichments in 
glutamate and glutamine C4, with the help of  a minimal mathematical model of  the neuronal TCA 
cycle and the glial glutamine synthetase, revealed that the glutamate-glutamine cycle is a major 
pathway of  cerebral metabolism accounting for up to eighty percent of  the energy derived from 
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glucose oxidation in the brain (Rothman et al. 2003).
An important aspect of  these studies concerned the energetics of  glutamatergic 
neurotransmission. For a TCA cycle fl ux of  0.6 µmol.min-1.g-1 and a glutamate-glutamine cycle 
fl ux of  0.2 µmol.min-1.g-1, the cerebral oxidative ATP production capacity approaches 20.4 µmol.
min-1.g-1, while the ATP demand for glutamine synthesis is 0.4 µmol.min-1.g-1. Thus, glutamine 
production and the glutamate-glutamine cycle account only for approximately 2% of  the energy 
produced during glucose oxidation, the rest being invested in the maintenance of  presynaptic and 
postsynaptic resting, action potentials, as well as other processes associated to neurotransmission. 
Figure 1.11. The cerebral tricarboxylic acid cycle and glutamatergic neurotransmission as detected by in 
vivo 13C NMR. A: Consecutive 13C NMR spectra of  rat brain during (1-13C) glucose infusion (Sibson et al. 1997). 
B: In vivo kinetics of  13C enrichment in cerebral glutamate C4 and glutamine C4 during (1-13C) glucose infusion, 
thought to represent the neuronal TCA cycle and the glutamine cycle, respectively (Sibson et al. 1997). C: Apparent 
stoichiometric relationship between the Cerebral Metabolic Rate for glucose oxidation (CMRglc) and the glutamate-
glutamine cycle fl ux (Vcycle), during the metabolism of  (1-
13C) glucose in the brain of  rats subjected to increasing 
degrees of  anesthesia (Sibson et al. 1998a). Reproduced with permission of  the publisher.
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This balance matches well the calculations of  Attwell and Iadecola who proposed an energy budget 
to interpret the energetics of  cerebral activation as observed in fMRI experiments (Atwell and 
Iadecola 2002). Their conclusions indicated that in rodents, 2% of  cerebral energy is dedicated to 
Figure 1.12. Role of  the astroglial tricarboxylic acid cycle supporting glutamatergic neurotransmission. 
Trifluoacetic acid (TFA) or methionine sulfoximine (MSO) strategies to inhibit the astroglial TCA cycle or glutamine 
syntethase, respectively (upper panel). Effects of  TFA or MSO on the steady state labeling of  (4-13C) glutamate, (4-
13C) glutamine and (2-13C) GABA after (1-13C) glucose infusions (lower panels). Reproduced from (Garcia-Espinosa 
et al. 2003) with permission of  the publisher.
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maintaining the glutamate-glutamine cycle, the remaining being invested in maintaining the resting 
membrane potential or presynaptic and postsynaptic action potentials. 
8.3. The Astroglial Tricarboxylic Acid Cycle
An important limitation of  these interpretations based on fMRI experiments relied on the 
neglected role of  the astroglial TCA cycle during glutamine synthesis and under conditions of  
cerebral activation. To address this aspect more specifi cally, other authors infused (1-13C) glucose 
in the presence and absence of  trifl uoroacetic acid (TFA), a selective inhibitor of  the astroglial 
TCA cycle or methionine sulfoximine (MSO), a selective inhibitor of  glutamine synthetase (García-
Espinosa et al. 2003). TFA inhibited ca. 60% of  glutamine synthesis, revealing a predominant 
contribution of  the glial TCA cycle to the energy used in glutamine synthesis (Figure 1.12). 
This fi nding introduced an important modifi cation over pre-existing concepts which considered 
glutamine synthesis exclusively dependent on glycolytic ATP production (García-Espinosa et al. 
2004). These results also showed that complete inhibition of  glutamine synthesis with MSO did 
not abort glutamate turnover, as it would be expected for a precise stoichiometric coupling of  
the glutamate-glutamine cycle. In contrast, the experiments showed that approximately 40% of  
cerebral glutamate was not derived from astroglial glutamine, suggesting that additional neuronal 
precursors such as glucose or lactate, should play an important role in its synthesis. Notably, non-
stoichiometric coupling of  the glutamine cycle with glucose uptake has also been found during 
(1-13C) glucose metabolism, with very similar data and a different model of  cerebral metabolism 
(Gruetter et al. 2001). Taken together these studies disclosed an important role for the astroglial 
TCA cycle supporting astrocytic energetics and glutamine synthesis, revealing that the coupling 
mechanisms between neurons and glial cells during glutamatergic neurotransmission were more 
complex than those initially envisioned.
9. Aim, Scope and Outline of  Thesis
This thesis covers mainly pyruvate and lactate metabolism in the neuronal and glial 
compartments as well as their intercellular interactions. Monocarboxylate exchange and metabolism 
represent a crucial cross roads of  cerebral metabolism, participating in intercellular signalling 
and coupling processes as well as energetic substrates. The central role of  monocarboxylates 
and their different functions complicate the methods to analyze unambiguously each one of  the 
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contributions to their overall cerebral metabolism. To overcome these limitations I combined in 
this thesis the classical neurochemical approach with more recent methodologies, including mainly 
13C and (13C,2H) NMR strategies. I emphasize an integrative interpretation of  previous neuroglial 
metabolic coupling hypotheses with the results communicated in this work, including the presence 
of  subcellular compartmentation of  pyruvate and glutamate and monocarboxylate recycling 
through the plasma membrane. 
The goal of  each chapter is to stand as an individual contribution with independence of  
the others, to facilitate independent reading. In order to present the thesis as a collection of  self-
standing, and independent chapters, the corresponding methodology, results and reference sections 
are included in each chapter. Nevertheless, the overall and progressive reading of  this thesis will 
provide the interested reader with a wider coverage and a better understanding of  “the entire 
story”.
Chapter 1 contains an introductory section with a fundamental overview to defi ne the 
state-of-the-art of  the general brain functions and metabolism. The main pathways of  the brain 
energetics and the techniques applied for its study are described in detail. In particular, an integrative 
description of  the cerebral metabolism, centered in pyruvate is presented and the NMR methods 
are explained, in order to allow better analysis and discussion in the following chapters. 
Lactate recycling between extracellular space and the cytosolic pools of  pyruvate through the 
monocarboxylate transporters of  the plasma membrane and the lactate dehydrogenase isozymes 
are discussed in Chapters 2 and 3. For this purpose, novel (13C,2H) and 1H NMR approaches were 
developed and implemented to characterize this recycling process. In particular, using (13C,2H) 
NMR we were able to demonstrate that the deuteration process involved in lactate recycling is 
redox sensitive.
The results gathered in the previous chapters lead us to propose a novel hypothesis describing 
the mechanisms underlying the neuroglial coupling in the brain, including the presence of  subcellular 
compartmentation of  pyruvate and monocarboxylate recycling through the plasma membrane of  
both neurons and glial cells. Chapter 4 is then dedicated to the investigation of  the mechanisms 
underlying this Redox Switch/Redox Coupling hypothesis, as well as its kinetic properties, in primary 
cultures of  cortical neurons and astrocytes from rat brain. Additionally, we also analyzed the current 
interpretations on the cellular and subcellular compartmentation of  TCA cycle during glutamatergic 
neurotransmission, on the basis of  the novel transcellular redox coupling mechanism.
Finally, Chapter 5 focuses on the interactions between dopaminergic and glutamatergic 
neurotransmission systems. Despite the neurobiological and clinical relevance of  these interactions, 
the underlying mechanisms remain poorly understood. Our approach, combining 13C NMR 
spectroscopy, molecular biology and behavioural techniques provided new insight into the mechanisms 
of  interaction between glutamatergic and dopaminergic systems.
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1. Abstract
We report a novel (13C,2H) Nuclear Magnetic Resonance (NMR) procedure to investigate lactate 
recycling through the monocarboxylate transporter (MCT) of  the plasma membrane of  cells in 
culture. C6 glioma cells were incubated with (3-13C) lactate in Krebs-Henseleit Buffer containing 
50% 2H2O (vol/vol) for up to 30 h. 
13C NMR analysis of  aliquots progressively taken from the 
medium, showed: (i) a linearly decreasing singlet at ca. 20.85 ppm (-0.119 µmol.mg protein-1.h-1) 
derived from the methyl carbon of  (3-13C) lactate and (ii) an exponentially increasing shifted singlet 
at ca. 20.74 ppm (0.227 µmol.mg protein-1.h-1) from the methyl carbon of  (3-13C, 2-2H) lactate. The 
shifted singlet appears because during transit through the cytosol, (3-13C) lactate generates (3-13C, 
2-2H) lactate in the lactate dehydrogenase (LDH) equilibrium, which may return to the incubation 
medium through the reversible monocarboxylate carrier. The methyl group of  (3-13C, 2-2H) lactate 
is shifted -0.11 ppm with respect to that of  (3-13C) lactate, making it possible to distinguish between 
both molecules by high-resolution 13C NMR. During incubations with 2.5 mM (1-13C) glucose 
and 3.98 mM (U-13C3) lactate or with 2.5 mM (1-
13C) glucose and 3.93 mM (2-13C) pyruvate, C2-
deuterated lactate was produced only from (1-13C) glucose or (U-13C3) lactate, revealing that this 
deuteration process is redox sensitive. When (1-13C) glucose and (U-13C3) lactate were used as 
substrates, no signifi cant (3-13C) lactate production from (1-13C) glucose was detected, suggesting 
that glycolytic lactate production may be stopped under the high lactate concentrations prevailing 
under mild hypoxic or ischemic episodes or during cerebral activation.
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2. Introduction
Lactate is thought to play a central role in cerebral pathophysiology both as an energy substrate 
for the brain and as a metabolic coupling intermediate between neurons and glial cells (Bouzier-
Sore et al. 2001; Bouzier-Sore et al. 2006; Bouzier-Sore et al. 2003; Bouzier et al. 1998a; Bouzier et al. 
1998b; Cater et al. 2003; Cerdán et al. 2006; Dienel and Hertz 2001; Hertz 2004; Pellerin 2003; Qu 
et al. 2000; Smith et al. 2003). In particular, lactate is believed to provide the coupling mechanism 
between the increased consumption of  glucose observed during cerebral activation and the energy 
demanded by neurons during glutamatergic neurotransmission (Dienel and Cruz 2003; Dienel 
and Hertz 2001; García-Espinosa et al. 2003; García-Espinosa et al. 2004; Magistretti and Pellerin 
1997; Magistretti and Pellerin 1999; Pellerin et al. 2002). Moreover, lactate is thought to serve as 
a vital substrate for neuronal recovery after hypoxia or ischemia (Cater et al. 2003; Muller et al. 
1994; Schurr 2002; Schurr et al. 2001), to contribute primarily to cerebral energetics (Pellerin and 
Magistretti 2004) and to modulate intra- and extracellular pH (García-Martín et al. 2001a; Gillies et 
al. 2004). 
Intracellular lactate production is normally small under physiological conditions, increasing 
signifi cantly in hypoxic or ischemic situations (Cater et al. 2003; Schurr 2002; Schurr et al. 2001). In 
these circumstances, the respiratory chain is unable to reoxidize the reducing equivalents produced 
by glycolysis, causing pyruvate to be reduced to lactate rather than oxidized (Perrin et al. 2002). 
Increased intracellular lactate may then be extruded to the extracellular space through the proton-
linked monocarboxylate transport (MCT) (Halestrap and Meredith 2004; Halestrap and Price 1999; 
Jackson and Halestrap 1996; Pierre and Pellerin 2005; Sierra et al. 2007). Reduced oxygen tension 
and compromised blood fl ow occurring under hypoxic or ischemic conditions preclude lactate 
oxidation and removal, resulting in lactate accumulation in the extracellular space. Under these 
conditions, extracellular lactate may reach concentrations even higher than those found in the 
intracellular space, eventually returning back to the cytosol, down its concentration gradient through 
the reversible MCT. Lactate molecules, however, are able to recycle between the extracellular and 
intracellular compartments, an advantageous situation that makes lactate ubiquitously available. 
Despite intensive research on lactate metabolism, however, to our knowledge no previous studies 
have investigated lactate recycling through the plasma membrane. This is due probably to the 
necessity to distinguish between lactate transport and metabolism and to differentiate those 
lactate molecules entering the cell from those leaving it, a very diffi cult aspect for conventional 
methodologies.
Recently, our laboratory has proposed and implemented hydrogen turnover measurements as 
alternatives to the classical approaches based on 13C or 14C turnover (Chapa et al. 2000; García-
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Martín et al. 2001b; García-Martín et al. 2002; Rodrigues and Cerdán 2005). Our method uses 
13C NMR to follow the exchange of  preexisting 1H by 2H, when metabolism occurs in media 
containing a 13C-labeled substrate and 2H2O (García-Martín et al. 2002; Hansen 1989; Moldes et al. 
1994). We herein report on an extension of  this approach to monitor lactate recycling in cultures 
of  C6 glioma cells. The method is based on the fact that the H2 hydrogen of  lactate is exchanged 
rapidly by a deuteron in the LDH equilibrium, only in those lactate molecules that have passed 
through the cytosol. 
 
3. Materials and Methods
3.1 Cell Culture and Incubation Conditions
The experimental protocols used in this study were approved by the appropriate institutional 
review committees and meet the guidelines of  their responsible governmental agency. C6 glioma 
cells were obtained from a local representative of  the American Tissue Culture Collection (LGC 
Promochem, Barcelona, Spain). Briefl y, C6 glioma cells were grown to confl uence in Dulbecco’s 
modifi ed Eagle’s medium (DMEM) supplemented with 5% fetal bovine serum (FBS), 100 µg/
mL streptomycin, 25 µg/mL gentamycin, 100 units/mL of  penicillin and fungizone (1% vol/vol). 
Cells were cultured in sterile Petri dishes (10-cm diameter) maintained in an incubator at 37 °C with 
a humidifi ed atmosphere containing 5% CO2 and 95% O2. For the incubations (3-30h, 37 ºC), the 
culture medium was replaced by Krebs-Henseleit Buffer (KHB) (NaCl, 119 mM; KCl, 4.7 mM; 
CaCl2, 1.3 mM; MgSO4, 1.2 mM; HEPES, 15 mM and KH2SO4, 1.2 mM) containing 50% (vol/vol) 
2H2O with the following combinations of  
13C-labeled substrates: i) 5 mM (3-13C) lactate, ii) 2.5 
mM (1-13C) glucose +  3.98 mM (U-13C3) lactate, (iii) 2.5 mM (1-
13C) glucose + 3.93 mM (2-13C) 
pyruvate, and (iv) 2.5 mM (1-13C) glucose. Aliquots (1 mL) from the medium were collected during 
the incubation period to measure the rates of  substrate utilization and product formation by 13C 
NMR and conventional spectrophotometric methods. 
3.2 (13C,2H) NMR Spectroscopy
Proton-decoupled 13C NMR spectra from 0.5-mL aliquots of  the incubation medium were 
obtained at 11.9 Tesla (125.13 MHz, 25 ºC, pH 7.2) with a Bruker AVANCE 500WB NMR 
spectrometer using a commercial (5-mm) triple resonance probe (1H,13C,2H) optimized for direct 13C 
NMR detection. Acquisition conditions were: π/3 pulses, 30.0 kHz spectral width, 1.09 s acquisition 
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time, 64k words data table and 6.0 s recycling time. Proton decoupling was gated on only during 
the acquisition using a broad band composite pulse decoupling (CPD) sequence that removed the 
scalar 13C-1H multiplets, maintaining 13C-13C and 13C-2H couplings. Chemical shifts were calibrated 
with an external reference of  dioxane (10% vol/vol, 67.4 ppm). Resonance assignments were based 
on literature values and on the addition of  internal standards (Cerdán et al. 1990; Fan 1996). Spectra 
deconvolution and multiplet structures were analyzed using a PC-based (Intel Centrino Platform) 
NMR processing program, NUTS™ (Acorn, Freemont, CA, USA).
High-resolution 13C NMR is well suited to detect complex deuteration patterns in 13C-labeled 
metabolites. This happens because the presence of  one or more 2H atoms bound vicinally or 
geminally to the observed 13C results in the appearance of  characteristic 2H-induced isotopic shifts 
and 13C-2H couplings (Hansen 1983; Hansen 1988). In the case of  (3-13C) lactate, the substitution 
of  one of  the H3 hydrogens of  the methyl group by one deuteron causes the geminal C3 methyl 
resonance to be: (i) shifted  (∆1 ca. -0.27 ppm) as well as (ii) split into a 1:1:1 triplet (
1J2H-13C = 
19.5 Hz). A smaller isotopic shift is also detected in the C3 lactate resonance (∆2 = -0.11 ppm), 
upon deuterium substitution of  the vicinal H2 hydrogen by a deuteron. In this case, the singlet 
multiplicity of  the original 13C resonance is maintained because the vicinal coupling constant 2H-
13C is too small to be resolved. The isotopic shifts are additive and thus analysis of  shifted and 
unshifted (1H,2H)13C multiplets of  the lactate C3 resonance allows one to detect the number of  
deuterium replacements both in C3 and C2 carbons of  (3-13C) lactate (Chapa et al. 2000; García-
Martín et al. 2001a; García-Martín et al. 2001b; Moldes et al. 1994; Rodrigues and Cerdán 2005). 
3.3 Other Determinations
Glucose and lactate concentration in the incubation media were determined 
spectrophotometrically using classical enzymatic end point methods (Bergmeyer 1983) coupled 
to the increase or decrease in NAD(P)H absorption at 340 nm. The conventional methods were 
adapted to become operative using 96-well microplates (0.25 mL) and a vertical microplate reader 
(Molecular Devices, Spectramax, CA, USA). Protein concentrations were measured using the 
bicinchoninic acid (BCA) assay (SIGMA Chemical Co., St. Louis, MS, USA). Linear (y=m.x +b) 
and nonlinear exponential (y = a (1-e-bx)) fi ttings were carried out using the Sigma Plot program 
(SPSS Inc., Chicago, IL, USA) as implemented on a Intel Centrino platform.
3.4 Materials
(1-13C) glucose, (U-13C) lactate, (2-13C) pyruvate, (3-13C) lactate (99.9% 13C) and deuterated 
solvents were obtained from Cambridge Isotope Laboratories (Andover, MA, USA). 2H2O (99.9% 
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2H) was obtained from Apollo Scientifi c Ltd. (Stockport, Cheshire, UK). Auxiliary enzymes and 
cofactors were from Boehringer Mannheim (Germany). FBS and DMEM were purchased from 
GIBCO BRL (Gent, Belgium). The rest of  the reagents were of  the highest purity available 
commercially from SIGMA Chemical Co. (St. Louis, MS, USA).
4. Results
We propose to investigate lactate recycling using the methodology presented in Figure 2.1. 
Figure 2.1-A illustrates the results of  a representative experiment with C6 glioma cells incubated 
with 5 mM (3-13C) lactate in the presence of  KHB containing 50% 2H2O (vol/vol). 
13C NMR 
analysis of  aliquots taken from the medium at increasing incubation times showed: (i) a linear 
decrease in the intensity of  the singlet resonance from C3 lactate (ca. 20.85 ppm); and (ii) an 
exponential increase in the intensity of  a vicinally shifted singlet from (3-13C, 2-2H) lactate (ca. 
20.74 ppm, arrows). A summary of  three similar experiments is shown in Figure 2.1-B. The shifted 
lactate resonances (Figure 2.1-A, arrows) do not appear in cell-free incubations of  KHB (50% 
2H2O) with (3-
13C) lactate, nor during incubations of  C6 cells with (3-13C) lactate in undeuterated 
KHB (not shown). These results indicate that the shifted resonances are derived from the methyl 
group of  (3-13C, 2-2H) lactate as produced by the enzymatic deuteration of  intracellular (3-13C) 
lactate in its C2 carbon. This process necessarily involves the cytosolic LDH equilibrium:
Pyruvate + NAD(2H) + H+ ↔ (2-2H) Lactate + NAD+                       [2.1]
The sequence of  events is illustrated in Figure 2.1-C. Extracellular lactate enters the cytoplasm 
of  the C6 cell through the monocarboxylate transporter MCT1. Once in the cytosol, it loses 
its H2 hydrogen by exchange with one deuteron from the solvent, as incorporated through the 
LDH equilibrium (Equation [2.1]). Finally, the cytosolic (3-13C, 2-2H) lactate produced in this way, 
may eventually abandon the cell (together with a H+) through the reversible MCT1 transporter, 
becoming detectable by 13C NMR in the incubation medium (Figure 2.1-A arrows, Figure 2.1-B). 
Intracellular (3-13C) lactate, however, may be either oxidized in the TCA cycle, resulting in the linear 
decrease of  the total signal intensity from (3-13C) lactate, or recycled to the incubation medium, 
originating the exponential increase of  the isotopically shifted singlets shown in Figures 2.1-A 
and 2.1-B, respectively. In these experiments, it was possible to determine a net (3-13C) lactate 
consumption of  0.119 ± 0.012 µmol.mg protein-1.h-1 and a time constant for lactate extrusion of  
Chapter 2
52
Figure 2.1.  Demonstration of  lactate recycling by 13C NMR (125.13 MHz, 25 oC, pH 7.2) in the medium 
of  C6 glioma cells incubated with 5 mM (3-13C) lactate in buffer containing 50% 2H2O (vol/vol). A: 
Representative time course of  the 13C resonances from the methyl groups of  (3-13C) and (3-13C, 2-2H) lactate 
(arrows). B: Linear (3-13C) lactate consumption (empty squares) and exponential (3-13C, 2-2H2) lactate production 
(full squares). C: Extracellular (3-13C) lactate (Laco, unshifted) enters the cytosol (Laci) through the MCT1 transporter. 
(3-13C) Laci loses its H2 hydrogen and incorporates a deuteron from NAD(
2H) in the LDH equilibrium. (3-13C, 2-
2H) Laci abandons the cell through the reversible MCT1 transporter originating the shifted singlet (
2H-Laco) in 
the incubation medium detected in Figure 2.1-A (arrows). LDH: lactate dehydrogenase, MCT1: monocarboxylate 
transporter 1.
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0.227 ± 0.031 h-1. For an intracellular lactate concentration of  ca. 5 mM, it is possible to calculate a 
lactate extrusion fl ux of  1.135 ± 0.155 µmol.mg protein-1.h-1 under these conditions. This indicates 
that lactate equilibration through the MCT is very rapid, occurring approximately ten times faster 
than the net lactate uptake. At the end of  these experiments, the relative ratios of  shifted and 
unshifted areas of  the methyl resonances of  lactate approached 0.5, suggesting that molecules of  
(3-13C) lactate deuterated and non deuterated in C2 lactate have virtually reached equilibrium with 
the ca. 50% deuterated solvent.
Figure 2.2 shows that lactate recycling is also observed in the presence of  physiologic 
concentrations of  glucose. In this experiment, C6 cells were incubated with 2.5 mM (1-13C) glucose 
and 3.98 mM (U-13C3) lactate in KHB containing 50% 
2H2O (vol/vol). Because the C3 resonance 
derived from (U-13C3) lactate is a doublet (
1JC2-C3 = 37.0 Hz) whereas the lactate C3 resonance 
derived from (1-13C) glucose is a singlet, it became possible to follow simultaneously the changes in 
concentration of  the different (13C,2H) isotopomers of  lactate derived from (1-13C) glucose or (U-
13C3) lactate, respectively. Figure 2.2-A shows that (3-
13C) lactate production from (1-13C) glucose 
was negligible as judged from the virtually unobservable (3-13C) lactate singlet after 9h incubation 
(dotted arrow). Under these conditions, most of  the recycled lactate (full arrows) was the doublet 
derived from the methyl group of  (U-13C3, 2-
2H) lactate, as produced from added (U-13C3) lactate. 
Consumption of  glucose (expressed in triose units) and lactate were linear with values of  0.240 ± 
0.084 µmol.mg protein-1.h-1 and 0.360 ± 0.071 respectively (Figure 2.2-B). Lactate extrusion was 
exponential, with a time constant of  0.489 ± 0.082 h-1, corresponding for ca. 4 mM lactate, to a 
recycled lactate effl ux of  1.94 ± 0.34 µmol.mg protein-1.h-1. Lactate recycling appears therefore to 
occur, again in this case, signifi cantly faster than glucose or lactate metabolism.
We next investigated the effect of  a more oxidized substrate on lactate production and recycling 
from glucose. C6 cells were incubated with 3.93 mM (2-13C) pyruvate and 2.5 mM (1-13C) glucose 
in KHB containing 50% 2H2O (vol/vol; Figure 2.3-A). Under these conditions, (3-
13C) lactate and 
(3-13C, 2-2H) lactate (full arrow) were produced from glucose in small but approximately equal 
amounts. Notably, no signifi cant amounts of  (2-13C, 2-2H) lactate derived from (2-13C) pyruvate 
were observed, as revealed by the absence of  the corresponding 1:1:1 triplets refl ecting geminal 
13C-2H coupling of  lactate C2 (dotted arrow). Moreover, the lactate C2 resonance depicted a 
1:2:1 structure, revealing the additive isotopic shifts (∆2 = -0.045 ppm) from a 1:2:1 mixture of  
vicinally deuterated isotopomers: (2-13C), (2-13C, 3-2H) and (2-13C, 3,3’-2H2) lactates, respectively. 
This distribution is consistent with an equilibrium deuteration on the two exchangeable hydrogens 
of  the methyl carbon of  (2-13C) lactate, derived from (3-13C, 3-2H) or (3-13C, 3,3’-2H2) malate in 
the TCA cycle. (2-13C) lactate produced from (2-13C) pyruvate thus does not appear to incorporate 
deuterons in H2, whereas (1-13C) glucose produces similar amounts of  (3-13C) and (3-13C, 2-2H) 
lactate. In these experiments, (2-13C) pyruvate consumption was linear only during the fi rst four 
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Figure 2.2. Lactate recycling during metabolism of  2.5 mM (1-13C) glucose and 3.98 mM (U-13C3) lactate 
in buffer containing 50% 2H2O (vol/vol) as detected by 13C NMR (125.13 MHz, 25 oC, pH 7.2). A: Doublet 
resonances from the methyl groups of  (U-13C3) or (U-
13C3, 2-
2H) lactate (full arrows) at 0 h and 9 h incubation time. 
Note the reduced intensity of  the (3-13C) lactate singlet derived from (1-13C) glucose after 9 h incubation (dotted 
arrow). B: Linear consumption of  (U-13C3) lactate (empty squares) and (1-13C) glucose (empty circles). Exponential 
production of  (U-13C3, 2-
2H) lactate (full squares). Note the small production of  (3-13C) lactate (empty diamonds). 
Figure 2.3. Lactate recycling during metabolism of  2.5 mM (1-13C) glucose and 3.93 mM (2-13C) pyruvate 
in KHB (50% 2H2O (vol/vol)) as detected by 13C NMR (125.13 MHz, 25 oC, pH 7.2). A: Singlet resonances 
from (2-13C) lactate (69.3 ppm, left panel) and (3-13C) lactate (20.85 ppm, right panel) after 9 h incubation. Note 
the 1:2:1 distribution of  the (2-13C) lactate resonances and the absence of  the 1:1:1 triplet of  (2-13C, 2-2H) lactate 
(dotted arrow). Note the 1:1 ratio of  shifted (full arrow)/unshifted singlets in (3-13C) lactate. B: Consumption of  (2-
13C) pyruvate (empty squares) or (1-13C) glucose (empty circles) and production of  (2-13C) lactate (empty triangles) 
or (3-13C) lactate (empty diamonds).
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hours of  the experiment as 1.087 ± 0.110 µmol.mg protein-1.h-1. Glucose consumption remained 
linear for a longer period, with a value of  0.350 ± 0.110 µmol. mg protein-1.h-1 (expressed in triose 
units); (3-13C) and (2-13C) lactate were produced at rates of  0.063 ± 0.021 and 0.155 ± 0.014 µmol. 
mg protein-1.h-1, respectively.
Finally, we explored the production of  undeuterated and deuterated lactate molecules during 
the metabolism of  (1-13C) glucose. C6 cells were incubated with 2.5 mM (1-13C) glucose and the 
production of  (3-13C) and (3-13C, 2-2H) lactate (arrows) were monitored as indicated in Figure 
2.4-A. In this case, (3-13C) and (3-13C, 2-2H) lactate were produced at a very similar rate from the 
very initial phases of  the incubation. This suggests that as expected, the equilibration of  lactate 
C2 deuteration in the LDH step occurs before lactate extrusion to the medium. Because lactate 
is deuterated before transport to the medium, the experiments with (1-13C) glucose do not allow 
directly monitoring of  lactate recycling through the plasma membrane, but simply the production 
Figure 2.4. Metabolism of  (1-13C) glucose in KHB (50% 2H2O (vol/vol)) as detected by 13C NMR (125.13 
MHz, 25 oC, pH 7.2). A: Time course of  production of  (3-13C) and (3-13C, 2-2H, arrow) lactate. Multiplets at 
higher field correspond to (3-13C, 3-2H,*) and (3-13C, 3-2H, 2-2H,#) lactate, originated from (3-13C, 3-2H) and (3-13C, 
3,3’-2H2) malate in the tricarboxylic acid cycle. B: Consumption of  (1-13C) glucose (empty circles) and production 
of  (3-13C) and (3-13C, 2-2H) lactates.
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of  (3-13C) and (3-13C, 2-2H) lactate. (1-13C) glucose consumption (expressed in triose units) was 0.706 
± 0.078 µmol. mg protein-1.h-1, while (3-13C) and (3-13C, 2-2H) lactate production were 0.013 ± 0.004 
and 0.015 ± 0.002 µmol. mg protein-1.h-1, respectively. Notably, the similar rates of  production of  
the undeuterated and deuterated species suggest a negligible deuterium kinetic isotopic effect in 
this process. A summary of  the metabolic balances obtained during these experiments is presented 
in Table 2.1.
5. Discussion
Lactate exchange between the intra- and extracellular spaces is thought to be a very fast 
process occurring in both directions because of  the reversible nature of  the MCT of  the plasma 
membrane (Halestrap and Meredith 2004; Halestrap and Price 1999; Jackson and Halestrap 1996; 
Poole and Halestrap 1993). These transporters are believed to operate under near thermodynamic 
equilibrium conditions, carrying one molecule of  lactate and one proton in the inward or outward 
directions depending on the corresponding transmembrane gradients of  lactate and protons (see [2.2]).
Incubation
conditions
Glc
consumptiona
Lac (L) or Pyr (P)
consumption
Lac production
(from Glc)
Lac
recycling
Glc
oxidation
Extracellular Lac (L)
or Pyr (P) oxidation
TABLE 2.1. Metabolic balances of substrate consumption, product formation, and lactate recycling in
 C6 cells incubated with different combinations of 13C-labeled substrates in 50% deuterated
 Krebs-Henseleit buffer*
Process investigated
*C6 cells were incubated in Krebs-Henseleit buffer containing 50% 2H2O with the specified 13C-labeled substrates. Values are 
expressed in µmol/mg protein/hr as the mean ± S.D. of  at least three replicates. Glc, glucose; Lac, lactate; Pyr, pyruvate; n.a., not 
applicable; n.d., not detectable.
aExpressed in triose units.
bLactate recycling from (2-13C)pyruvate or [1-13C]glucose not detectable.
cIncludes the addition of  (3-13C) and (3-13C, 2-2H) lactates, 0.013±0.004 and 0.015±0.002, respectively.
d[3-13C]Lactate produced from (1-13C)glucose.
e[2-13C]Lactate produced from (2-13C)pyruvate.
5 mM
(3-13C)Lac
2.5 mM
(1-13C)Glc+
3.98 mM
(U-13C3)Lac
2.5 mM
(1-13C)Glc+
3.93 mM
(2-13C)Pyr
2.5 mM
(1-13C) Glc
n.a.
0.237 ± 0.092
0.287 ± 0.131
0.678 ± 0.084
n.a.
0.003 ± 0.008
0.063 ± 0.021d
0.155 ± 0.014e
0.028 ± 0.006c
0.227 ± 0.031
0.489 ± 0.082
n.d.b
n.d.b
0.119 ± 0.012 (L)
0.360 ± 0.071 (L)
0.152 ± 0.060 (P)
n.a.
0.119 ± 0.012 (L)
0.360 ± 0.071 (L)
0.152 ± 0.060 (P)
n.d.
n.a.
 
0.240 ± 0.084
0.350 ± 0.110
0.706 ± 0.078
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                 Lactatein + H
+
in ↔ Lactateout  + H
+
out              [2.2]
Lactate exchange entails important physiological consequences. In particular, it sets the lactate 
concentration in the intra- and extracellular spaces and determines its subsequent metabolism, 
coupling it to the transmembrane pH gradient and pH homeostasis. Despite its importance, direct 
measurements of  lactate exchange are complicated because of  its relatively fast timescale and the 
need to discriminate between transport and metabolism and between lactate molecules moving 
inward or outward.  Previous measurements used radioactive isotopes or fl uorescence methods 
to probe extracellular lactate transport to the intracellular space (Jackson and Halestrap 1996; 
Poole and Halestrap 1993). We are unaware, however, of  any previous measurements of  direct 
intracellular lactate transport to the extracellular space through the proton-linked MCT of  the 
plasma membrane.
In this work, we report on a novel procedure to investigate intracellular lactate exchange with 
the medium in cell cultures. The method is based on the fact that, in deuterium oxide-containing 
media, perprotonated extracellular lactate molecules entering the cytosol and exchange their H2 
proton by a deuteron, in the LDH equilibrium. In the case of  (3-13C) lactate, the following cytosolic 
processes take place (see [2.3] and [2.4]):
           (3-13C) Lactate  + NAD+ ↔ (3-13C) Pyruvate + NADH + H+                [2.3]
     (3-13C) Pyruvate + NAD(2H) + H+ ↔ (3-13C, 2-2H) Lactate + NAD+           [2.4]
The combination of  both, results in the net exchange of  a deuteron between NAD(2H) and the 
H2 hydrogen of  lactate [2.5]:
        (3-13C) Lactate + NAD(2H) ↔ (3-13C, 2-2H) Lactate  + NADH          [2.5] 
The (3-13C, 2-2H) lactate originated in this way may return to the incubation medium where it is 
distinguished easily from (3-13C) lactate by high-resolution 13C NMR, because the methyl group of  
the deuterated species resonates -0.11 ppm from the methyl group of  the perprotonated species. 
Deuteration of  the C2 carbon of  lactate requires the transfer of  one deuteron from the heavy 
water in the solvent to NAD(P)2H. This must involve fi rst one hydration-dehydration reaction (see 
[2.6]), and second, a redox process of  the general type (see [2.7]):
           AH + 2H2O ↔ AH(
2H) + 2HO-          [2.6]
   AH(2H) + NAD(P)+ ↔ AH + NAD(P)2H                       [2.7]
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where A is the metabolite incorporating the 2H from 2H2O that will be transferred later to NAD(P)
+ 
in the redox process. The combination of  reactions in equations [2.6] and [2.7] accounts for the 
exchange of  deuterons between 2H2O and NAD(P)
+:
     2H2O + NAD(P)
+ ↔ NAD(P)2H + 2HO-          [2.8]
These considerations account for the fact that lactate deuteration is observed easily when (3-
13C) lactate or (1-13C) glucose are the substrates, but becomes undetectable when (2-13C) pyruvate 
is the precursor. Indeed, under the reduced redox conditions prevailing during lactate or glucose 
and lactate metabolisms, the concentration of  NAD(P)2H is high enough and deuterations derived 
from it become easily observable. Under the oxidized conditions occurring when glucose and 
pyruvate are used, however, the concentration of  NAD(P)2H is reduced markedly, concomitantly 
decreasing the transfers of  reducing deuterons. In addition, the much faster pyruvate (ca. 1.07 
µmol.mg protein-1.h-1) than lactate uptake could result even faster than the combined hydration-
dehydration/redox deuterations, reducing lactate deuteration from 2H2O to negligible levels by 
kinetic constrains.
The present experiments provide also valuable information concerning the redox control 
of  glycolysis. When 2.5 mM (1-13C) glucose is used as the only substrate, glucose consumption 
and lactate production rates are 0.70 (triose units) and 0.03 µmol. mg protein-1. h-1, respectively. 
Incubations with 5 mM (3-13C) lactate alone show that C6 cells are able to oxidize lactate at a 
rate of  0.12 µmol.h-1.mg protein-1. When mixtures of  2.5 mM (1-13C) glucose and 3.98 mM (U-
13C3) lactate are used, however, glucose consumption is reduced to 0.240 µmol.mg protein
-1.h-1 
and lactate consumption is increased to 0.36 µmol.mg protein-1.h-1. Notably, no signifi cant (3-
13C) lactate production from (1-13C) glucose is observed under these conditions. This indicates 
that high extracellular lactate concentrations are able to inhibit (3-13C) lactate production from 
(1-13C) glucose, at the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) step because of  the 
competition between lactate and glycolysis for the severely limited cytosolic pool of  NAD+. Our 
data also show that lactate can effi ciently substitute glucose for oxidation and that the presence 
of  glucose increases lactate uptake under these conditions. Finally, when 2.5 mM (1-13C) glucose 
and 3.93 mM (2-13C) pyruvate are used, both (2-13C) and (3-13C) lactate are produced, derived 
from (2-13C) pyruvate and (1-13C) glucose, respectively. This result indicates, as expected, that the 
oxidized redox state does not inhibit fl ux through GAPDH. Under these conditions, only (3-13C) 
lactate molecules are deuterated in C2. Taken together, these fi ndings are consistent with previous 
reports showing pyruvate compartmentation in C6 cells and other neural cells (Bouzier et al. 1998a; 
Bouzier et al. 1998b; Cruz et al. 2001; Zwingmann et al. 2001). 
Figure 2.5 summarizes adequately these and earlier results on pyruvate compartmentation 
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Figure 2.5. Intracellular pyruvate compartmentation and lactate recycling during metabolism of  (1-13C) 
glucose and (U-13C3) lactate (A) or (2-13C) pyruvate (B). Two kinetically different cytosolic pools of  pyruvate 
exist in C6 cells; Pg: Pyruvate pool derived from glucose, Pp: Pyruvate pool derived from extracellular lactate or 
pyruvate. Coupling of  a hydration/dehydration reaction and a redox process allows NAD(2H) to be formed 
from a solvent deuteron previously incorporated in metabolite A. A: Intracellular lactate (Laci) competes with 
glycolysis for NAD+, inhibiting (3-13C) lactate production. Deuteration of  the Pp pool in the LDH reaction occurs 
extensively, extruding large amounts of  (U-13C, 2-2H) lactate to the medium but not of  (3-13C, 2-2H) lactate (dotted 
arrow). B: Intracellular lactate derived from the Pp pool of  (2-13C) pyruvate is formed before H2 deuteration can 
occur, extruding to the medium mainly (2-13C) lactate. Glycolytic (3-13C) pyruvate is formed significantly slower, 
allowing (3-13C, 2-2H) lactate to be formed and extruded to the medium. LDH: lactate dehydrogenase, MCT1: 
monocarboxylate transporter type 1, (●) 13C, (▲) 2H.
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(Cruz et al. 2001). During the incubations with 2.5 mM (1-13C) glucose and 3.98 mM (U-13C3) 
lactate (Figure 2.5-A), both substrates compete for the same intracellular pool of  NAD+. (U-13C3) 
lactate transport and equilibration is signifi cantly faster than is glycolysis, limiting glycolytic fl ow at 
the GAPDH step through NAD+ depletion. Under these conditions, virtually no (3-13C) or (3-13C, 
2-2H) lactate are produced from glucose, because NAD(2H) is used much faster in reducing the 
cytosolic (U-13C3) pyruvate pool originating from lactate Pp than in reducing the cytosolic (3-
13C) 
pyruvate pool originated from (1-13C) glucose Pg. Kinetic compartmentation is also observed in the 
incubations with 2.5 mM (1-13C) glucose and 3.93 mM (2-13C) pyruvate (Figure 2.5-B). In this case, 
the fast pyruvate transport and oxidized redox do not allow the production of  (2-13C, 2-2H) lactate 
from the Pp pool. However, the slower glycolytic fl ow is compatible with the productions of  (3-
13C) 
and (3-13C, 2-2H) lactates from the Pg pool. 
In summary, using (13C,2H) NMR, we have been able to resolve in time the deuteration of  C2 
carbon of  intracellular lactate by solvent deuterons and its transport to the extracellular medium. 
C2 deuteration of  lactate is extensive when (3-13C) lactate or combinations of  (3-13C) lactate and 
(1-13C) glucose are the substrates. It becomes negligible, however, when (2-13C) pyruvate is used as 
substrate. We also show that increased (U-13C3) lactate concentrations in the incubation medium, 
such as those commonly found during neuronal excitation or during mild hypoxic or ischemic 
conditions, inhibit (3-13C) lactate production from (1-13C) glucose, suggesting that under these 
conditions, lactate could become a preferred substrate to glucose. 
Finally, the present methodology to evaluate lactate exchange through the plasma membrane 
can be extended easily to other neural cells in culture (Fonseca et al. 2004) or to other metabolites 
as long as they present exchangeable hydrogens becoming deuterated during the pass of  the 
metabolite through the intracellular space. 
6. References
Bergmeyer HU. 1983. Methods of  Enzymatic Analysis: Weinheim: Verlag Chemie.
Bouzier-Sore AK, Canioni P, Merle M. 2001. Effect of  exogenous lactate on rat glioma metabolism. Journal of  
Neuroscience Research 65(6):543-548.
Bouzier-Sore AK, Voisin P, Bouchaud V, Bezancon E, Franconi JM, Pellerin L. 2006. Competition between glucose and 
lactate as oxidative energy substrates in both neurons and astrocytes: a comparative NMR study. Eur J Neurosci 
24(6):1687-1694.
Bouzier-Sore AK, Voisin P, Canioni P, Magistretti TJ, Pellerin T. 2003. Lactate is a preferential oxidative energy substrate 
Futile Lactate Cycling in Glioma Cells 
61
over glucose for neurons in culture. Journal of  Cerebral Blood Flow and Metabolism 23(11):1298-1306.
Bouzier AK, Goodwin R, de Gannes FMP, Valeins H, Voisin P, Canioni P, Merle M. 1998a. Compartmentation of  
lactate and glucose metabolism in C6 glioma cells - A C-13 and H-1 NMR study. Journal of  Biological Chemistry 
273(42):27162-27169.
Bouzier AK, Voisin P, Goodwin R, Canioni P, Merle M. 1998b. Glucose and lactate metabolism in C6 glioma cells: 
Evidence for the preferential utilization of  lactate for cell oxidative metabolism. Developmental Neuroscience 20(4-
5):331-338.
Cater HL, Chandratheva A, Benham CD, Morrison B, Sundstrom LE. 2003. Lactate and glucose as energy substrates 
during, and after, oxygen deprivation in rat hippocampal acute and cultured slices. Journal of  Neurochemistry 
87(6):1381-1390.
Cerdán S, Kunnecke B, Seelig J. 1990. Cerebral metabolism of  [1,2-13C2]acetate as detected by in vivo and in vitro 
13C NMR. 
J Biol Chem 265(22):12916-12926.
Cerdán S, Rodrigues TB, Sierra A, Benito M, Fonseca LL, Fonseca CP, García-Martín ML. 2006. The redox switch/redox 
coupling hypothesis. Neurochem Int 48(6-7):523-530.
Chapa F, Cruz F, García-Martín ML, García-Espinosa MA, Cerdán S. 2000. Metabolism of  (1-13C) glucose and (2-13C, 2-
2H3) acetate in the neuronal and glial compartments of  the adult rat brain as detected by [
13C, 2H] NMR spectroscopy. 
Neurochem Int 37(2-3):217-228.
Cruz F, Villalba M, García-Espinosa MA, Ballesteros P, Bogonez E, Satrustegui J, Cerdán S. 2001. Intracellular 
compartmentation of  pyruvate in primary cultures of  cortical neurons as detected by 13C NMR spectroscopy with 
multiple 13C labels. J Neurosci Res 66(5):771-781.
Dienel GA, Cruz NF. 2003. Neighborly interactions of  metabolically-activated astrocytes in vivo. Neurochemistry 
International 43(4-5):339-354.
Dienel GA, Hertz L. 2001. Glucose and lactate metabolism during brain activation. Journal of  Neuroscience Research 
66(5):824-838.
Fan TWM. 1996. Metabolite profi ling by one- and two-dimensional NMR analysis of  complex mixtures. Progress in NMR 
Spectrosc 28(2):161-219.
Fonseca LL, Sierra A, Santos H, Cerdán S. Lactate Recycling In Primary Cultures of  Astrocytes and Neurons Studied by 
(2H)13C-NMR Spectroscopy; 2004; Heraklion, Crete, Greece. p 48.
García-Espinosa MA, García-Martín ML, Cerdán S. 2003. Role of  glial metabolism in diabetic encephalopathy as detected 
by high resolution 13C NMR. NMR Biomed 16(6-7):440-449.
García-Espinosa MA, Rodrigues TB, Sierra A, Benito M, Fonseca C, Gray HL, Bartnik BL, García-Martín ML, Ballesteros 
P, Cerdán S. 2004. Cerebral glucose metabolism and the glutamine cycle as detected by in vivo and in vitro 13C NMR 
spectroscopy. Neurochem Int 45(2-3):297-303.
García-Martín M-L, Herigault G, Remy C, Farion R, Ballesteros P, Coles JA, Cerdán S, Ziegler A. 2001a. Mapping 
extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps 
of  metabolites. Cancer Res 61(17):6524-6531.
García-Martín ML, Ballesteros P, Cerdán S. 2001b. The metabolism of  water in cells and tissues as detected by NMR 
methods. Prog Nucl Mag Res Spectroscopy 39:41-77.
García-Martín ML, García-Espinosa MA, Ballesteros P, Bruix M, Cerdán S. 2002. Hydrogen turnover and subcellular 
compartmentation of  hepatic [2-13C]glutamate and [3-13C]aspartate as detected by 13C NMR. J Biol Chem 277(10):7799-7807.
Chapter 2
62
Gillies RJ, Raghunand N, García-Martín ML, Gatenby RA. 2004. pH imaging. A review of  pH measurement methods and 
applications in cancers. IEEE Eng Med Biol Mag 23(5):57-64.
Halestrap AP, Meredith D. 2004. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino 
acid transporters and beyond. Pfl ugers Arch 447(5):619-628.
Halestrap AP, Price NT. 1999. The proton-linked monocarboxylate transporter (MCT) family: structure, function and 
regulation. Biochem J 343 Pt 2:281-299.
Hansen PE. 1983. Isotope Effects on Nuclear Shielding. Ann Rep NMR Spectrosc 15:105-234.
Hansen PE. 1988. Deuterium Isotope Effects on Nuclear Shielding. Progress in NMR Spectrosc 20:207-257.
Hansen PE. 1989. Isotope effects on nuclear shielding. Ann Rep NMR Spectrosc 15:105-234.
Hertz L. 2004. The astrocyte-neuron lactate shuttle: a challenge of  a challenge. J Cereb Blood Flow Metab 24(11):1241-1248.
Jackson VN, Halestrap AP. 1996. The kinetics, substrate, and inhibitor specifi city of  the monocarboxylate (lactate) 
transporter of  rat liver cells determined using the fl uorescent intracellular pH indicator, 2’,7’-bis(carboxyethyl)-5(6)-
carboxyfl uorescein. J Biol Chem 271(2):861-868.
Magistretti PJ, Pellerin L. 1997. The cellular bases of  functional brain imaging: Evidence for astrocyte-neuron metabolic 
coupling. Neuroscientist 3(6):361-365.
Magistretti PJ, Pellerin L. 1999. Astrocytes couple synaptic activity to glucose utilization in the brain. News in Physiological 
Sciences 14:177-182.
Moldes M, Cerdán S, Erhard P, Seelig J. 1994. 1H-2H exchange in the perfused rat liver metabolizing [3-13C]alanine and 
2H2O as detected by multinuclear NMR spectroscopy. NMR Biomed 7(6):249-262.
Muller TB, Sonnewald U, Westergaard N, Schousboe A, Petersen SB, Unsgard G. 1994. C-13 Nmr-Spectroscopy Study of  
Cortical Nerve-Cell Cultures Exposed to Hypoxia. Journal of  Neuroscience Research 38(3):319-326.
Pellerin L. 2003. Lactate as a pivotal element in neuron-glia metabolic cooperation. Neurochemistry International 43(4-
5):331-338.
Pellerin L, Bonvento G, Chatton JY, Pierre K, Magistretti PJ. 2002. Role of  neuron-glia interaction in the regulation of  
brain glucose utilization. Diabetes Nutrition & Metabolism 15(5):268-273.
Pellerin L, Magistretti PJ. 2004. Neuroenergetics: Calling upon astrocytes to satisfy hungry neurons. Neuroscientist 
10(1):53-62.
Perrin A, Roudier E, Duborjal H, Bachelet C, Riva-Lavieille C, Leverve X, Massarelli R. 2002. Pyruvate reverses metabolic 
effects produced by hypoxia in glioma and hepatoma cell cultures. Biochimie 84(10):1003-1011.
Pierre K, Pellerin L. 2005. Monocarboxylate transporters in the central nervous system: distribution, regulation and 
function. J Neurochem 94(1):1-14.
Poole RC, Halestrap AP. 1993. Transport of  Lactate and Other Monocarboxylates across Mammalian Plasma-Membranes. 
American Journal of  Physiology 264(4):C761-C782.
Qu H, Haberg A, Haraldseth O, Unsgard G, Sonnewald U. 2000. C-13 MR spectroscopy study of  lactate as substrate for 
rat brain. Developmental Neuroscience 22(5-6):429-436.
Rodrigues TB, Cerdán S. 2005. 13C MRS: an outstanding tool for metabolic studies. Concepts in Magnetic Resonance, Part 
A 27A(1):1-16.
Schurr A. 2002. Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochemistry 
International 41(1):1-8.
Schurr A, Payne RS, Miller JJ, Tseng MT. 2001. Preischemic hyperglycemia-aggravated damage: Evidence that lactate 
Futile Lactate Cycling in Glioma Cells 
63
utilization is benefi cial and glucose-induced corticosterone release is detrimental. Journal of  Neuroscience Research 
66(5):782-789.
Sierra A, Rodrigues TB, Benito M, Ballesteros P, García-Espinosa MA, García-Martín ML, Cerdán S. 2007. Pyruvate 
Oxidation and Mitochondrial Substrate Transport in the Central Nervous System. In: Lajhta A, Gruetter R, editors. 
Neural Metabolism in Vivo. New York: Springer.
Smith D, Pernet A, Hallett WA, Bingham E, Marsden PK, Amiel SA. 2003. Lactate: A preferred fuel for human brain 
metabolism in vivo. Journal of  Cerebral Blood Flow and Metabolism 23(6):658-664.
Zwingmann C, Richter-Landsberg C, Leibfritz D. 2001. 13C isotopomer analysis of  glucose and alanine metabolism reveals 
cytosolic pyruvate compartmentation as part of  energy metabolism in astrocytes. Glia 34(3):200-212.

Fast and Robust 1H NMR Methods to Measure
the Turnover of the H2 Hydrogen of Lactate
Chapter 3

67
1H NMR to Measure Lactate H2 Deuteration
1. Abstract 
Two fast and sensitive procedures to determine the turnover of  the H2 hydrogen of  lactate 
and quantify its 2H-enrichment by 1H NMR are illustrated using C6 cells metabolizing lactate in 
50% 2H2O (vol/vol). The fi rst one is based on the fact that 
2H substitution of  the lactate H2 
hydrogen results in two easily detectable transformations of  the vicinal H3 doublet resonance: (i) 
the formation of  an H3 singlet due to the disappearance of  the homonuclear coupling to H2 (3JβH-αH = 
6.9 Hz) and (ii) an upfi eld isotopic shift derived from the vicinal 2H2 substitution (∆3 = -0.007 ppm). 
Only those lactate molecules that have passed through the cell cytosol experience these effects, 
since H2 deuteration involves lactate dehydrogenase (LDH) activity and NAD(2H). Thus, analysis 
of  the observed shifted and unshifted H3 lactate resonances from the incubation medium allows 
the discrimination of  the perprotonated lactate added as substrate, and the lactate recycled to the 
incubation medium after passage through the cytosol. The second approach discriminates between 
non-deuterated and deuterated H2 lactate molecules through the use of  a specifi c lactate editing 
sequence. The experiment involves two separate acquisitions using a regular spin echo sequence 
with an appropriate echo time to produce a phase-modulation of  180 degrees on the H2 and H3 
resonances of  lactate. By applying a selective decoupling pulse on the H2 resonance of  lactate in 
the fi rst acquisition, we destroyed the phase-modulation. Adding both spectra obtained in these 
two subsequent acquisitions, non-deuterated lactate resonances are canceled out whereas non-
modulated resonances’ intensities are effectively added, including the H3 singlet of  H2 deuterated 
lactate.
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2. Introduction
Lactate is considered to play a pivotal role in cerebral metabolism, both as an intracellular 
energy substrate for oxidation in neural cells and as a shuttle intermediate for the transcellular 
metabolic coupling between neurons and astrocytes (Bouzier-Sore et al. 2003a; Bouzier-Sore 
et al. 2003b; Cerdán et al. 2006; Dienel and Hertz 2001; Qu et al. 2000; Smith et al. 2003). In 
particular, the classical Astrocyte to Neuron Lactate Shuttle (ANLS) hypothesis proposed a fl ux of  
lactate from astrocytes to neurons, to support the energy demand occurring during glutamatergic 
neurotransmission (Dienel and Hertz 2001; Pellerin and Magistretti 1994). Under the reduced 
vascular clearance conditions occurring in cerebral excitation, ischemic episodes or even in tumors, 
lactate has also been proposed to play a crucial role in cellular survival, approaching more the 
nature of  a vital substrate than that of  a lethal product (Cater et al. 2003; Muller et al. 1994; Schurr 
et al. 2001). These lactate molecules have been reported to accumulate in the extracellular space 
reaching concentrations that exceed those found in the cell cytosol (Cater et al. 2003; Schurr et al. 
2001). In these situations, extracellular lactate molecules may return to the cytosol through the 
reversible MCT, located in the plasma membrane of  all normal and transformed cells (Halestrap 
and Meredith 2004; Halestrap and Price 1999). This lactate recycling through the plasma membrane, 
driven by the concentration of  lactate inside and outside the cell and the pH gradient, remains as 
a diffi cult process to investigate, given the identical nature of  recycled and non-recycled lactate 
molecules hindering their unambiguous identifi cation.
We previously proposed several hydrogen turnover methods to investigate traffi cking of  various 
(13C,2H) labeled isotopomers, including lactate (see Chapter 2), between different compartments in 
cell cultures, perfused liver, and brain (Chapa et al. 2000; García-Martín et al. 2002; Rodrigues et al. 
2005). These methods are able to monitor, by 13C NMR, the incorporation of  deuterium into 13C- 
labeled metabolites, because covalent binding of  2H results in characteristic 13C-2H heteronuclear 
couplings and geminal or vicinal isotopic shifts of  the corresponding 13C resonances (García-
Martín et al. 2001; Hansen 1989). The methodology combines the inherent advantage of  detecting 
deuterium incorporation with the positional selectivity and increased sensitivity of  13C NMR, as 
compared to the direct 2H NMR detection (Perdigoto et al. 2003; Vianello et al. 1997). It requires, 
however, the use of  relatively expensive 13C labeled substrates as well as suffi ciently long 13C NMR 
acquisitions.
Figure 3.1 illustrates the process of  lactate recycling through the plasma membrane of  a 
representative tumor cell. Once lactate molecules reach the cytosolic space, they participate in the 
LDH equilibrium, incorporating one deuteron in their methine carbon and eventually returning 
to the extracellular space. This circumstance is observed by 1H NMR because of  the vicinal 
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isotopic effect of  2H2 on the chemical shifts of  the methyl resonance of  lactate in the incubation 
medium. This makes it possible to discriminate lactate molecules that have passed through the cell 
cytosol from those that have not, because only the former become deuterated by cytosolic LDH 
in incubation media containing 2H2O. Notably, the proposed methodologies allow the detection of  
H2 deuteration with the increased sensitivity of  1H NMR, and thus avoid the necessity of  using 
13C-labeled substrates. Even if  these are used, however, our methods allow the turnover of  the H2 
hydrogen in both 13C-labeled and 12C lactate molecules to be measured simultaneously, and thus provide 
robust methods to investigate 2H and 13C isotopic effects simultaneously on lactate turnover.
In this chapter, we describe two new rapid and robust methods for 1H NMR spectroscopy 
discrimination between non-deuterated and H2 deuterated lactate molecules. The fi rst one is a 
conventional non-edited 1H NMR spectroscopy and the second approach is based on the use of  a 
specifi c lactate editing sequence (Choi et al. 2006; Rothman et al. 1984b). 
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Figure 3.1. Mechanism of  lactate recycling during metabolism of  5 mM (3-13C) lactate in Krebs-Henseleit 
Buffer containing 50% 2H
2
O (vol/vol). Extracellular (3-13C) lactate (Laco, unshifted) enters the cytosol (Laci) 
through the MCT1 transporter. (3-13C) Laci loses its H2 hydrogen and incorporates a deuteron from NAD(
2H) 
in the cytosolic LDH equilibrium. (3-13C, 2-2H) Laci abandons the cell through the reversible MCT1 transporter 
originating the shifted singlet (2H-Laco) in the incubation medium (cf. Figures 3.2 and 3.3). Deuterons are transferred 
to NAD+ through a combination of  hydration-dehydration (formation of  A2H) and red-ox reactions (formation of  
NAD2H). Lac: lactate, LDH: lactate dehydrogenase, MCT1: monocarboxylate transporter type 1, Pyr: pyruvate.
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Both protocols may be easily extendable to other molecules and exchange pathways between 
intra- and extracellular spaces, where a deuterium exchange site is present only in the intracellular 
milieu.
3. Materials and Methods 
3.1 Cell Culture and Preparation
C6 glioma cells were purchased from the local representative of  the American Tissue Culture 
Collection (LGC Promochem, Barcelona, Spain). Briefl y, C6 glioma cells were grown to confl uence 
in Dulbecco’s modifi ed Eagle’s medium (DMEM) supplemented with fetal bovine serum (5%) 
(FBS), 100 µg/mL streptomycin, 25 µg/mL gentamycin, 100 U/mL of  penicillin and fungizone 
(1% vol/vol), in sterile Petri dishes (10-cm diameter) at 37 °C in a humidifi ed atmosphere containing 
5% CO2-95% O2. Nine independent cultures of  C6 cells were used. When cells reached a confl uent 
appearance, fi ve cultures were incubated (3-30 h, 37 ºC) in Krebs-Henseleit Buffer (KHB) (NaCl, 
119 mM; KCl, 4.7 mM; CaCl2, 1.3 mM; MgSO4, 1.2 mM; HEPES, 15 mM and KH2SO4, 1.2 mM) 
containing 50% (vol/vol) 2H2O with 5 mM (3-
13C) lactate. Other fi ve confl uent cultures were 
incubated in the same conditions for the development of  the edited 1H NMR spectroscopy approach, 
except by the fact that the lactate used was unlabeled. In both cases, aliquots from the medium 
(0.5 mL) were collected for increasing incubation periods, lyophilized and ressuspended in 0.5 mL 
2H2O (99.9% 
2H) prior to high-resolution 1H NMR analysis. Appropriate control experiments were 
carried out with cell free incubations or incubations carried out under similar cellular conditions 
(one culture) in the absence of  2H2O.
3.2 Non-Edited 1H NMR Spectroscopy 
1H NMR spectra from 0.5-mL samples of  the incubation medium were obtained at 11.7 
Tesla (500.130 MHz, 25 ºC, pH 7.2) with a Bruker AVANCE 500WB NMR spectrometer using a 
commercial (5-mm) triple resonance probe (1H,13C,2H). Acquisition conditions were: π/3 pulses, 
10.3 kHz spectral width, 3.17 s acquisition time, 64 k words data table and an interpulse delay of  
3.0 s, resulting in a repetition time of  6.17 s. Fully-relaxed 1H NMR spectra were acquired under the 
same conditions using π/3 fl ip angle and a relaxation delay of  20 s. T1 measurements were obtained 
and analyzed with the Bruker analysis software (Bruker BioSpin GmbH, Rheinstetten, Germany), 
being calculated from inversion recovery experiments with at least 15 different τ values. The T1 
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values of  the (3-13C) and (3-12C) lactate methyl multiplets ranged from 114 to 128 ms, indicating an 
almost complete relaxation in our acquisition protocol. Under these conditions it is not necessary to 
introduce correction factors to account for partial saturation of  any multiplet resonance.
The 1H spectra were line-broadened (0.2 Hz), zero-fi lled, Fourier-transformed, phased, and 
referenced to external TSP (0.0 ppm). Selectively 13C-decoupled 1H NMR spectra of  the methyl 
resonance of  lactate were obtained with low power single-frequency irradiation over the 13C3 
lactate resonance (20.9 ppm), using the GARP technique (Globally optimized Alternating-phase 
Rectangular Pulses) (Shaka et al. 1985). Simulated spectra were generated with program NUTS™ 
(Acorn, Freemont, CA, USA) to investigate the isotopic shifts and quantify relative resonance 
areas. 
The 1H NMR time courses M(t) were fi tted to single exponentials of  the type M(t) = M(∞) (1-exp(-
k.t)) to obtain the values of  the rate constant k and the asymptote M(∞). For this purpose we used 
the nonlinear least-squares routines of  the Sigma Plot program (SPSS Inc., Chicago, IL, USA) as 
implemented on an Intel PC platform. Statistical signifi cance in the comparisons of  values of  k 
and M(∞) was assessed using the Student’s t-test. 
3.3 Edited 1H NMR Spectroscopy 
High-resolution 1H NMR spectra from 0.5-mL aliquots of  the incubation medium were obtained 
at 11.7 Tesla (500.130 MHz, 4 ºC, pH 7.2) with a Bruker AVANCE 500WB NMR spectrometer 
using a commercial (5-mm) triple resonance probe (1H,13C,2H). As indicated above, the non-edited 
1H NMR spectra of  these samples are relatively complex, mainly because Η3 proton resonances 
from both H2 non-deuterated and deuterated lactate molecules overlap at 1.31 ppm (Rodrigues 
and Cerdán 2005). To resolve this overlap, we implemented the lactate editing method previously 
described to isolate lactate from lipids (Rothman et al. 1984a; Rothman et al. 1984b). Briefl y, the 
experiment comprises two separate acquisitions using a regular spin echo sequence with an echo 
time of  144 ms (1/J), which produces a phase-modulation (J-modulation) of  180 degrees on the 
Η2 and Η3 resonances of  lactate. In the fi rst acquisition a selective decoupling pulse is applied 
on the H2 resonance of  lactate that destroys the phase modulation. The second spectrum is 
acquired in the absence of  the decoupling pulse and hence lactate resonances appear with a phase 
modulation of  180 degrees. The summation of  the two spectra cancels out the non-deuterated 
lactate resonances (modulated) whereas it adds the resonance intensities of  the other resonances 
(non-modulated), including the H3 singlet of  H2 deuterated lactate. 
The 1H spectra were line-broadened (0.3 Hz), zero-fi lled, Fourier-transformed, phased, and 
referenced to internal TSP (0.0 ppm) at a concentration of  1 mM. Comparing the TSP area with 
the ones obtained in the edited spectra, we were able to easily quantify the time course of  (2-2H) 
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lactate concentration. The program NUTS™ (Acorn, Freemont, CA, USA) was used to analyze the 
isotopic shifts and quantify the relative areas of  shifted and non shifted resonances.
Finally, the 1H NMR time course of  H2 deuteration as detected with our editing sequence C(t) 
was fi tted to a single exponential of  the type C(t) = C(∞) (1-exp(-k.t)) to obtain the values of  the 
rate constant k and the asymptote C(∞). For this purpose, we also used the non linear least squares 
routines of  the Sigma Plot program (SPSS Inc., Chicago, IL, USA). 
3.4 Determination of  Lactate Concentration
The lactate concentration in the incubation media was determined spectrophotometrically 
using classical enzymatic end-point methods coupled to the increase in NADH absorption at 340 
nm. Conventional methods were adapted to become operative using 96-well microplates (0.25 mL) 
and a vertical microplate reader (Molecular Devices, Spectramax, Sunnyvale, CA, USA). 
3.5 Materials
(3-13C) lactate (98% 13C) and deuterated solvents were obtained from Cambridge Isotope 
Laboratories (Andover, MA, USA). 2H2O (99.9% 
2H) was obtained from Apollo Scientifi c Ltd. 
(Stockport, Cheshire, UK). Auxiliary enzymes and cofactors were from Boehringer Mannheim 
(Germany). FBS and DMEM were purchased from GIBCO BRL (Gent, Belgium). Other items 
were of  the highest purity available commercially from SIGMA Chemical Co. (St. Louis, MS, 
USA).
4. Results and Discussion
4.1 Non-Edited 1H NMR Spectroscopy
Figures 3.2-A and 3.2-B show the 1H NMR resonances of  the methyl group of  (3-13C) and (3-12C) 
lactate from the incubation medium of  C6 cells, immediately after the addition of  (3-13C) lactate in 
KHB containing 50% 2H2O (vol/vol) (Figure 3.2-A), or 30 h later (Figure 3.2-B). At the beginning 
of  the incubation (Figure 3.2-A), the 1H NMR multiplet from the methyl group of  lactate consists 
of  six resonances: (i) a central doublet originated from the vicinal homonuclear coupling JβH-αH (6.9 
Hz) of  the methyl group from (3-12C) lactate molecules (Figure 3.2-A: resonances c-c´) and (ii) a 
doublet of  doublets derived from the combination of  the larger geminal heteronuclear coupling 
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Figure 3.2. 1H NMR resonances (500.13 MHz, 25 oC, pH 7.2) of  the methyl signals of  lactate from the 
medium of  C6 glioma cells incubated with 5 mM (3-13C) lactate in Krebs-Henseleit Buffer containing 50% 
2H
2
O (vol/vol). A: immediately after the addition of  the 13C label. (3-13C) and (3-12C) lactate originate an isointense 
doublet of  doublets a,a´-b,b´ (1JβH-βC = 128.0 Hz + 
3JβH-αH = 6.9 Hz) and a doublet c,c´ (
3JβH-αH = 6.9 Hz), respectively. 
B: 30 h later, (3-13C, 2-2H) and (3-12C, 2-2H) originate an isotopically shifted doublet (∆3 = -0.007 ppm, 
1JβH-βC = 
128.0 Hz) and a singlet (∆3 = -0.007 ppm), respectively. The shifted resonances are superimposed over those of  
the perprotonated multiplet, originating an asymmetric increase in the intensity of  the upfi eld transitions of  the 
multiplets d,e (Φ) and f  (φ).
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JβH-βC (128.0 Hz) (Figure 3.2-A: a-b, a´-b´) with the smaller vicinal homonuclear JβH-αH coupling (6.9 
Hz) (Figure 3.2-A: a-a´, b-b´) from the methyl group of  (3-13C) lactate molecules. The ratio of  
intensities of  the external doublet of  doublets to the internal doublet allows the determination of  
the fractional 13C enrichment in the lactate C3 carbon (Rothman et al. 1985). 
The substitution of  the H2 hydrogen of  (3-13C) lactate by one deuteron introduces remarkable 
changes in the multiplet structure of  the Η3 resonance: (i) the transformation of  the original 
doublet of  doublets into an apparent doublet, because of  the disappearance of  the homonuclear 
vicinal JβH-αH coupling (6.9 Hz) and (ii) the upfi eld shift of  this doublet caused by the vicinal heavy 
atom isotope effect (∆3 = -0.007 ppm). This upfi eld isotopic shift has a very similar value to ½ 
JβH-αH coupling constant, a situation that results in the superposition of  the shifted doublet over the 
higher-fi eld components of  the doublet of  doublets, causing an apparent doublet of  doublets with 
dissymmetric intensities (Figure 3.2-B, dotted lines, e-b = Φ). 
Similar effects of  H2 deuteration are observed in the central (3-12C) lactate doublet, which loses 
the vicinal, JβH-αH coupling (6.9 Hz) to originate a vicinal and isotopically shifted singlet (Figure 3.2-
B: f) that superimposes on the high-fi eld component of  the doublet. This superposition causes a 
difference in intensity between the otherwise isointense transitions of  the (3-12C) lactate doublet 
(see c-c´ in Figure 3.2-A), the imbalance being due to superposition of  the (3-12C, 2-2H) singlet 
over the high-fi eld component of  the doublet (Figure 3.2-B: dotted lines, f-c = φ). Notably, H2 
deuteration of  lactate was not observed  in the same experimental time when cell-free incubations 
with (3-13C) lactate in KHB containing 50% 2H2O (vol/vol) were used, revealing the intracellular 
origin of  the deuteration process.
Figure 3.3 illustrates these changes in more detail by showing the simulated deconvolution of  the 
heteronuclear multiplet from the methyl group of  (3-13C) lactate in the corresponding components. 
Figure 3.3-A depicts the structure of  the doublet of  doublets derived from (3-13C) lactate. Figure 
3.3-B shows the methyl resonance from (3-13C, 2-2H) lactate, in which the vicinal homonuclear 
JβH-αH coupling (6.9 Hz) is lost because of  the 
2H2 substitution. A residual heteronuclear coupling 
JβH-α2H remains resolved (ca. 1.07 Hz) in the simulation. This residual doublet is approximately 6.25 
times smaller than the corresponding doublet derived from homonuclear coupling (ca. 7 Hz in 
Figure 3.3-A), as would be expected from the 6.25 smaller value of  the gyromagnetic ratios of  2H 
vs. 1H (Evans 1995). Unfortunately, the small vicinal heteronuclear 1H-2H scalar coupling constant 
(ca. 1.07 Hz) observed in the simulation is smaller than the natural linewidth of  the H3 proton 
doublet in extracts or in vivo, which makes this heteronuclear JβH-α2H coupling virtually unobservable 
experimentally. Figure 3.3-C shows the combined multiplet structure of  the methyl resonances 
from a mixture of  (3-13C) and (3-13C, 2-2H) lactate isotopomers, after the linewidth of  the latter is 
increased to the natural linewidths observed in extracts (2-2.5 Hz). The same effect occurs in (3-
12C) lactate (not shown). In this case, 2H binding to C2 transforms and shifts the doublet resonance 
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from the methyl group of  (3-12C) lactate into an apparent singlet, which appears superimposed 
on the high-fi eld portion of  the doublet, resulting in an increase in intensity that depends on the 
amount of  2H incorporated (c.f. Figure 3.2-A, central multiplet). 
Therefore, analysis of  the structure of  the 1H NMR multiplets from (3-13C) and (3-12C) 
lactate allows the determination of  the relative amounts of  (3-13C) and (3-12C) lactate vs. (3-13C, 
2-2H) and (3-12C, 2-2H) lactate, respectively. The differences in multiplet structure of  the methyl 
resonances (3-13C) and (3-12C) lactate and those of  (3-13C, 2-2H) and (3-12C, 2-2H) lactate allow 
Figure 3.3. Representative 1H NMR simulations of  the methyl resonances of: A: (3-13C) lactate (1JβH-βC = 
128.0 Hz, 3JβH-αH = 6.9 Hz), B: (3-
13C, 2-2H) lactate (1JβH-βC = 128.0 Hz, 
1JβH-α2H = 1.07 Hz; ∆3 = -0.007 ppm) and 
C: a mixture of  (3-13C, 66%) and (3-13C, 2-2H, 33%) lactate with natural linewidth of  2.0 Hz. Simulations were 
performed with the NUTS™ program. Φ: increase in intensity due to the appearance of  (3-13C, 2-2H) lactate.
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the determination of  the fractional deuterium enrichment in H2 of  (3-13C) and (3-12C) lactate, as 
indicated by equations. [3.1] and [3.2], respectively:
     [3.1]
       [3.2]
The intensities of  resonances a, b, c, d, e and f are those illustrated in Figure 3.2-B.
Figure 3.4 depicts the time dependence of  the H2 deuteration process as detected by the changes 
in the structure of  the methyl multiplets of  (3-13C) and (3-12C) lactate, during a 30 h incubation 
1.4 1.3 1.2 1.1
PPM
1.5
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24 h
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Φ
φ
Figure 3.4. Representative time course of  H2 deuteration as detected by the changes in the relative 
intensities of  the multiplet resonances from the methyl groups of  (3-13C) and (3-12C) lactate. C6 glioma 
cells were incubated for 30 h with 5 mM (3-13C) lactate in Krebs-Henseleit Buffer containing 50% 2H
2
O 
(vol/vol). Deuteration can be easily followed through the asymmetric increase in the intensity of  the upper fi eld 
transitions refl ecting the increase in concentration of  (3-13C, 2-2H) lactate (Φ) or (3-12C, 2-2H) lactate (φ).
     [2H2]              (d + e) - (a + b)               2 Φ
     ([2H2] + [1H2])        a + b + d + e           a + b + c + d    
= = Fractional 2H2 enrichment in (3 - 13C) lactate =
Fractional 2H2 enrichment in (3 - 13C) lactate =
     [2H2]               f - c              φ
     ([2H2] + [1H2])      c + f            c + f        
= =
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of  C6 cells with (3-13C) lactate in KHB containing 50% 2H2O (vol/vol). During this period, total 
lactate concentrations in the incubation medium decreased from 4.2 ± 0.6 mM at the beginning of  
the incubation to 3.3 ± 1.2 mM at the end. An exponential increase in the deuterared portion of  
the (3-13C) and (3-12C) multiplets was detected (arrows). These modifi cations are not observed in 
cell free incubations of  KHB (50% 2H2O, vol/vol) with (3-
13C) lactate, or in during incubations of  
C6 cells with  (3-13C) lactate in undeuterated KHB (data not shown), confi rming that the described 
modifi cations are indeed derived from de novo enzymatic production of  (3-13C, 2-2H) lactate. In 
addition, Figure 3.4 also shows that it is possible to analyze the deuteration of  (3-13C) and (3-12C) 
lactate molecules simultaneously, allowing the evaluation of  the kinetics of  H2 deuteration both in 
(3-13C) and (3-12C) lactate, as indicated in Figure 3.5.
Figure 3.5 shows the time course of  H2 deuteration in (3-13C) and (3-12C) lactate, as obtained 
from three experiments with different cultures of  C6 cells. The kinetics were fi tted to a single 
exponential and gave values for the rate constants k (n = 3, mean ± S.D.) of  0.06 ± 0.02 h-1 and 
0.15 ± 0.05 h-1, for the production of  (3-13C, 2-2H) lactate and (3-12C, 2-2H)  lactate, respectively. 
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Figure 3.5. Turnover of  the H2 hydrogen from (3-13C) lactate (empty circles, dotted line) and (3-12C) 
lactate (fi lled circles, full line) during incubations with 5 mM (3-13C) lactate in Krebs-Henseleit Buffer 
containing 50% 2H
2
O (vol/vol). Fractional 2H enrichments in H2 lactate for each time point were determined 
as described in the text. The experimental points M(t) were fi tted to a single exponential of  the type M(t) = M(∞) (1-
exp(-k.t)) to determine M(∞) and k.  Results are shown as the mean ± S.D. of  three independent experiments with 
different cell cultures.
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Similarly, the asymptote values M(∞) were 0.30 ± 0.05 and 0.21 ± 0.02 for (3-
13C, 2-2H) lactate and 
(3-12C, 2-2H) lactate, respectively. The differences found between the average rate constants and 
asymptote values were not statistically signifi cant as revealed by the Student t test (P=0.12 for k 
and P = 0.14 for M(∞)).  
4.2 Edited 1H NMR Spectroscopy
Figure 3.6 depicts representative 1H NMR (500.130 MHz, 4 ºC, pH 7.2) non-modulated (1), 
modulated (2) and edited (1+2) spectra, obtained from the incubation medium of  C6 glioma cells, 
30 h after the addition of  lactate to the incubation buffer. At the beginning of  the incubation, 
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Figure 3.6. Representative 1H NMR spectra (500.130 MHz, 4 ºC, pH 7.2) non-modulated (1), modulated 
(2) and edited (1+2) from the medium of  C6 glioma cells incubated during 30 hours with 10 mM lactate 
in Krebs-Henseleit buffer containing 50% 2H
2
O (vol/vol). The lactate Η3 resonance doublet (3JβH-αH = 6.9 Hz) 
is observed at 1.31 ppm in spectrum 1. Note that the upfi eld moiety of  the lactate doublet shows higher intensity 
(Φ) because of  the overlap with the isotopically shifted methyl resonance of  2H2 lactate. The arrow symbolizes 
the selective decoupling pulse applied on the H2 proton resonance at 4.08 ppm (not observable because of  the 
saturation caused by the decoupling pulse). An echo time of  144 ms results in a 180 degrees phase modulation 
on the non-deuterated lactate H2 and H3 resonances (inverted peaks in spectrum 2), which is not present in the 
non-modulated spectrum (1). Note that the upfi eld moiety of  the lactate doublet depicts now lower intensity (φ). 
By adding spectra 1 and 2, we can readily observe a peak that represents the double of  the concentration of  (2-2H) 
lactate (δ ≈ 1.3 ppm, Φ + φ).
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the edited lactate resonance from the lactate methyl group is virtually zero (not shown). The 
subsequent substitution of  the lactate hydrogen of  the Η2 proton by one deuteron gives rise to 
an upfi eld shifted singlet in the H3 resonance, which can be clearly isolated and resolved in the 
edited spectrum. When the same experimental design was used in the cell-free incubations, this 
deuteration was not observed (data not shown), confi rming that the observed deuteration process 
is necessarily intracellular.
Figure 3.7 shows the time course of  H2 deuteration in lactate, as detected with this edition 
protocol in fi ve experiments with different cultures of  C6 cells. Since we used 1 mM TSP as an 
internal reference, it became possible to calculate quantitatively the increase in deuterated lactate 
concentration. The kinetics for the production of  (2-2H) lactate were fi tted to a single exponential, 
providing a value for the rate constant k of  0.09 ± 0.01 h-1, and an asymptote value C(∞) of  1.59 
± 0.07 mM (mean ± S.E.M.). These values are similar to those obtained by non-edited 1H NMR 
(Rodrigues and Cerdán 2005).
Finally, the present study shows that it is possible to distinguish lactate molecules that are 
moving from the cytosol to the incubation medium because they become labeled with 2H in the 
LDH equilibrium (c.f. Figure 3.1, equation [3.3]).  
      Pyruvate + NAD(2H) + H+ ↔ (2-2H) Lactate + NAD+        [3.3]
The required NAD(2H) for this process may be derived from the sequential combination 
of  a hydration-dehydration reaction (equation [3.4]) and a redox process (equation [3.5]) as 
follows,
                        AH2 + 
2H2O ↔ AH(
2H) + (2H)HO          [3.4]
        AH(2H) + NAD+ + H+ ↔ AH2 + NAD(
2H)                       [3.5]
         Total        2H2O + NAD
+ + H+ ↔ H(2H)O + NAD(2H),                                   [3.6]
where A is the metabolite incorporating the 2H from 2H2O that will be transferred later to NAD
+ in 
the redox process. Both reactions are stereospecifi c and only deuterons incorporated through malic 
enzyme or isocitrate dehydrogenase activities produce the correct stereochemistry in NAD(2H) 
to become a cofactor in the LDH equilibrium (García-Martín et al. 2001). Therefore, cytosolic 
deuteration of  lactate in H2 is a complex process involving several enzymes. The rate limiting step 
of  this process is currently under investigation in our laboratory.
In conclusion, the present report shows how to distinguish nondeuterated lactate from the (2-
2H) lactate. For this purpose, we developed two simple, robust and sensitive 1H NMR approaches 
for the measurement of  the turnover of  the H2 hydrogen of  lactate, one of  them based on a 
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lactate editing protocol.
 Both methods are faster than previous 13C NMR approaches and can be easily implemented 
virtually in all NMR apparatus. It is important to remark that while the measurement of  
perdeuteration was done in 13C-labeled lactate in the non-edited 1H NMR approach, with all the 
demonstrated benefi ts, it is also applicable to lactate in the absence of  13C labeling.
Using the lactate editing sequence, we were able to eliminate the spectral overlap in the H3 
lactate doublet, allowing the H2 deuteration measurement with greater accuracy than possible with 
non-edited 1H NMR. This edited 1H NMR method may be of  potential interest for in vivo studies 
of  lactate turnover, where other available methodologies, like 13C NMR spectroscopy, are not only 
more expensive, but also much more diffi cult to implement. 
Figure 3.7. Turnover of  the lactate Η2 during incubations with 5 mM lactate in Krebs-Henseleit buffer 
containing 50% 2H
2
O (vol/vol). Concentrations of  (2-2H) lactate for each time point were determined as 
described in the text. The experimental points C(t) were fi tted to a single exponential C(t) = C(∞) (1-exp(-k.t)) in order 
to determine the optimized C(∞) and k parameter values. Results are the mean ± SEM of  fi ve experiments with 
different cell cultures.
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1. Abstract
We provide an integrative interpretation of  neuroglial metabolic coupling including the presence 
of  subcellular compartmentation of  pyruvate and monocarboxylate recycling through the plasma 
membrane of  both neurons and glial cells. The subcellular compartmentation of  pyruvate allows 
neurons and astrocytes to select between glucose and lactate as alternative substrates, depending 
on their relative extracellular concentration and the operation of  a redox switch. This mechanism 
is based on the inhibition of  glycolysis at glyceraldehyde 3-phosphate dehydrogenase level by 
NAD+ limitation, under suffi ciently reduced cytosolic NAD+/NADH redox conditions. Lactate 
and pyruvate recycling through the plasma membrane allows the return to the extracellular medium 
of  cytosolic monocarboxylates enabling their transcellular, reversible, exchange between neurons 
and astrocytes. Together, intracellular pyruvate compartmentation and monocarboxylate recycling 
result in an effective transcellular coupling between the cytosolic NAD+/NADH redox states 
of  both neurons and glial cells. Following glutamatergic neurotransmission, increased glutamate 
uptake by the astrocytes is proposed to augment glycolysis and TCA cycle activity, balancing to 
a reduced cytosolic NAD+/NADH in the glia. Reducing equivalents are then transferred to the 
neuron resulting in a reduced neuronal NAD+/NADH redox state. This may eventually switch off  
neuronal glycolysis, favoring the oxidation of  extracellular lactate in the LDH equilibrium and in 
the neuronal TCA cycles. Finally, pyruvate derived from neuronal lactate oxidation, may return to 
the extracellular space and to the astrocyte, restoring the basal redox state and beginning a new loop 
of  the lactate/pyruvate transcellular coupling cycle. Transcellular redox coupling operates through 
MCTs at the plasma membrane, similarly to the intracellular redox shuttles coupling the cytosolic 
and mitochondrial redox states through the transporters of  the inner mitochondrial membrane.
Additionally, we investigate the kinetic mechanisms underlying this Redox Switch/Redox 
Coupling hypothesis by characterizing the competitive consumption of  glucose or lactate and the 
kinetics of  pyruvate production in primary cultures of  cortical neurons and astrocytes from rat brain. 
Glucose consumption was determined in neuronal cultures incubated in Krebs-Ringer bicarbonate 
buffer containing 0.25-5 mM glucose, in the presence and absence of  5 mM lactate as an alternative 
substrate. Lactate consumption was measured in neuronal cultures incubated with 1-15 mM lactate, 
in the presence and absence of  1 mM glucose. In both cases, the alternative substrate increased the 
Km (mM) values for glucose consumption (from 2.2 ± 0.2 to 3.6 ± 0.1) or lactate consumption (from 
7.8 ± 0.1 to 8.5 ± 0.1) without signifi cant changes on the corresponding Vmax. This is consistent 
with a competitive inhibition between simultaneous consumption of  glucose and lactate. When 
cultures of  neurons or astrocytes were incubated with increasing lactate concentrations 1-20 mM, 
pyruvate production was observed with Km (mM) and Vmax (nmols.mg
-1.h-1) values of  1.0 ± 0.1 and 
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109 ± 4 in neurons, or 0.28 ± 0.1 and 342 ± 54 in astrocytes. Thus, astrocytes or neurons are able 
to return to the incubation medium as pyruvate, a signifi cant part of  the consumed lactate. Present 
results support the reversible exchange of  reducing equivalents between neurons and astrocytes 
in the form of  lactate or pyruvate. Monocarboxylate exchange is envisioned to operate under 
near equilibrium, with the transcellular fl ux directed thermodynamically towards the more oxidized 
intracellular redox environment. Transcellular redox coupling mechanisms may couple glycolytic 
and oxidative zones in other heterogeneous tissues including muscle and tumors.
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2. Introduction
 Metabolism of  the monocarboxylates lactate and pyruvate plays a central role in cerebral 
energetics, providing a crucial link between glycolytic and oxidative metabolisms in the brain (Gruetter 
2002; Hertz and Dienel 2002; Pellerin 2003; Rodrigues and Cerdán 2007; Sierra et al. 2007). Lactate 
and pyruvate metabolism in neural cells involves necessarily the activity of  the MCTs of  the plasma 
membrane and the cytosolic LDH isoenzymes. It has been described that neurons and astrocytes 
are equipped with different isoforms of  these proteins, namely MCT1 and MCT2 or LDH1 and 
LDH5, respectively (Bittar et al. 1996; Laughton et al. 2000; Pellerin et al. 2005; Pierre and Pellerin 
2005). This selective distribution of  MCTs and LDH isozymes is thought to be consistent with a 
unidirectional fl ux of  lactate from astrocytes to neurons, as proposed in the classical Astrocyte to 
Neuron Lactate Shuttle (ANLS) metabolic coupling hypothesis (Magistretti 2000; Magistretti and 
Pellerin 2000; Pellerin and Magistretti 1994; Tsacopoulos and Magistretti 1996). Additionally, the 
fl ow of  carbon skeletons from glucose to CO2, in neurons and astrocytes, during cerebral activation 
is currently understood to proceed as outlined by this hypothesis (Magistretti et al. 1999; Pellerin 
and Magistretti 1994; Tsacopoulos and Magistretti 1996). During the past decades much attention 
has been given to this fl ow of  carbon skeletons and their relationship to cerebral energetics and 
neurotransmission (Cruz and Cerdán 1999; Rothman et al. 2003). However, the pathways for the 
transfer of  reducing equivalents to O2 and H2O remained much less explored. In particular, the 
highly heterogeneous cellular composition of  the cerebral tissue led to considerable uncertainties 
concerning the roles, relative contributions, subcellular compartmentation and coordination of  the 
metabolisms of  carbon skeletons and reducing equivalents, in neurons and glial cells. 
Pyruvate and lactate transport through the MCTs is known to be reversible and driven by 
concentration gradients of  monocarboxylate and protons (Halestrap and Meredith 2004; Halestrap 
and Price 1999; Hertz and Dienel 2005). Similarly, LDH is classically known to operate in the cytosol 
reversibly and close to thermodynamic equilibrium conditions (Veech 1991; Ward and Winzor 
1983). Together, these concepts support the presence of  reversible, rather than unidirectional, 
exchanges of  lactate or pyruvate through plasma membrane of  neurons and astrocytes, respectively. 
In this respect, intracellular compartmentation of  lactate and pyruvate pools has been described 
both in neurons and astrocytes (Cruz et al. 2001; Sonnewald et al. 1993; Waagepetersen et al. 2001; 
Zwingmann et al. 2001), as well as in glioma cells (Bouzier et al. 1998). Two different intracellular 
pyruvate pools were characterized: one thought to operate in fast kinetic exchange with extracellular 
lactate or pyruvate (the Pp pool), the other proposed to be derived from the slower glycolytic 
degradation of  glucose (the Pg pool) (Cruz et al. 2001). Earlier descriptions of  neuroglial coupling 
did not consider these aspects. Thus, this reversibility of  the LDH isozymes and MCT of  neurons 
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and astrocytes allows these neural cells to produce and consume lactate or pyruvate, resulting 
in recycling of  carbon and reducing equivalents through the corresponding plasma membranes 
(Rodrigues and Cerdán 2005b; Rodrigues et al. 2005). Moreover, because both lactate and pyruvate 
can exchange reversibly between cytosol of  each cell and extracellular space, it follows that these 
metabolites can also be exchanged transcellular between both cells in a lactate/pyruvate shuttle, an 
aspect previously not envisioned. The competitive metabolism of  glucose or lactate in neurons and 
astrocytes and the transcellular exchange of  the monocarboxylates lactate and pyruvate between 
neurons and astrocytes, provided the basis for the Redox Switch/Redox Coupling hypothesis 
(Cerdán et al. 2006). However, despite a number of  studies on the consumption of  pyruvate by 
neurons and astrocytes (Cruz et al. 2001; Desagher et al. 1997; Matsumoto et al. 1994; Zwingmann 
and Leibfritz 2003), no evidence had been presented to our knowledge on the crucial aspect of  
pyruvate production by these cells.
In this chapter we provide a novel interpretation of  neuroglial coupling that accounts for the 
proposals mentioned above. We begin summarizing the classical concepts of  metabolic coupling, 
we continue our approach by analyzing the evidences of  metabolic compartmentation of  pyruvate 
and lactate, and then the presence of  lactate recycling and the redox switch. In this chapter, we 
explore also the kinetics of  the Redox Switch/Redox Coupling mechanisms by investigating the 
consumption of  glucose and lactate in primary cultures of  cortical neurons and demonstrate that 
pyruvate can be produced from lactate, both by neurons and astrocytes. Our results show that 
lactate and glucose are consumed competitively and simultaneously, the dominant substrate being 
determined by their relative extracellular concentrations, the specifi c kinetic constants for substrate 
consumption and the cytosolic redox states. In addition, we were also able to demonstrate that 
pyruvate is produced from lactate in primary cultures of  neurons and glial cells, establishing a 
crucial link for the operation of  the redox coupling mechanism. We conclude by describing the 
Redox Switch/Redox Coupling hypothesis as an integrative interpretation of  neuroglial coupling.
2.1 The Astrocyte to Neuron Lactate Shuttle Hypothesis
In the section 8.1 of  the fi rst chapter of  this thesis, and more particularly in Figure 1.10, we 
introduced the main aspects of  the astrocyte to neuron lactate shuttle (ANLS) hypothesis (Magistretti 
2000; Magistretti and Pellerin 2000; Pellerin 2003; Pellerin and Magistretti 1994; Tsacopoulos 2002; 
Tsacopoulos and Magistretti 1996; Tsacopoulos et al. 1998). Briefl y, in this proposal, astrocytes 
are thought to play a central role in cerebral bioenergetics by coupling glucose consumption to 
neuronal activation. In summary, Pellerin and Magistretti suggested that the uptake of  glutamate 
by astrocytes increases intracellular Na+ activating Na+/K+ ATPase, which in turn reduces the 
levels of  ATP that stimulates glycolytic activity, initiating production and release of  lactate from 
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astrocytes. This enhanced lactate production is proposed to support neural metabolism during 
neurotransmission. In addition, calculated fl uxes though the cerebral TCA cycle and the glutamate-
glutamine cycle during (1-13C) glucose metabolism, provided additional support to this hypothesis 
(Magistretti et al. 1999; Rothman et al. 1999; Shulman et al. 2001).
Since then, considerable experimental evidences have accumulated revealing that a major portion 
of  the energy used to synthesize glutamine is derived from the astroglial TCA cycle rather than 
from glycolysis (García-Espinosa et al. 2003), that up to 40% of  cerebral glutamate is obtained from 
alternative sources to glutamine (García-Espinosa et al. 2003) and that the glutamate-glutamine 
cycle may not present a 1:1 stoichiometry (Gruetter et al. 2001). Moreover, it was shown that 
different kinetic pools of  pyruvate and lactate exist in neurons and astrocytes and that part of  the 
lactate consumed by the neuron could be recycled back to the medium during the lactate recycling 
process (Cruz et al. 2001; Fonseca et al. 2004; Rodrigues and Cerdán 2005b; Rodrigues et al. 2005; 
Zwingmann et al. 2001). Finally, independent studies from several laboratories found that glutamate 
was signifi cantly oxidized by astrocyte preparations and that increased glutamate concentrations 
resulted in a decrease of  glucose consumption by these cells (Hertz 2004a; Peng et al. 2001; 
Sonnewald et al. 1997). Together, these fi ndings suggested that the coupling mechanisms between 
neuronal and glial metabolisms during glutamatergic neurotransmission were more complex than 
initially envisioned. The following sections provide a more detailed analysis of  these concepts.
2.2 Monocarboxylate Compartmentation in Neural Cells and the Redox Switch 
Hypothesis
Figure 4.1 illustrates the existence of  two different intracellular pools of  pyruvate in primary 
cultures of  neurons and astrocytes (Cruz et al. 2001; García-Espinosa et al. 2004). Neurons incubated 
with mixtures containing 1 mM (1,2-13C2) glucose and increasing (3-
13C) pyruvate concentrations 
produced exclusively (3-13C) lactate, rather than the corresponding mixtures of  (3-13C) and (2,3-
13C2) lactate. This indicated that the cytosolic pools of  (3-
13C) and (2,3-13C2) pyruvates derived 
from (3-13C) pyruvate and (1,2-13C2) glucose, did not equilibrate rapidly in the neuronal cytosol. 
In contrast, data suggested that one pyruvate pool (the Pp pool) was derived from extracellular 
pyruvate (or other monocarboxylates as lactate) while the other (the Pg pool) was produced by 
glycolysis from extracellular glucose.
The detection of  two intracellular pyruvate pools disclosed the mechanism by which neurons 
could select glucose or lactate as fuels to support neurotransmission. Indeed, both substrates are 
available in the extracellular fl uid and could be, simultaneously or alternatively, consumed by neurons. 
A redox switch mechanism was proposed then to coordinate the subcellular compartmentation of  
the pyruvate pools and regulate glucose and monocarboxylate metabolism in neural cells. This 
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mechanism allowed neurons (and astrocytes) to switch between glucose and lactate as substrates 
for oxidation, depending on their relative availability in the extracellular space (García-Espinosa et 
al. 2004).
Briefl y, fast monocarboxylate transport through the neuronal plasma membrane made the high 
lactate concentration in extracellular space derived from astrocytic glycolysis, to result rapidly, in 
augmented cytosolic lactate concentration in the neurons. Increased neuronal lactate in cytosol 
could switch off  glycolysis in these cells by competition for NAD+ between glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and LDH systems (Figure 4.1-A). Under these conditions, 
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Figure 4.1. Intracellular compartmentation of  pyruvate in primary cultures of  neurons. A: 13C NMR 
spectrum of  neurons medium after incubation with 1 mM (1,2-13C2) glucose and 1 mM (3-
13C) pyruvate. Note that 
only (3-13C) lactate is produced, as derived from (3-13C) pyruvate. No (2,3-13C2) lactate is produced from (1,2-
13C2) 
glucose. B: Two kinetically different pyruvate pools exist in neurons. The fast turnover Pp pool is derived from 
extracellular lactate or pyruvate while the slow turnover Pg pool is derived from glucose. In the presence of  high 
lactate concentrations, glycolytic fl ow may be reduced or stopped by competition with lactate dehydrogenase for 
cytosolic NAD+. Glc, glucose; Pyr, pyruvate; Lac, lactate. Adapted from (Cruz et al. 2001) with permission of  the 
publisher.
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glucose metabolism in neurons is reduced and lactate is oxidized in the TCA cycle until its 
concentration decreases to preactivation levels, restoring then normal neuronal glycolysis and TCA 
cycle activity. 
Recently, dual photon NADH fl uorescence confocal microscopy has been able to resolve in 
time the NADH balances occurring in neurons and astrocytes during glutamatergic activation 
(Figure 4.2) (Kasischke et al. 2004). Using cerebral cortex slices stimulated electrically, authors 
fi rst found a transient decrease in NADH fl uorescence colocalized with neuronal markers and 
sensitive to postsynaptic receptor inhibitors. Following this fast neuronal NADH depression, it was 
observed a sustained and more pronounced increase in NADH fl uorescence, which colocalized 
with astrocytic markers. The transient decrease of  neuronal NADH fl uorescence could be due to 
net aerobic oxidation of  glucose in the neuronal respiratory chain, while the increase in astrocytic 
NADH fl uorescence could be attributed to anaerobic net lactate production in the astrocytes. 
NADH fl uorescence results show that the (18F)-2-deoxyglucose (FDG) accumulation observed 
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Figure 4.2. Confocal dual photon NADH fl uorescence of  neurons and glial cells ex vivo during electrical 
stimulation of  cerebral cortex slices. A: Biphasic response after activation (orange) as compared to the resting 
state (blue). An initial NADH fl uorescence dip is followed by an NADH fl uorescence overshoot (orange). B: 
The NADH-dip colocalizes with neurons (green). C: The NADH-overshoot colocalizes with astrocytes (red). D: 
Binary image of  NADH-dip and NADH-overshoot showing anticolocalization of  both phases. Reproduced from 
(Kasischke et al. 2004) with permission of  the publisher.
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in vivo by PET techniques during cerebral activation occurs in the astrocytes, rather than in the 
neurons (Kasischke et al. 2004; Raichle 1998). Nevertheless, it should be noted here that the detected 
changes in NADH fl uorescence in neurons and astrocytes, represent only the net balance between 
NADH production and consumption processes, rather than their absolute oxidative or glycolytic 
capacities in these cells (discussed later). Therefore, these fi ndings are also consistent with the 
signifi cant oxidative capacity described in astrocytes as well as with the considerable glycolytic 
capacity available to neurons, as long as the net balance between both processes favors neuronal 
oxidation or astrocytic glycolysis in the early or late phases of  cerebral activation, respectively.
2.3 Lactate Recycling
Recently developed NMR methods (chapters 2 and 3) have allowed the demonstration of  lactate 
recycling through the plasma membrane of  glioma cell lines and primary cultures of  neurons and 
astrocytes (Fonseca et al. 2004; Rodrigues and Cerdán 2005b; Rodrigues et al. 2005). A relevant 
consequence of  the lactate recycling process in the ANLS hypothesis is that part of  the neuronal 
lactate may return to the extracellular fl uid rather than being metabolized intracellularly and that 
part of  astrocytic lactate may recycle back from the extracellular fl uid to the astrocyte cytosol. 
Lactate recycling could thus account in part for a non-stoichiometric relationship between glucose 
consumption and glutamate-glutamine cycling. A similar recycling situation may be found with 
pyruvate, suggesting that reversible exchange of  lactate and pyruvate with the extracellular space 
occurs both in neurons and in astrocytes. Indeed, both neurons and astrocytes are known to be 
able to consume pyruvate (Cruz et al. 2001; Sharma et al. 2003; Zwingmann and Leibfritz 2003). 
In general, the exchange of  reducing equivalents between neurons and astrocytes mimics, at the 
transcellular level, the intracellular exchange of  reducing equivalents in the redox shuttles of  the 
inner mitochondrial membrane (Palmieri 2004), providing the background for the transcellular 
redox coupling hypothesis proposed here.
 
3. Materials and Methods
3.1 Preparation and Characterization of  Primary Cultures from Neural Cells and Incubation 
Conditions
Primary cultures of  cortical neurons were prepared from embryos of  Wistar rats with 17 days 
of  gestation, essentially as described previously (Cruz et al. 2001). Briefl y, the brains were isolated 
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from the embryos, the meninges removed, and the cortical areas collected in a PBS solution with 
6 mM glucose and 1% BSA. Then, the cerebral tissue was minced and resuspended with a pipette. 
The suspension was then passed through a 80 µm fi lter and the cells seeded at 1.3×106 cells/mL 
in poly-lysine coated 8 cm plates with 10 mL of  culture medium (DMEM with 15 mM HEPES, 
2.5 µg/mL of  fungizone, 100 U/mL of  penicillin/streptomycin, 5 ng/mL Na2SeO4, 5 µg/mL 
insulin, 5 µg/mL transferrin, 6.3 ng/mL progesterone and 100 µM putrescine) with 5% FBS, 5% 
HS. Plates were maintained in a humidifi ed incubator chamber at 37 ºC with 5% CO2. After 24 
hours, the cells were transferred to culture medium without serum and maintained for 6 more days 
in culture. 48 hours before the experiments, 10 µM cytosine β-D-arabinofuranoside was added to 
the culture medium. 
On the day of  the experiment, the DMEM medium was removed and substituted by Krebs-
Ringer bicarbonate buffer containing increasing glucose concentrations of  0.25, 0.5, 1, 2.5 and 5 
mM in the absence and presence of  5 mM lactate, or increasing lactate concentrations of  1, 2.5, 5, 
10 and 15 mM in the absence and presence of  1 mM glucose. The concentrations of  the competing 
substrates used were chosen from pilot sensitivity tests of  glucose and lactate consumption to 
the presence of  lactate and glucose, respectively. Two aliquots from the incubation medium 
(0.5 mL each) were withdrawn after three and six hours of  incubation to determine glucose or 
lactate consumption and investigate the kinetic constants of  these processes. An independent set 
of  experiments was performed to evaluate neuronal pyruvate production from lactate. Primary 
cultures of  neurons, prepared as described above, were incubated in Krebs Ringer bicarbonate 
buffer containing increasing lactate concentrations in the same range. In some experiments, the 
neuronal cultures were incubated with (3-13C) lactate, to monitor (3-13C) pyruvate production by 13C 
NMR. Two aliquots (0.5 mL) from the incubation medium were withdrawn at three and six hours 
and the pyruvate concentration determined spectrophotometrically. The incubation was continued 
up to 24 hours, the medium collected and concentrated for high-resolution 13C NMR analysis. At 
least three primary cultures from neurons prepared from foetuses derived from different animals 
were used for every experimental condition.
Primary cultures of  cortical astrocytes were prepared from newborn (up to 2-day-old) Wistar 
rats. Briefl y, the cortices were removed and cleaned from the meninges. Cerebral tissue was then 
minced, resuspended with a pipette and vortexed for 1 minute. The resulting suspension was 
passed through a 80 µm fi lter and the cells seeded in poly-lysine coated 8 cm plate with 10 mL 
DMEM with 10% FBS, 10% HS, 10 mM HEPES, 2.5 µg/mL of  fungizone and 100 U/mL of  
penicillin/streptomycin. Plates were maintained in a humidifi ed incubator chamber at 37ºC with 
5% CO2. After one week in culture cells were transferred to DMEM with 5% FBS, 5% HS, 10 mM 
HEPES, 2.5 µg/mL of  fungizone and 100 U/mL of  penicillin/streptomycin. Confl uent cultures 
were obtained and used for experiments after two weeks in culture. In the day of  the experiment, 
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the DMEM medium was removed and substituted by Krebs-Ringer bicarbonate buffer containing 
increasing concentrations of  lactate in the range 1-15 mM in the absence and presence of  1 mM 
glucose. In some experiments, astrocyte cultures were incubated with (3-13C) lactate to evaluate (3-
13C) pyruvate production under similar conditions to those described above for neurons. At least 
three primary astrocyte cultures prepared from different animals were used for every experimental 
condition.
Cell culture purity was assessed using standard immunolabeling techniques. Cells were washed 
three times with PBS for 10 minutes, fi xed in 4% (weight/vol) paraformaldehyde in PBS for 5 min 
and permeabilized with 0.2% (vol/vol) Triton in PBS. Neurons were visualized (negative staining) 
using rabbit anti-Glial Fibrillary Acidic Protein (GFAP, 1:200) and (positive staining) rat anti-β-
III-tubulin (1:200) as primary antibodies and biotin conjugated anti-rat Immuno gamma Globulin 
(IgG,1:200), Streptavidin Alexa Fluor® 488 (1:2000) and Alexa Fluor® 594 goat anti-rabbit IgG 
(1:2000) as secondary antibodies. Astrocytes were visualised with rabbit anti-GFAP (1:200) and 
Alexa Fluor® 594 goat anti-rabbit IgG (1:2000). Cellular nuclei were labeled with 4’-6-diamidino-
2-phenylindol (DAPI). The purities of  neuron or astrocyte cultures determined in this way were 
higher than 95%.
3.2 Analytical Determinations
Glucose, lactate or pyruvate in the incubation medium of  neurons or astrocytes, were 
determined spectrophotometrically (340 nm, 37 ºC) using a vertical spectrophotometer (Molecular 
Devices Spectramax TM 340 PC, Sunnyvale, CA, U.S.A.) in 96-well polypropylene plates. To this 
end, we adapted conventional enzymatic end point methods coupled to NAD(P)H production or 
consumption (Bergemeyer 1983). Briefl y, glucose was determined through the NADPH production 
by hexokinase and glucose-6-phosphate dehydrogenase, lactate and pyruvate through NADH 
production or consumption by lactate dehydrogenase. Total protein was determined in cell pellets 
obtained after the incubation using the Bradford assay (Bradford 1976).
3.3 Determination of  Kinetic Constants
The apparent Km and Vmax values for glucose consumption in the absence and presence of  
lactate, lactate consumption in the presence and absence of  glucose and pyruvate production, were 
determined by non-linear least squares fi t of  the measured rates to the Michaelis-Menten expression 
v = Vmax [S]/ Km + [S] where v or [S] represent the initial rates of  substrate consumption or the 
initial concentrations of  substrate and Km and Vmax, the corresponding apparent kinetic constants. 
The apparent inhibition constant Ki was determined using the expression for competitive inhibition 
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KmI = Km + (1 + [I]/ Ki) where KmI and Km represent the Km values in the presence and absence 
of  the inhibitor and [I] the inhibitor concentration. Non-linear fi ts were performed using the 
Mathematica v4.0 software (Wolfram Research, Champaign, IL, USA) as implemented in an Intel 
Centrino Pentium M 1.5 GHz platform.
3.4 13C NMR Spectroscopy
High-resolution 13C NMR spectra (4 ºC, pH = 7.2) from aliquots of  the incubation medium after 
incubation with (3-13C) lactate were acquired in a Bruker AVANCE 500 WB NMR spectrometer 
using a commercial 5-mm high resolution triple probe (13C,1H,2H). Conditions were: π/3 pulses, 
1.09 s acquisition time, 7.0 s recycle time, 30 kHz sweep width, 64k points zero-fi lled to 256k 
points prior to Fourier transformation and 20.000 scans. Broad band proton decoupling was gated 
on only during acquisition. Chemical shifts were measured with respect to the resonance of  a 10% 
dioxane solution in water at 67.4 ppm, placed in a coaxial capillary. Assignments were performed 
using literature values and confi rmed through the addition of  the authentic compounds (Cruz and 
Cerdán 1999; Rodrigues and Cerdán 2005a).
3.5 Statistics
Kinetic constants obtained under different incubation conditions were compared using the 
Student t test, as implemented in the SAS package (Statistical Analysis System, Cary, NC, USA) 
running on an Intel Centrino Pentium M 1.5 GHz Platform. Comparisons with P < 0.05 were 
considered statistically signifi cant.
3.6 Materials
Dulbecco’s modifi ed Eagle’s medium (DMEM), foetal bovine serum (FBS), horse serum (HS) 
and phosphate-buffered saline (PBS) were purchased from GIBCO (Glasgow, Scotland, U.K.). 
Kits for analytical determinations of  glucose, lactate and pyruvate were from Roche (Mannheim, 
Germany). Sodium (3-13C) L-lactate (99% 13C) was purchased from Cambridge Isotope Laboratories, 
Inc. (Andover, MA, USA). 2H2O (99.9 % 
2H) was purchased from Apollo Scientifi c (Bradbury, 
Stockport, UK). All other chemicals were of  the purest grade available from commercial sources.
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4. Results
4.1 Competitive Consumption of  Glucose and Lactate
Table 4.1 summarizes the kinetic constants for glucose consumption in the absence and presence 
of  5 mM lactate or those for lactate consumption in the presence and absence of  1 mM glucose. 
Aliquots withdrawn at three and six hours of  incubation showed a linear decrease in the initial 
glucose or lactate concentrations allowing the determination of  the initial rates. Glucose or lactate 
consumption rates depicted a clear hyperbolic pattern, consistent with Michaelis-Menten kinetics. 
These experiments were reproduced with neuronal cultures from foetuses of  three different litters 
and the combined results fi tted to the Michaelis-Menten expression to determine the apparent Km 
and Vmax values. The Km for glucose consumption increased from 2.2 ± 0.2 mM in the absence of  
lactate, to 3.6 ± 0.1 mM (P < 0.001) in the presence of  5 mM lactate, with no signifi cant effects on 
the Vmax value. This is consistent with a competitive inhibition mechanism, with a Ki value of  3.6 
mM for the inhibition of  glucose consumption by extracellular lactate. The Km and Vmax values for 
lactate consumption increased from 7.8 ± 0.1 mM and 440 ± 3 nmols. min-1. h-1 in the absence of  
glucose to 8.5 ± 0.1 and 451 ± 3 nmols. min-1. h-1 (P < 0.05) in the presence of  1 mM glucose, also 
consistent with a competitive inhibition mechanism with a Ki value of  11.1 mM.
To evaluate the effects of  the competing substrates over the full range of  substrate and inhibitor 
concentrations, 0.25-5 mM glucose and 1-15 mM lactate, we generated 3D plots of  glucose (Figure 
4.3-A) or lactate (Figure 4.3-B) consumption rates, as a function of  concentration variations of  
the competing substrate. To this end, we used the expression for hyperbolic competitive inhibition 
Glucose consumption
Glucose consumption
in the presence of lactate
Lactate consumption
Lactate consumption
in the presence of glucose
2.2 ± 0.2
3.6 ± 0.1
7.8 ± 0.1
8.5 ± 0.1
Glucose 0.25–5 mM
Glucose 0.25–5 mM
and 5 mM lactate
Lactate 1–15 mM
Lactate 1–15 mM
and 1 mM glucose
Process Incubation condition Km (mM)
a Vmax (nmol/mg/hr)
a Ki (mM)
b
TABLE 4.1. Apparent kinetic constants of glucose and lactate consumption in primary
 cultures of cortical neurons in the absence and presence of the corresponding
 competitive substrate
±
±
±
±
65
54
3
3
n.a.
3.6
n.a.
11.1
600
674
440
451
aApparent kinetic constants were obtained from non-linear fits of  substrate consumption curves to the Michaelis-
Menten equation as described in Materials and Methods.
bApparent Ki values were obtained as described in Materials and Methods from the expression K´m = Km (1 + [I]/Ki) 
where K´m is the Km in the presence concentration of  inhibitor [I] and Km the value obtained in the absence of  inhibi-
tor. n.a., not applicable.
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v = Vmax [S]/ (Km (1 + [I]/Ki) + [S]) for the consumption of  glucose or lactate in the presence 
and absence of  one competitive inhibitor. Our results revealed that at resting glucose and lactate 
concentrations of  ca. 1 mM in the extracellular fl uid, primary cultures of  neurons consumed 81% 
glucose and 19% lactate. However, when the extracellular glucose concentration was maintained at 
1 mM and the extracellular lactate concentration increased to 2 mM and 5 mM, the relative lactate 
consumption rate increased to 30% and 60%, respectively.
4.2 Pyruvate Production
We continued by investigating the reversible exchange of  monocarboxylate reducing equivalents 
between astrocytes and neurons. This process involves necessarily not only the reversible transfer 
of  reduced substrates such as lactate between neurons and astrocytes, but the transfer of  oxidized 
equivalents in the form of  pyruvate, in the opposite direction. Figure 4.4 illustrates the kinetics of  
pyruvate production in the medium of  primary cultures of  astrocytes (Figure 4.4-A) or neurons 
(Figure 4.4-B) incubated with increasing concentrations of  lactate in the range 1-20 mM. Pyruvate 
production showed hyperbolic kinetics in both cell types. However, neurons were able to release 
pyruvate with Km and Vmax values of  1.0 ± 0.2 mM and 109 ± 4.4 nmol.mg
-1.h-1, while astrocytes 
incubated under similar conditions released pyruvate to the medium with Km and Vmax values of  
0.3 ± 0.1  mM and 341 ± 53.7 nmol. mg-1.h-1, respectively.
Finally, we investigated if  pyruvate produced by primary cultures of  neurons or astrocytes 
during incubation with (3-13C) lactate could be detected by 13C NMR in the incubation medium. 
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Figure 4.3. 3D simulations of   (A) glucose consumption (nmol.mg-1.h-1) for the range 0.25-5 mM glucose 
and 1-15 mM lactate and (B) lactate consumption (nmol.mg-1.h-1) for the range 1-15 mM lactate and 0.25-
5 mM glucose. 3D Simulations were performed with the Mathematica v4.0 software package, using the kinetic 
constants of  Table 4.1.
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Figure 4.4-C shows a representative 13C NMR spectrum from astrocytes incubation medium 
incubated for 24 h with 5 mM (3-13C) lactate. After extensive concentration of  the 8 ml medium 
to dryness and resuspension in 0.5 ml of  2H2O, it was possible to observe the resonance of  (3-
13C) 
pyruvate at 27.4 ppm, together with other additional resonances derived from the (3-13C) lactate 
(20.9 ppm) used as substrate. The lower capacity of  pyruvate production by neurons made it not 
possible to detect the corresponding (3-13C) pyruvate resonance in their incubation media after 
similar incubation conditions and concentration steps (not shown).
Figure 4.4. Kinetics of  pyruvate production in primary cultures of  cortical astrocytes (A) and neurons (B). 
Initial rates of  pyruvate consumption were determined spectrophotometrically in the incubation media of  neuronal 
and glial cultures containing lactate concentrations in the range 1-20 mM. 13C NMR spectra of  the media of  cortical 
astrocytes incubated with 5 mM (3-13C) lactate for 24 h (C).
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5. Discussion
5.1 Simultaneous and Competitive Consumption of  Glucose and Lactate
The competition between glucose and lactate as neuronal oxidative substrates has been 
previously addressed a number of  times, both in vitro and in vivo (Bouzier-Sore et al. 2006; Bouzier-
Sore et al. 2003; Dienel and Hertz 2001; Waagepetersen et al. 1998). In vitro studies used primary 
cultures of  neurons or astrocytes and combinations of  13C labeled glucose or lactate in the presence 
of  the unlabeled competitor whereas in vivo studies infused different combinations of  labeled and 
unlabeled glucose and lactate (Bouzier-Sore et al. 2006; Bouzier-Sore et al. 2003). The in vitro results 
revealed a preferential oxidation of  lactate by neurons as shown by increased 13C labeling of  the 
amino acids glutamate and glutamine. Similarly, the in vivo data were consistent with a preferential 
oxidation of  lactate in a compartment devoid of  pyruvate carboxylase activity, presumably the 
neuronal environment (Bouzier et al. 2000).
In contrast, the inhibitory effects of  glucose or lactate on the consumption of  each other 
received less attention and no kinetic studies are available to our knowledge. Primary cultures of  
cortical neurons incubated with glucose or lactate only, consumed preferentially glucose because of  
its more favorable kinetic constants Km and Vmax. Lactate increased the Km for glucose consumption 
without a signifi cant effect on Vmax and glucose increased the Km for lactate consumption, without 
apparent effects on Vmax. These results showed that glucose and lactate are consumed competitively 
and simultaneously, rather than alternatively as thought previously. Moreover, the kinetics for 
glucose and lactate consumption in the presence of  each other are consistent with a one-site 
inhibition by the competing substrate in both cases. We hypothesize that the common inhibition 
site occurs at the GADPH step, the inhibition mechanism relying in the competition for cytosolic 
NAD+ between glycolysis and lactate oxidation (Cruz et al. 2001; García-Espinosa et al. 2004). The 
apparent Ki values indicate that relatively high lactate concentrations (ca. 3.6 mM) are required to 
inhibit by 50% glucose consumption. This concentration is in the range of  the high Km value of  
the dominant LDH activity of  synaptosol (O’Brien et al. 2007), suggesting that this isoform is the 
main participant in the regulation of  the redox switch.
The relevance of  these results to the in vivo situation in the adult brain remains diffi cult to 
evaluate at present. Lactate concentrations in the in vivo brain have been measured previously by 
1H NMR spectroscopy and in vivo microdialysis methods, with values in the range of  0.5 µmol.g-1 
or 0.4 mM, respectively (Darbin et al. 2006; Gruetter et al. 1998). Moderate increases ranging 50-
150% have been reported on cerebral activation (Giove et al. 2003). These concentrations seem to 
be too small to elicit a signifi cant inhibition of  glucose consumption or an important relative rate 
of  lactate consumption, in our cultures. Under these in vivo conditions, present results indicate that 
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neurons would consume preferentially glucose. This conclusion agrees with the in vivo accumulation 
of  fl uorescently labeled deoxyglucose observed in neurons from the hippocampus or cerebellar 
Purkinje cells (Itoh et al. 2004). It is also possible that the actual concentrations of  lactate in the 
highly constrained space of  the synaptic cleft are signifi cantly higher than the average concentrations 
measured by NMR over larger volumes or determined by microdialysis in the extracellular spaces. 
Under these conditions, synaptic lactate could operate effectively the redox switch, provided that 
its concentration approaches or exceeds signifi cantly the Ki value. Extracellular lactate can also 
approach a complete switch off  of  glycolysis under hypoxic or ischemic conditions, when lactate 
concentrations reach the 10-15 mM range. This confi rms previous proposals of  lactate becoming 
a predominant substrate under ischemic conditions (Schurr 2006; Schurr et al. 1988). 
In addition to these considerations, it should be noted that cerebral activation can induce 
changes in the rates of  lactate production and consumption by the neuronal and glial compartments 
in vivo (Serres et al. 2004; Serres et al. 2005; Serres et al. 2003). Increased glutamate concentrations 
obtained during activation have been shown to increase the uptake of  fl uorescently labeled glucose 
by astrocytes and reduce it in neurons (Loaiza et al. 2003; Porras et al. 2004). Together, this evidence 
indicates that the cerebral activation process in vivo could involve changes in the kinetic parameters 
investigated in this study for primary cultures of  neurons or astrocytes under resting conditions. 
In summary, our results suggest that glucose and lactate can be consumed simultaneously, the 
consumption of  one substituting partially the need for the other. This is a useful bioenergetic 
circumstance because both substrates appear to be equally effective energizing activity dependent 
synaptic vesicle turnover (Morgenthaler et al. 2006). 
Importantly, it should be noted that the kinetics of  relative glucose or lactate consumption 
reported here are different from the relative glucose or lactate oxidation rates described previously 
(Bouzier-Sore et al. 2006; Bouzier-Sore et al. 2003). For the combination of  1 mM glucose and 
1 mM lactate, it was previously calculated that lactate contributed with 75% of  the carbons 
oxidized in the neuronal cycle, whereas lactate consumption values reported here would indicate 
that lactate consumption represents only 20% of  the glucose consumed. Together, these results 
indicate that even though lactate consumption may be smaller than glucose consumption, the 
lactate consumed may be preferentially oxidized. This situation is consistent with our previous 
fi ndings of  two kinetically different pyruvate pools in neurons, one derived from glucose (Pg) pool 
and the other from monocarboxylates (Pp) pool, able to be oxidized preferentially under different 
substrate and redox conditions (Cruz et al. 2001; García-Espinosa et al. 2004). Thus, glucose or 
lactate consumption rates may not be linearly correlated to the respective oxidation rates.
5.2 The Transcellular Monocarboxylate Redox Shuttle
A number of  studies have reported previously lactate and pyruvate consumption by primary 
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cultures of  neural cells (Bouzier-Sore et al. 2006; Cruz et al. 2001; Dienel and Hertz 2001; 
Zwingmann and Leibfritz 2003). In addition, the presence of  pyruvate in the extracellular fl uid 
has been classically described in a variety of  microdialysis experiments (Ronne-Engstrom et al. 
1995; Valtysson et al. 1998). The origin of  the cerebral pyruvate present in the extracellular fl uid 
and its consumption by neural cells has not, however, been suffi ciently addressed. The present 
study provides an advance in this direction by showing pyruvate production and its kinetics in 
primary cultures of  neurons and glial cells. Interestingly, our results indicate that both neural cells 
are able to produce pyruvate from lactate but with different kinetics. For the same extracellular 
lactate concentration, astrocytes present a larger capacity of  pyruvate production than neurons. 
This occurs, most probably, because of  different kinetic properties of  the LDH isozymes present 
in both cells (O’Brien et al. 2007). Although both neurons and astrocytes have been shown recently 
to contain the fi ve isoforms of  LDH, the muscle LDH5 isoenzyme seems to be predominant in 
astrocytes whereas the heart LDH1 isoenzyme in neurons (Bittar et al. 1996; Pellerin et al. 1998). 
The kinetic constants of  LDH5 favor lactate production whereas those LDH1 favor pyruvate 
formation. The fact that from the same amount of  lactate neurons produce less pyruvate than 
astrocytes indicates that the pyruvate produced by neurons may be, as expected, preferentially 
oxidized rather than exported to the extracellular medium. It should be noted that the capacity for 
pyruvate production in neurons may account for a very large proportion of  the consumed lactate. 
Considering the kinetic constants of  lactate consumption (Table 4.1) and pyruvate production 
for a 1 mM extracellular lactate concentration, it can be calculated that both lactate and pyruvate 
can be consumed and produced virtually at the same rate of  50 nmols.mg-1.h-1. This represents 
an important observation because many previous studies considered that all lactate consumed by 
neural cells was completely oxidized. On this basis, our results suggest that the rates of  lactate 
oxidation reported previously, based on metabolic balances not considering pyruvate production, 
could be overestimated.
5.3 The Redox Switch/Redox Coupling Hypothesis
The results described above, and in particular the demonstration of  pyruvate production by 
neurons and astrocytes, entail considerable implications for the traditional interpretations of  
metabolic coupling between neurons and glial cells during glutamatergic neurotransmission. In 
particular, it is now known that oxidative metabolism in the neurons and astrocytes can switch between 
glucose or lactate as alternative substrates, depending on their relative availability in the extracellular 
fl uid (García-Espinosa et al. 2004). This is possible because of  the kinetic compartmentation of  
the intracellular pyruvate pools, mentioned above. Thus, the relative extracellular concentrations 
of  lactate, pyruvate and glucose determine, by operating the redox switch, the fi nal oxidation of  
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the Pp or Pg pyruvate pools, respectively (Cruz et al. 2001). In addition, the exchange of  cytosolic 
lactate and pyruvate with the extracellular milieu in neurons and astrocytes has been shown 
to be reversible, rather than unidirectional. This supports the reversible exchange of  reducing 
equivalents between neurons and astrocytes, driven by the transcellular redox gradient, rather than 
the traditional vectorial transfer of  a single metabolite as lactate. Although lactate release from 
primary cultures of  neurons and astrocytes is well documented, no information is available to our 
knowledge on pyruvate release by these cells. Furthermore, numerous evidences have reported 
previously the presence of  pyruvate in the extracellular fl uid of  the adult rat and human brain as 
well as alterations in the extracellular lactate/pyruvate ratio following ischemic episodes, seizures 
or other physiopathological events (Darbin et al. 2005; Nilsson et al. 1990). These fi ndings support 
pyruvate production and release to the extracellular fl uid in the adult brain. In summary, these 
fi ndings imply that changes in cytosolic NAD+/NADH redox state of  astrocytes can be effi ciently 
transferred to the extracellular space and to the neurons and vice versa, following the concentration 
gradients of  extracellular glucose, lactate, pyruvate and oxygen. In addition to pyruvate, glutamate, 
glutamine and GABA have also been shown to be compartmented intracellularly (Hertz 2004b; 
Waagepetersen et al. 2006; Waagepetersen et al. 2001; Waagepetersen et al. 1999; Waagepetersen et 
al. 2003). 
Taken together, present evidences suggest that intracellular monocarboxylate and glutamate 
compartmentation as well as the Redox Switch/Redox Coupling processes play a fundamental role 
in the integration of  the oxidative and non-oxidative metabolisms of  neurons and glial cells during 
glutamatergic neurotransmission. More concretely, the Redox Switch/Redox Coupling hypothesis 
proposed here supports the following sequence of  events (Figure 4.5). Following presynaptic 
glutamate release, astrocytic transporters incorporate glutamate and three Na+ to the astrocytic 
cytosol, which are later removed through the plasma membrane Na+/K+ ATPase. Increased activity 
of  the Na+/K+ ATPase in the astrocytes decreases their cytosolic ATP/ADP concentrations, 
stimulating both glycolysis and the TCA cycle in these cells. Astrocytic glycolysis and the TCA 
cycle contribute together with the ATP necessary for glutamine synthesis, with a predominant 
contribution of  the oxidative sources of  ATP during resting conditions and the non-oxidative 
sources during stimulated conditions. This is so because the energy demands in the astrocyte 
during glutamatergic neurotransmission may exceed the glial TCA cycle capacity, resulting in a net 
activation of  the glycolytic fl ux and a net production of  lactate and pyruvate. Both metabolites 
are rapidly extruded to the extracellular space which refl ects, under these conditions, the reduced 
NAD+/NADH redox of  the astrocytic cytosol. Extracellular lactate and pyruvate are then taken 
up rapidly by neurons, reducing their cytosolic redox which then, refl ects the extracellular (and 
astrocytic) lactate/pyruvate ratio. Neuronal NAD+/NADH redox state may become reduced to a 
point where glycolysis is reduced or even switched off  at the GAPDH step. The same inhibition 
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of  glycolysis, by redox switching under high extracellular lactate concentrations, may occur also 
in astrocytes. Under these conditions, extracellular lactate and pyruvate will be mainly consumed 
by oxidation both in neurons and astrocytes, until their extracellular concentration decreases to 
preactivation levels, setting up the stage for a new glutamatergic event. In this way, the present 
proposal accounts for the simultaneous operation of  both neuronal and glial TCA cycles during 
activation, a situation now fi rmly established (Cruz et al. 2005; Dienel and Hertz 2005). Neuroglial 
coupling is most probably achieved through a reversible exchange of  reducing equivalents between 
neurons and astrocytes in the form of  lactate and pyruvate, rather than from the unidirectional 
transfer of  lactate molecules. Thus, the operation of  this transcellular redox coupling mechanism 
appears to relay ultimately in the regulation of  the intracellular redox states of  neurons and astrocytes 
and, consequently, is determined by the activity of  the intracellular redox shuttles through the 
inner mitochondrial membrane (Arco and Satrustegui 2005; McKenna et al. 2006) and also the 
bioenergetic requirements of  both cells. Under these strong redox coupling conditions, neurons 
and glial cells behave effectively as a “single neural cell”, containing one anaerobic (astrocytic or 
cytosolic) and one aerobic (neuronal or mitochondrial) compartment, which exchange NADH 
reducing equivalents through very potent transcellular and intracellular shuttle mechanisms.
The transcellular exchange of  reducing equivalents underlies most probably the biphasic 
changes in NADH fl uorescence observed in hippocampal slice preparations (Kasischke et al. 
2004) or the extracellular lactate dynamics calculated during activation (Aubert and Costalat 2005; 
Aubert et al. 2005). Following stimulation, the dynamics of  NADH fl uorescence and extracellular 
lactate concentration follow a biphasic time course with an initial dip followed by a pronounced 
overshoot. Dip and overshoot kinetics have been interpreted to refl ect the initial neuronal oxidation 
of  lactate followed by an increase in its glycolytic delivery from astrocytes. Present results suggest 
that the decrease in neuronal NADH fl uorescence, or in the extracellular lactate concentration, 
may not necessarily refl ect neuronal lactate oxidation. In fact, both processes could well be due to 
an increase in the transcellular transfer of  neuronal pyruvate to the astrocyte, a process resulting 
also in neuronal NADH oxidation and reduced extracellular lactate levels. Similarly, the overshoot 
in NADH fl uorescence in astrocytes or the increase in extracellular lactate concentrations may not 
simply refl ect lactate production and its stoichiometric oxidation in the neurons. These processes 
reveal the net balance between lactate produced and oxidized in the astrocyte, lactate and pyruvate 
transferred to the neuron and the balance between lactate oxidized in neurons and returned to 
astrocytes in the transcellular redox shuttle. 
An interesting implication of  the present proposal is that the coupling between neuronal and 
glial metabolisms could be monitored in vivo, in addition to the NADH fl uorescence approach, 
by following non-invasively changes in extracellular and intracellular pH. This is so because the 
reversible NAD+/NADH redox exchange involves proton production for NAD+ reductions and 
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Figure 4.5. The redox switch/redox coupling hypothesis and the subcellular compartmentation of  
pyruvate and glutamate in neurons and astrocytes. Two pools of  pyruvate exist in neurons and astrocytes 
derived from extracellular monocarboxylates (Pp) or glucose (Pg). A lactate/pyruvate redox shuttle is able to transfer 
continuously lactate from astrocytes to neurons, taking advantage of  the kinetics of  plasma membrane transporters 
and lactate dehydrogenase isoenzymes. High cytosolic lactate inhibits neuronal glycolysis at the GAPDH step by 
competition with cytosolic NAD+, favoring the oxidation of  extracellular lactate. Neuronal pyruvate (from the 
Pp pool) is then transferred to the astrocytes to close the redox loop and restart a new redox transfer process. 
Two α-ketoglutarate/glutamate pools exist in neurons and astrocytes, associated to cytosolic and mitochondrial 
compartments, respectively. Exchange of  α-ketoglutarate/glutamate between mitochondria and cytosol is slow and 
dependent of  the cytosolic and mitochondrial NAD(P)+/ΝΑD(P)H ratios, as determined by the malate-aspartate 
shuttle. Both glycolysis and oxidative astrocytic metabolism contribute energy for glutamine production in the 
astrocytes. Asp, aspartate; Glc, glucose; Gln, glutamine; Glu, glutamate; GLUT1 and GLUT3, glutamate transporters 
1 and 3; α-KG, α-ketoglutarate; Lac, lactate; LDH1 and LDH5, lactate dehydrogenase 1 and 5; Mal, malate.
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proton consumption for NADH oxidations. Lactate and protons are cotransported through the 
MCTs [4.1] and the LDH redox equilibrium is dependent of  the proton concentration [4.2],
    Laci +Hi 
+    ↔      Laco + Ho
+                       [4.1] 
           Lac + NAD+     ↔    Pyr + NADH +H+         [4.2]
Consequently, the transcellular redox shuttle seems to be intimately related to intra- and 
extracellular pH regulation and, because of  the proton involvement in many monovalent and 
divalent cation transport processes, linked to the overall ionic homeostasis. In this context, the 
transcellular monocarboxylate shuttle investigated in this study is envisioned to play a central role in 
the integration of  redox processes, pH regulation, and ion homeostasis in the CNS. Redox shuttles 
based on monocarboxylate exchange may present a more general biological signifi cance, coupling 
hypoxic and oxidative environments in many other heterogeneous tissues including muscle and 
tumors.
A variety of  NMR methods have become available to determine intra- and extracellular pH 
that potentially make it possible to investigate the operation of  the redox shuttle in vivo and in vitro 
(García-Martín et al. 2001; Gillies et al. 2004).
Glutamate and glutamine compartmentation are also taken into account in our hypothesis. The 
recently proposed slow exchange of  α-ketoglutarate/glutamate through the inner mitochondrial 
membrane may result in cytosolic and mitochondrial glutamate pools (Berkich et al. 2005). We 
propose here that only the cytosolic (and vesicular) pools of  glutamate or glutamine are involved 
in glutamate-glutamine cycling and neurotransmission.
In summary, we delineated a revised interpretation of  the mechanisms underlying metabolic 
coupling between neurons and astrocytes. Our mechanism is compatible with the subcellular 
compartmentations of  pyruvate, lactate and glutamate, with the redox switch and with 
monocarboxylate recycling through the plasma membrane. Finally, the present proposal may not 
be restricted to the coupling of  neurons and glial cells in the nervous system. It could well be 
extended to other heterogeneous tissues where oxidative and glycolytic environments coexist, such 
as muscle and tumors (Brooks 2002; Henderson et al. 2004). In all these cases, redox shuttles could 
couple the activity of  glycolytic and oxidative environments, providing a general mechanism of  
intra- and intercellular coupling supporting metabolic heterogeneity in cells and tissues.
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1. Abstract 
The interactions between the dopaminergic and glutamatergic neurotransmission systems were 
investigated in the adult brain of  wild type and transgenic mice lacking the dopamine D1 or D2 receptor 
subtypes. Activity of  the glutamine cycle was evaluated by using 13C NMR spectroscopy, and striatal 
activity was assessed by c-Fos expression and motor coordination. Brain extracts from (1,2-13C2) 
acetate-infused mice were prepared and analyzed by 13C NMR to determine the incorporation of  
the label into the C4 and C5 carbons of  glutamate and glutamine. D1R
-/- mice showed a signifi cantly 
higher concentration of  cerebral (4,5-13C2) glutamine, consistent with an increased activity of  the 
glutamate-glutamine cycle and of  glutamatergic neurotransmission. Conversely, D2R
-/- mice did not 
show signifi cant changes in (4,5-13C2) glutamate or (4,5-
13C2) glutamine, suggesting that alterations 
in glutamine metabolism are mediated through D1 receptors. This was confi rmed using D1R
-/- and 
wild type mice treated with reserpine, a dopamine-depleting drug, or with reserpine followed by L-
DOPA, a dopamine precursor. Exposure to reserpine increased (4,5-13C2) glutamine in wild type to 
levels similar to those found in untreated D1R
-/- mice. These values were the same as those reached 
in the reserpine-treated D1R
-/- mice. Treatment of  wild type animals with L-DOPA returned (4,5-
13C2) glutamine levels to normal, but this was not verifi ed in D1R
-/- animals. Reserpine impaired 
motor coordination and decreased c-Fos expression, whereas L-DOPA restored both variables 
to normal values in wild type but not in D1R
-/-. Together, our results reveal novel neurometabolic 
interactions between glutamatergic and dopaminergic systems that are mediated through the D1, 
but not the D2, dopamine receptor subtype.
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2. Introduction
Precise integration of  the different neurotransmitter signalling pathways is necessary to provide 
effi cient and coordinated responses to internal and external stimuli in the Central Nervous System 
(CNS). Glutamate is the principal neurotransmitter in the excitatory circuits of  the CNS, participating 
in many neuronal activities (Conn 2003; Lipsky and Goldman 2003; Malenka 2003). Similarly, 
dopamine is implicated in motor control, cognition, motivation, and emotional processing. Notably, 
indirect pharmacological and behavioural evidences revealed that glutamatergic neurotransmission 
is altered in several pathological disorders traditionally associated with abnormal dopamine signalling 
(Coyle 2006; Kalivas et al. 2003; Sanacora et al. 2003; Tamminga et al. 2003). These fi ndings indicate 
the existence of  interactions between dopaminergic and glutamatergic neurotransmission. Such 
interactions may underlie not only the adaptive and plastic responses to pathophysiological states 
such as Parkinson’s disease (Chase and Oh 2000; Lange et al. 1997), schizophrenia (de Bartolomeis 
et al. 2005), drug abuse (Lapish et al. 2006) and personality disorders (Karasawa et al. 2006), but also 
the operation of  the normal brain under physiological conditions (Lee et al. 2002; Pei et al. 2004; 
Salter 2003; Sesack et al. 2003; West et al. 2003). However, despite the neurobiological and clinical 
relevance of  these interactions, the underlying mechanisms remain poorly understood (Abekawa 
et al. 2000; David and Abraini 2001). In particular, the dopamine receptor subtype that mediates 
communication between glutamatergic and dopaminergic systems has not been identifi ed.  
The use of  13C NMR and the 13C-enriched precursors 13C glucose or 13C acetate has provided 
extensive information on glutamate metabolism in neurons and glia as well as the interactions 
between these cell types through glutamate-glutamine cycling and glutamatergic neurotransmission 
(Rodrigues and Cerdán 2005; Rothman et al. 2003). This approach can be used to reveal glutamate 
turnover, and it is sensitive to perturbations at the glutamate receptor and transport levels as well 
as in the transport of  glucose or acetate precursors (García-Espinosa et al. 2004; Waagepetersen et 
al. 2001). On the other hand, transgenic animals also provide an excellent tool for investigating the 
effects of  gene and protein ablation on their function in vivo (Chen and Zhuang 2003).
On these grounds, we employed 13C NMR (Rodrigues and Cerdán 2005; Rothman et al. 2003), 
to investigate the metabolism of  glutamate and glutamine in the brain of  wild type (WT) and 
transgenic mice that lack dopamine D1 or D2 receptors (Baik et al. 1995; Kelly et al. 1998; Xu et al. 
1994). We confi rmed these results using a complementary pharmacological approach. Accordingly, 
WT and D1R
-/- mice were treated with reserpine, a dopamine-depleting drug (Graybiel et al. 1990; 
Slattery et al. 2004), and also with reserpine and L-DOPA, an acute antiparkinsonian treatment 
(Carlsson et al. 1957; Hornykiewicz 2002; Pavon et al. 2006; Schildkraut et al. 1965), to investigate the 
effects of  these drugs on the glutamate-glutamine cycle and on glutamatergic neurotransmission. 
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Finally, we correlated the information obtained by 13C NMR with tests of  motor coordination and 
with the expression of  the c-Fos protein, a marker of  dopaminergic activity in neurons. Together, 
our results indicate that the interactions observed between glutamatergic and dopaminergic 
neurotransmitter systems are mediated through the D1 but not the D2 dopamine receptors and that 
the lack of  dopamine or lack of  D1 receptors results in an increase in glutamatergic activity. 
3. Materials and Methods
3.1 Animals, Drug Treatments, and Infusion Techniques
The experimental protocols used in this study were approved by the appropriate institutional 
review committees and met the guidelines of  the appropriate government agency. All efforts were 
made to minimize animal suffering. Experiments were carried out in male dopamine D1 and D2 
receptor knock out (D1R
-/-, D2R
-/-) mice (Baik et al. 1995; Kelly et al. 1998) as well as in their 
heterozygous (+/-) and wild type (+/+) littermates. Mice were used at 2-3 months of  age, and the 
genotype of  each mouse was determined by genomic Southern blot analysis as described previously 
(Chen et al. 1999). The mice were housed at the Cajal Institute, in a humidity- and temperature-
controlled room on a 12-h light/dark cycle, receiving water and food ad libitum.
In the fi rst series of  experiments, two groups of  mice were used without any kind of  
pharmacological intervention: group 1 included D1R
+/+, D1R
-/+ and D1R
-/- mice; group 2 included 
D2R
+/+, D2R
-/- mice (n = 6 per genotype). The involvement of  D1 receptors was further investigated 
by analyzing the effects of  dopamine depletion in WT and D1R
-/- mice (n = 12 for each genotype). 
Half  of  these animals (n = 6 per genotype) were given the dopamine depleting drug reserpine (5 
mg/kg, i.p.) 18 h before the infusion of  the 13C label (group 3). The other half  (n = 6 per genotype) 
also received an intraperitoneal injection of  L-DOPA (50 mg/kg) combined with benserazide-
HCl (20 mg/kg), a DOPA-decarboxylase inhibitor, 18 h after reserpine administration and 60 min 
before the infusion of  the 13C label (group 4). This reserpine treatment protocol has previously been 
shown to lower striatal dopamine content by 81-96% and to produce changes in behaviour and in 
IEG expression (Day et al. 2006; Graybiel et al. 1990; LaHoste and Marshall 1992; Moratalla et al. 
1996b). Before the infusion of  the 13C label, the animals were deeply anesthetised by administering 
1-2% of  isofl urane in 1 liter/min O2 through a nose cap. Body temperature was maintained at 
approximately 37 ºC using a thermostatic blanket and a temperature-regulated circulating water 
bath, and it was measured with a rectal probe (Panlab, Barcelona, Spain). The physiological state 
of  the animal was monitored by a Biotrig physiological monitor (Bruker Medical Gmbh, Ettlingen, 
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Germany), measuring the respiratory rate and the body temperature. The right jugular vein was 
dissected and cannulated, and (1,2-13C2) acetate (0.24 µmol min
-1 g-1) was infused for 60 min. At the 
end of  this infusion, the head of  the animal was funnel-frozen, and perchloric acid extracts of  the 
brain, excluding the cerebellum, were prepared as described previously prior to high-resolution 13C 
NMR spectroscopy (Cerdán et al. 1990; Chapa et al. 1995)
3.2 13C NMR Spectroscopy
 High-resolution proton-decoupled 13C NMR spectra of  brain extracts were obtained at 
11.9 Tesla (125.13 MHz, 25 ºC, pH 7.2) with a Bruker AVANCE 500WB NMR spectrometer 
using a commercial (5 mm) triple-resonance probe (1H,13C,2H) optimized for direct 13C NMR 
detection. The acquisition conditions were: π/3 pulses; 30.0 kHz spectral width; 1.09 s acquisition 
time; 64k words data table; and 6.0 s recycling time. Proton decoupling was only gated during 
the acquisition using a broad-band composite pulse decoupling (CPD) sequence, and chemical 
shifts were calibrated with an external reference of  dioxane (10% vol/vol, 67.4 ppm). Resonance 
assignments were based on literature values and on the addition of  internal standards (Cerdán 
et al. 1990). Spectra deconvolution and multiplet structures were analyzed using the PC-based 
(Intel Centrino Platform) NMR program, NUTS™ (Acorn, Freemont, CA, USA). All 13C NMR 
resonance areas were normalized relative to the unchanged myo-inositol resonance areas of  the 
corresponding perchloric acid extracts. This was possible because myo-inositol had a low turnover 
and did not becoming enriched after the 60-min (1,2-13C2) acetate infusion, providing a robust 
internal reference from which all 13C resonances can be derived (Bouzier et al. 1998).
3.3 Behavioural Experiments (Motor Coordination, Rota-rod)
Motor coordination was measured using an accelerating rota-rod apparatus (Hugo Basile, Rome, 
Italy). Two groups of  adult mice were used, D1R
-/- and D1R
+/+ mice (n = 6 per group). On the fi rst 
day, the mice were subjected to a practice trial, placing the animal on the rota-rod without rotation 
for 60 seconds, followed by a 1-min period during which the rod rotated at a constant speed of  4 
r.p.m. After this, the mice were returned to their cages and 20 min later they were trained to use 
the rota-rod with six sessions of  5 min at a constant acceleration and with an interval of  20 min 
between trials. The following day, mice were tested on the accelerated rota-rod and the time to fall 
from the rod was measured, with a cut off  time established at 5 min. Animals were tested in basal 
conditions or 3 days after administration of  reserpine (5 mg/kg) or 30 minutes after L-DOPA 
administration (20 mg/kg) given 3 days after the reserpine.
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3.4 c-Fos Immunocytochemical Staining and Quantifi cation Experiments
At the end of  the experiments, animals were anaesthetized with pentobarbital and transcardially 
perfused with 4% paraformaldehyde in 0.1% phosphate buffer (PB), pH 7.4. After perfusion, the 
brains were dissected out and immersed overnight in the same fi xative solution. The brains were then 
cryoprotected in a solution of  30% sucrose for one day. Coronal brain sections (30 μm) throughout 
the striatal area were obtained on a slicing microtome (Leica, Madrid, Spain) and they were kept 
in PB solution at 4 ºC until use. Immunostaining was carried out on free-fl oating sections with 
a standard avidin-biotin immunocytochemical protocol previously described (Grande et al. 2004; 
Pavon et al. 2006; Rivera et al. 2002). Striatal sections were incubated overnight with specifi c c-Fos 
antisera (Chemicon, Temecula, CA, USA) and after three washes, the sections were incubated for 
two hours with the secondary antisera at room temperature. Peroxidase reactions were developed 
with 0.06% of  diaminobenzidine (DAB) in PB buffer containing 1% nickel ammonium sulphate 
and 5 µl of  H2O2, and the reaction was monitored every 5 min using an optical microscope. After 
being washed, the sections were mounted on gelatin-coated slides, air dried and dehydrated in 
ascending series of  ethanol, cleared with xylene, and coverslipped with Permount. Quantifi cation 
of  c-Fos striatal expression was performed with the aid of  an image analysis system (AIS, Imaging 
Research Inc., Linton, England) using a ×10 lens. Before counting, a standardized threshold was 
established in the images at the gray-scale level, empirically determined by two different observers, 
to permit the detection of  stained nuclei of  low to high intensity and to suppress the very lightly 
stained nuclei. Thus, the number of  positive nuclei for c-Fos was determined and expressed as 
number of  positive nuclei per µm. Counting was performed on fi ve sections from each animal and 
on three different mice. 
3.5 Statistical Analysis
Statistical analysis was performed using the SPSS package (SAS Institute Inc., Cary, NC, USA). 
The results are expressed as means ± standard deviation. When indicated, the statistical signifi cance 
of  the differences was assessed using the Student’s t-test. Statistical analysis for gene expression 
and motor coordination between mice of  different genotypes and drug treatments were performed 
by two-way ANOVA, followed by post-hoc Tukey’s test. The threshold for statistical signifi cance 
was set at P < 0.05.
3.6 Materials
Reserpine, L-DOPA, benserazide-HCl and d-amphetamine sulphate were obtained from Sigma-
Aldrich (Madrid, Spain). (1,2-13C2) acetate (99.9% 
13C) was obtained from Cambridge Isotope 
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Laboratories (Andover, MA, USA). 2H2O (99.9% 
2H) was obtained from Apollo Scientifi c Ltd. 
(Stockport, Cheshire, USA). All the other items were of  the highest purity available commercially 
from Sigma-Aldrich (Madrid, Spain).
4. Results
4.1 13C NMR Spectroscopy
High-resolution 13C NMR spectra from perchloric acid brain extracts from a homozygous 
mutant mouse (D1R
-/-, Figure 5.1-A) and from a wild type (D1R
+/+, Figure 5.1-B) were obtained 
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Figure 5.1. Representative proton-decoupled 13C NMR spectra (125.13 MHz, 25 oC, pH 7.2) of  neutralized 
perchloric acid brain extracts from D
1
R-/- (A) and D
1
R+/+ (B) mice infused with (1,2-13C
2
) acetate. Only 
the 20-40 ppm region is shown. Ac: acetate (C2: 24.2 ppm); GABA: γ-aminobutyric acid (C2: 35.1 ppm; C4: 40.4 
ppm); Glu: glutamate (C3: 27.7 ppm; C4: 34.2 ppm); Gln: glutamine (C3: 27.0 ppm; C4: 32.4 ppm); PPM: parts per 
million.
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sixty minutes after infusion of  (1,2-13C2) acetate. The spectra display different characteristics, 
indicating that the loss of  D1 receptor has signifi cant consequences on acetate metabolism in the 
brain. After (1,2-13C2) acetate infusion, glutamate, glutamine and GABA are labeled in different 
carbon positions depending on the metabolic pathways connecting these intermediates (Cerdán et 
al. 1990; Rodrigues and Cerdán 2005). Glutamate and glutamine (Glx) are both labeled contiguously 
at C-4 and C-5 during the fi rst turn of  the cycle, because these carbons are derived directly from 
a (1,2-13C2) acetyl-CoA precursor. It is readily apparent that mice lacking D1 dopamine receptors 
were characterized by a signifi cant increase in 13C incorporation into the cerebral glutamine C4 
resonance doublet when compared to the glutamate precursor C4 (dotted lines). 
The incorporation of  13C into the resonance doublet for cerebral glutamate C4 and glutamine 
C4 in the four different groups examined in our experiments and relative to the natural abundance 
of  13C inositol C1-C3 resonance is summarized in Figure 5.2. There were no detectable changes 
in glutamate C4 labeling, when both D1 and D2 receptor expression was genetically deleted. 
However, glutamine C4 labeling increased signifi cantly in D1R
-/- mice compared with the values 
obtained from the WT and heterozygous counterparts (group 1). In contrast, complete ablation of  
D2 receptors appeared to provoke only a small increase in the incorporation of  
13C in glutamine 
C4, although when both groups of  animals were compared this difference was not statistically 
signifi cant. Interestingly, heterozygous D1R
+/- mice exhibited 13C labeling patterns very similar to 
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Figure 5.2. Inactivation of  dopamine D
1
 receptors or dopamine depletion increases the incorporation 
of  13C from (1,2-13C
2
) acetate in (4,5-13C
2
) glutamine. Relative 13C incorporation in the doublet resonances of  
cerebral glutamine C4 (GlnC4d) and glutamate C4 (GluC4d) in (A) D1R
+/+, heterozygous D1R
+/- and D1R
-/- mice, 
under basal conditions or after treatment with reserpine (5 mg/kg), with or without subsequent exposure to L-
DOPA (50 mg/kg) and (B) in D2R
+/+ and D2R
-/- mice in basal conditions. Values represent the mean ± SD, n = 6 
animals per group. * Signifi cantly different from basal D1R
+/+ and heterozygous D1R
+/-, P < 0.003. Glx: Glutamate 
or glutamine.
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those observed in WT mice. This indicates that, at least, only half  of  the D1 receptors are suffi cient 
to account for a complete physiological response. To avoid uncertainties derived from incomplete 
receptor ablation, we restricted the rest of  the study to WT and D1R
-/- mice only. To confi rm these 
results, we adopted a complementary pharmacological approach using WT and D1R
-/- mice. Hence, 
a third group of  animals (group 3) was given reserpine, a dopamine-depleting drug, 18 h prior to 
infusion of  (1,2-13C2) acetate. This treatment resulted in an increase in glutamine C4 labeling in WT 
mice but not in glutamine C4 labeling in D1R
-/- mice. Indeed, both reserpine-treated WT and D1R
-
/- mice have values of  glutamine C4 labeling similar to those observed in D1R
-/- animals in basal 
conditions. The reserpine treatment in group 4 was supplemented with L-DOPA, administered in 
combination with benserazide, a DOPA-decarboylase inhibitor. With these conditions, we observed 
a reversion of  the effect of  reserpine on the pattern of  glutamine C4 labeling. Thus, WT mice 
exhibited values of  glutamine C4 labeling very similar to those obtained in untreated animals. In 
contrast, mice lacking the D1 dopamine receptor did not show signifi cant differences in glutamine 
C4 labeling following reserpine-plus-L-DOPA treatment when compared to the untreated D1R
-
/- animals or those treated with reserpine alone. Together, these results indicate that the effect of  
genetic ablation of  the D1 receptor can be mimicked by treatment with reserpine and reversed by 
L-DOPA.
4.2 Implication of  Dopamine and D
1
 Receptors in Motor Coordination
To test the infl uence of  dopaminergic activity through dopamine D1 receptors on motor 
coordination and to correlate this with our previous 13C NMR results, we used a rota-rod apparatus 
to analyze the behaviour of  the animals under the same conditions. Under basal conditions, WT 
mice quickly adapted to the accelerating rod, and most of  the mice reached the cutoff  time (300 s) 
on the rod (Figure 5.3). However, the D1R
-/- mice were unable to remain on the rod, and achieved 
an average latency time of  only 162 s. Reserpine administration signifi cantly reduced the time 
on the rod for both genotypes with an average permanence time of  32.1 and 34.5 s for WT and 
D1R
-/-, respectively (P < 0.001 vs. basal conditions). This reduction highlighted the relevance of  
dopaminergic activity in motor coordination. Finally, administration of  L-DOPA (20 mg/kg i.p.) 
reverted the effects of  reserpine in WT animals, increasing the latency time to normal values. 
However, while L-DOPA increased the latency time on the rod for D1R
-/- animals (from 34 to 128 
s), this increase did not completely restore motor coordination to the level of  WT mice. Indeed, 
the average time on the rod of  128 s for D1R
-/- animals after L-DOPA treatment was similar to 
the latency time obtained under basal condition (average 162 s, Figure 5.3). These results indicate 
that dopamine is necessary for proper motor coordination but that it is not suffi cient, insofar the 
integrity of  dopamine D1 receptors is critical for a complete motor function.
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4.3 Implication of  Dopamine and D
1
 Receptor in Neuronal Activity as Demonstrated 
by c-Fos Induction
To investigate dopaminergic function in the basal ganglia further and its correlation with the 
13C NMR parameters determined in the present study, we used c-Fos expression in the striatum 
as a readout of  neuronal activity (Hiroi et al. 2002; Moratalla et al. 1996a; Pavon et al. 2006). The 
c-Fos transcription factor is constitutively expressed in the basal ganglia, and it has been shown 
to be activated after dopaminergic stimulation (Grande et al. 2004; Pavon et al. 2006). Under basal 
conditions, WT mice displayed a low level of  c-Fos expression in the striatum and c-Fos-positive 
nuclei were homogeneously yet sparsely distributed throughout the caudoputamen. Inactivation 
of  dopamine D1 receptors caused a signifi cant decrease of  c-Fos expression in the striatum (P ≤ 
0.001, WT vs. D1R
-/-, Figure 5.4). Reserpine treatment signifi cantly diminished c-Fos expression in 
the caudoputamen of  WT mice but did not alter the already weak expression in D1R
-/- mice. This 
loss of  c-Fos in WT mice was mainly observed in the middle of  the caudoputamen. However, 
administering L-DOPA after reserpine treatment resulted in a signifi cant increase in c-Fos 
expression in WT but not in D1R
-/- mice, in which the level of  c-Fos expression was similar to 
those found in basal conditions, (P < 0,001, WT vs. D1R
-/- mice, Figure 5.4, Table 5.1). These results 
indicate that the constitutive c-Fos gene expression found in the caudoputamen of  WT mice was 
due to dopaminergic activity via D1 receptor activation, insofar as the absence of  dopamine or 
Figure 5.3. Inactivation of  dopamine D
1
 receptors or dopamine depletion impairs motor coordination. 
Histograms illustrating how the lack of  dopamine or the ablation of  D1R decreases the latency time of  mice on an 
accelerating rota-rod. Animals were tested in basal conditions or 3 days after 5 mg/kg of  reserpine, or 30 min after 
20 mg/kg of  L-DOPA administered 3 days after reserpine. Note that reserpine impairs motor coordination and 
that L-DOPA restores this impairment in WT but not in D1R
-/- mice. * P < 0.005 compared to WT and & P < 0.001 
compared to basal or reserpine plus L-DOPA treatment, Post-hoc Tukey’s test, n = 6.
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c-Fos expression in the striatum. Photomicrographs of  coronal sections from the striatum of  D1R+/+ and D1R-/- mice 
illustrating c-Fos expression under basal conditions (A, B), after treatment with 5 mg/kg of  reserpine (C, D) and 
reserpine plus 20 mg/kg of  L-DOPA (E, F). Note the constitutive expression of  c-Fos nuclei in D1R+/+ mice in 
basal conditions compared to D1R
-/-. Treatment with reserpine diminishes c-Fos expression and treatment with L-
DOPA restores c-Fos expression in the WT, but not in D1R
-/- animals. Bar represents 200 microns; Res: reserpine.
1.18**
3.12*
2.97**
3.11
13.71
9.92
±
±
±
WT D1R
-/-
TABLE 5.1. Quantification of c-Fos-positive nuclei expression per
 square millimeter†
Number of positive nucleus c-Fos
Basal conditions
Reserpine
Reserpine + L-DOPA
±
±
±
83.16
15.86
292.33
10.56
4.26***
24.61****
†Immunostained cell nuclei were counted in striatal sections from 3 different animals per 
group, 5 sections each. Data are expressed as mean of  c-fos-positive nuclei per mm2 (mean 
± SEM).
*P < 0.05 compared with basal condition in D1R-/-.
**P < 0.001 compared with WT mice.
***P < 0.001 compared with basal conditions in WT mice.
****P < 0.001 compared with reserpine and basal conditions in WT mice; post hoc Tukey test.
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dopamine D1 receptors signifi cantly reduced c-Fos expression. In summary, the decrease in c-Fos 
expression revealed diminished dopaminergic activity, and this correlated well with the increase in 
the (4,5-13C2) glutamine labeling and glutamatergic activity detected by 
13C NMR.
5. Discussion
Our results confi rm that an interaction exists between the dopaminergic and glutamatergic 
neurotransmission systems, demonstrating that functional D1 dopamine receptors are required for 
adequate glutamatergic neurotransmission. Based on the data presented in this study regarding 
the metabolism of  (1,2-13C2) acetate, we present an overview of  the neurometabolic interactions 
between the dopaminergic and glutamatergic or GABAergic systems (see Figure 5.5). In brain 
metabolism, (1,2-13C2) acetate is incorporated mainly through the glial compartment (Cruz and 
Cerdán 1999; Lebon et al. 2002; Waniewski and Martin 1998). The (4,5-13C2) glutamine produced by 
glutamine synthase, an enzyme exclusively found in glia, is exported to glutamatergic neurons. It is 
in these neurons that the neurotransmitter glutamate is stored in vesicles and eventually released to 
the synaptic cleft during the action potential. Synaptic glutamate is recaptured by the astrocytes and 
transformed into glutamine, completing the glutamate-glutamine cycle that supports glutamatergic 
neurotransmission. In GABAergic neurons, glial glutamate is transformed into GABA by the GABA 
decarboxylase isozymes, and it is eventually released following GABAergic stimulation. Released 
GABA is recaptured by astrocytes and inactivated through GABA transaminase and semialdehyde 
succinic dehydrogenase isozymes. Thus, astrocytic glutamate and glutamine play a crucial role 
during glutamatergic or GABAergic neurotransmission, providing a common metabolic precursor 
that supports both neurotransmission systems. 
The present study shows that the supporting role of  astrocytes can be further extended to the 
dopaminergic system, to which no direct metabolic links are immediately apparent to our knowledge. 
Dopaminergic neurons release dopamine to the synaptic cleft and this dopamine eventually binds 
to the postsynaptic dopamine D1 or D2 receptors. Our results show that D1R
-/- mice display 
signifi cant increases in (4,5-13C2) glutamine, revealing an increase in glutamine synthetase activity. 
Therefore, the question that arises is how a metabolic signal originating from the dopaminergic 
system, or the lack of  it, may trigger an astrocytic response involving the glutamatergic system 
or vice versa. There is evidence that dopamine D1 receptors are coexpressed with ionotropic and 
metabotropic NMDA receptors in the striatum (Landwehrmeyer et al. 1995). Moreover, functional 
protein-protein interactions between D1 and glutamate receptors have also been described. In 
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this environment, dopamine D1 receptors can physically interact with the NR1 or NR2A subunits 
of  NMDA receptors, modulating their activity (Lee et al. 2002; Pei et al. 2004; Salter 2003). The 
coactivation of  these two receptors stimulates protein synthesis, up-regulates the expression of  
the GluR1 receptor subunit, and increases the surface expression of  the GluR1 subunit of  AMPA 
receptors at synaptic sites (Smith et al. 2005). In addition, we have also demonstrated that the integrity 
of  D1 receptors is required for corticostriatal and hippocampal LTP (Centonze et al. 2003; Granado 
et al. in press), a phenomenon known to be dependent on glutamate receptors. Therefore, these 
two classes of  receptors could interact with each other to modulate glutamatergic or dopaminergic 
neurotransmission. In agreement with previous in vivo microdialysis studies, adaptive changes in 
(4,5-13C2) Glu
L-DOPA
(1,2-13C2) GABA
GABAERGIC
DOPAMINERGIC TERMINAL POSTSYNAPTIC MEMBRANE
GLUTAMATERGIC
ASTROCYTE (1,2-
13C2) Acetate
(4,5-13C2) Glu
GS
(4,5-13C2) Gln
(4,5-13C2) Gln
(4,5-13C2) Glu
L-DOPA
Dopamine
D1R
D2R
Reserpine
 (  DA Efflux)
+
Dopamine
+
TCAg
Figure 5.5. Neurometabolic interactions between glial cells and the glutamatergic, the GABAergic and 
the dopaminergic systems. Note that the interactions between the glutamatergic and GABAergic systems appear 
to involve transport and metabolism of  glutamate and GABA, whereas the dopaminergic interaction with the 
glutamatergic system is transmitted through D1 dopamine receptors. GABA: γ-aminobutyric acid; Gln: Glutamine; 
GS: Glutamine Synthase; Glu: Glutamate; TCAg: glial tricarboxylic acid cycle.
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the glutamatergic system have been observed in rats and in reserpinized mice, as in the present 
study, probably as a feedback mechanism to increase synaptic activity after lesion (Day et al. 2006; 
Jonkers et al. 2002; Meshul et al. 1999). Moreover, decreases in the level of  cerebral glutamate have 
been reported following dopaminergic treatments (Yamamoto and Davy 1992). In summary, the 
simultaneous presence of  dopamine D1 receptors in glutamatergic neurons in the cortex, or the 
coexpression of  D1 and glutamate receptors in the caudoputamen opens the possibility that these 
two neurotransmitter systems interact and infl uence each other. Thus, pathologic disturbances or 
genetic ablation of  either of  these partners can induce an increase in the activity of  the other in an 
attempt to reestablish normal synaptic activity. 
In the present study, we also correlated the in vivo neuronal glutamatergic activity defi ned in 13C 
labeling studies, with motor coordination and the expression of  markers of  neuronal activity in 
selected brain regions in wild-type mice, dopamine-depleted animals, and dopamine D1R
-/- mice. 
Our results show that dopamine depletion or inactivation of  dopamine D1 receptors in mice 
augments the activity of  the glutamine cycle, producing impairment in motor coordination and a 
signifi cant decrease in c-Fos expression in the striatum. Replacing dopamine in animals treated with 
reserpine by administering L-DOPA normalizes glutamatergic activity, motor coordination, and 
c-Fos activity in the striatum of  WT but not D1R
-/- mice. All these results suggest that the increase 
in glutamatergic activity that we found in dopamine-depleted animals or in D1R
-/- mice is inversely 
correlated with c-Fos expression and with motor coordination. Thus, we think that the increase in 
(4,5-13C2) glutamine, consistent with an increase in the activity of  the glutamine cycle, is the result 
of  a compensatory mechanism in the glutamatergic system to cope with the loss of  dopamine 
or D1R function. However, this increase in glutamatergic activity appears not to be suffi cient to 
restore normal motor coordination, as revealed by the rota-rod experiments, or normal c-Fos 
expression. On the other hand, we have found repeatedly over the years that D1R
-/- mice have 
enhanced horizontal motor activity (Centonze et al. 2003; Granado et al. in press.; Xu et al. 1994), a 
result that could refl ect the increased glutamatergic activity we report here. In addition, our results 
also show that the reduction in motor coordination observed in D1R
-/- mice further decreased after 
exposure to reserpine and it was restored by L-DOPA administration. These data clearly indicate 
that components of  the dopaminergic system besides D1 dopamine receptors are implicated in 
motor coordination. Among the components potentially implicated in this effect, the dopamine D2 
receptor appears most likely to be involved, because the lack of  D2 receptors in the mutant mice 
impairs motor activity (Baik et al, 1995; Kelly et al, 1998). Thus, the present results disclose novel 
implications of  the 13C NMR labeling patterns, revealing motor coordination or localized c-Fos 
expression. 
The results of  the present study invoke additional circumstances to be able to interpret the 13C 
NMR spectra of  brain metabolism in vivo and in vitro. A variety of  13C NMR studies have revealed 
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signifi cant alterations in glutamate and glutamine metabolism during neurodegenerative diseases, 
ischemia, or psychiatric disorders (Krystal et al. 2002; Lin et al. 2003; Pascual et al. 1998; Ross et 
al. 2003). Our work indicates that these alterations may include, embedded, the contributions of  
altered dopaminergic neurotransmission. Moreover, current therapeutic protocols for Parkinson’s 
disease are mainly based on substitution therapies with dopamine analogues or precursors such as L-
DOPA. Present results indicate that more adequate therapeutic regimes should also be considered, 
including the use of  inhibitors of  glutamatergic neurotransmission.
Finally, it is possible that the neurometabolic interactions of  the glutamatergic neurotransmission 
system not only involve the dopaminergic system, as disclosed in the present study, but additional 
neurotransmitters such as the cholinergic or serotoninergic systems. More experiments in this 
direction will be necessary, but it could be envisioned now, that strong coupling mechanisms 
may exist between the different neurotransmission systems and glial cells to ensure a coordinated 
response of  the brain under physiological or pathological conditions.
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1. Concluding Remarks
This thesis provides a novel interpretation of  cerebral metabolism and energetics based on 
the transcellular exchange of  monocarboxilates and reducing equivalents. I address the intra- 
and intercellular metabolism of  pyruvate and lactate, the subcellular compartmentation of  
the monocarboxylate pool and its interactions with the neuronal and glial TCA cycles or with 
glutamatergic neurotransmission. To investigate these topics appropriately, we implemented and 
validated a variety of  novel NMR approaches. Our experiments revealed that:
i) It is possible to investigate lactate recycling through the reversible LDH isozymes and 
monocarboxylate transporter of  the plasma membrane of  C6 cells in culture using a novel 
(13C,2H) NMR approach. Our methodology relies on the fact that the H2 hydrogen of  
intracellular lactate, in incubation media containing deuterium oxide, is rapidly exchanged by 
a deuteron in the LDH equilibrium, only in those lactate molecules that have passed through 
the cytosol. The methodology can be easily extended to other metabolites recycling between 
the intra- and extracellular spaces, as long as they present exchangeable hydrogens becoming 
deuterated only in one of  these spaces.
ii) Using different combinations of  glucose, lactate and pyruvate, we investigated the redox 
control of  glycolysis. Incubations with different proportions of  glucose and lactate revealed 
a competition between both substrates for the same intracellular pool of  NAD+. Lactate 
transport and equilibration is signifi cantly faster than glycolysis, limiting glycolytic fl ow 
at the GAPDH step through NAD+ depletion. Therefore, under conditions of  relative 
excess of  lactate over glucose concentration in the extracellular fl uid, lactate could become 
the preferred substrate. Our results revealed also the existence of  two kinetically different 
cytosolic pools of  pyruvate, one derived from glucose and the other from extracellular 
monocarboxylates.
iii) Our novel 1H NMR approaches allow the investigation of  the turnover of  the H2 hydrogen 
of  lactate. The advantages rely on the increased sensitivity as compared to 13C NMR and 
the possibility to avoid the use of  relatively expensive 13C labeled substrates. Even if  the 
13C labeled substrates are used, our method allows the simultaneous measurement of  the 
turnover of  the H2 hydrogen in 13C labeled and in 12C lactate molecules. This favourable 
circumstance provides a unique and robust method to investigate simultaneously 2H and 
13C isotopic effects on lactate turnover. In our hands, the presence of  13C did not alter the 
Chapter 6
134
kinetics of  the deuteration process. The edited 1H NMR method described herein, may be 
of  potential interest for in vivo studies of  lactate turnover, once it is relatively inexpensive 
and easy to implement.
iv) The fact that part of  the neuronal lactate may return to the extracellular fl uid rather than 
being metabolized, and that astrocytic lactate may recycle back from the extracellular fl uid 
to the astrocyte cytosol, could account in part for the transcellular exchange of  reducing 
equivalents and the non-stoichiometric relationship between glucose consumption and 
glutamate-glutamine cycling.
v) We investigated the kinetics of  glucose or lactate consumption and pyruvate production 
using primary cultures of  cortical neurons or astrocytes from rat brain. Glucose and lactate 
are demonstrated to be consumed competitively, the dominant substrate being determined 
by their relative extracellular concentrations, the corresponding kinetic constant and the 
relevant cytosolic redox states. In addition, our data also demonstrated that pyruvate is 
produced from lactate both in primary cultures of  neurons or glial cells, establishing a 
crucial link for the operation of  the redox coupling mechanism.
vi) Taken together, our conclusions provided the basis for a revised interpretation of  the 
mechanisms underlying neuroglial coupling during glutamatergic neurotransmission, the 
Redox Switch/Redox Coupling hypothesis. Neuroglial coupling is achieved through a 
reversible exchange of  reducing equivalents between neurons and astrocytes in the form 
of  lactate and pyruvate, rather than from the unidirectional transfer of  lactate molecules. 
The operation of  this transcellular redox coupling mechanism appears to rely ultimately in 
the regulation of  the intracellular redox states of  neurons and astrocytes and, consequently, 
being determined by the activity of  the corresponding intracellular redox shuttles through 
the inner mitochondrial membrane. Our proposal could well be extended to other 
heterogeneous tissues where oxidative and glycolytic environments coexist, such as muscle 
or tumors.
vii) Using 13C NMR spectroscopy of brain extracts of D1- or D2-defi cient mice, we established 
that the interaction between the dopaminergic and glutamatergic neurotransmission 
systems is mediated by the D1 dopamine receptors. Using a complementary pharmacological 
approach, consisting in the administration of  reserpine and L-DOPA to D1- defi cient and 
wild type mice, we show that: 1) reserpine-induced dopamine depletion increases the activity 
of  glutamate-glutamine cycle, yielding similar results to those obtained in D1R
-/- mice, and 2) 
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L-DOPA restored to normal values the glutamate-glutamine cycle. Furthermore, our results 
show that dopamine depletion or inactivation of  dopamine D1 receptors in mice produced 
impairment in motor coordination and a signifi cant decrease in c-Fos expression in the 
striatum. 
viii) Present results indicate that more adequate therapeutic regimes for Parkinson’s disease 
should include inhibitors of  glutamatergic neurotransmission. Moreover, the possibility 
exists that the neurometabolic interactions of  the glutamatergic neurotransmission system 
not only involve the dopaminergic system, but additional neurotransmitter systems such 
as the cholinergic or serotoninergic systems. In this context, it is now clearly envisioned 
that strong coupling mechanisms exist between the various neurotransmitter systems and 
glial cells, ensuring a coordinated response of  the brain under physiological or pathological 
conditions.
In summary, our work clarifi es some concepts of  current neurochemical knowledge. It 
emphasizes the operation of  transcellular pyruvate and lactate shuttling, the neuronal and glial 
TCA cycles, and glutamatergic activity and their respective bilateral and multilateral interactions. 
Multinuclear NMR Spectroscopy is demonstrated to be a useful and effective tool to investigate 
cerebral metabolism, revealing unique aspects not accessible to other more conventional techniques 
and opening new frontiers in the understanding of  cerebral metabolism and energetics.
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